TOKEN	PREDICTED
PubMed	O
Central	O
:	O

This	O
combination	O
of	O
interactive	O
pathways	O
helps	O
to	O
confer	O
efficiency	O
,	O
redundancy	O
,	O
robustness	O
and	O
fidelity	O
onto	O
epigenetic	O
re	O
-	O
programing	O
/	O
programing	O
during	O
development	O
,	O
and	O
thus	O
the	O
successful	O
and	O
continued	O
production	O
of	O
multiple	O
generations	O
.	O

Established	O
risk	O
factors	O
include	O
ionizing	O
radiation	O
and	O
a	O
few	O
genetic	O
syndromes	O
[	O
2	O
].	O

2	O
.	O

Furthermore	O
,	O
mean	O
LINE	O
-	O
1	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
;	O
however	O
,	O
limited	O
numbers	O
may	O
affect	O
our	O
precision	O
,	O
so	O
this	O
result	O
should	O
be	O
confirmed	O
in	O
further	O
analyses	O
.	O

Ad	O
libitum	O
access	O
to	O
food	O
and	O
water	O
was	O
provided	O
throughout	O
the	O
study	O
period	O
.	O

The	O
normality	O
of	O
the	O
data	O
was	O
evaluated	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

Although	O
most	O
drugs	O
do	O
not	O
harm	O
the	O
fetus	O
,	O
this	O
knowledge	O
is	O
incomplete	O
.	O

Vitamin	O
D	O
status	O
will	O
be	O
determined	O
by	O
measuring	O
total	O
25	O
-	O
Hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentrations	O
in	O
serum	O
using	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LCMSMS	O
)	O
[	O
72	O
].	O

Perceptions	O
of	O
antenatal	O
care	O
services	O
by	O
pregnant	O
women	O
attending	O
government	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
Cameroon	O
:	O
a	O
cross	O
sectional	O
study	O
Abstract	O
Introduction	O
User	O
'	O
sperception	O
of	O
quality	O
of	O
ANC	O
services	O
crucially	O
impacts	O
continuity	O
of	O
use	O
of	O
these	O
services	O
and	O
hence	O
pregnancy	O
outcome	O
.	O

no	O
.	O

The	O
same	O
report	O
estimated	O
that	O
up	O
to	O
2	O
kg	O
of	O
starch	O
/	O
d	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
of	O
dairy	O
cows	O
;	O
the	O
average	O
starch	O
digestibility	O
in	O
the	O
small	O
intestine	O
was	O
60	O
.	O
6	O
%.	O

The	O
risk	O
of	O
vitamin	O
D	O
insufficiency	O
was	O
significantly	O
lower	O
for	O
more	O
educated	O
women	O
and	O
for	O
persons	O
reporting	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

We	O
sequentially	O
excluded	O
12	O
women	O
with	O
early	O
pregnancy	O
losses	O
,	O
52	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
,	O
and	O
23	O
who	O
did	O
not	O
complete	O
the	O
interview	O
.	O

This	O
information	O
is	O
critical	O
for	O
the	O
design	O
of	O
future	O
intervention	O
trials	O
targeting	O
obesity	O
prevention	O
in	O
children	O
.	O

We	O
have	O
no	O
baseline	O
measure	O
of	O
symptom	O
levels	O
to	O
further	O
elucidate	O
causality	O
between	O
different	O
levels	O
of	O
intake	O
of	O
fatty	O
fish	O
or	O
shellfish	O
and	O
the	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Because	O
BDNF	O
may	O
be	O
differentially	O
expressed	O
in	O
specific	O
regions	O
of	O
the	O
hypothalamus	O
,	O
where	O
high	O
levels	O
are	O
present	O
in	O
the	O
ventromedial	O
hypothalamus	O
,	O
32the	O
relationship	O
between	O
BDNF	O
and	O
SeroR	O
is	O
unknown	O
from	O
whole	O
hypothalamus	O
in	O
our	O
study	O
.	O

By	O
self	O
-	O
selection	O
,	O
those	O
who	O
manifest	O
seasonal	O
allergies	O
may	O
choose	O
a	O
career	O
path	O
other	O
than	O
farming	O
(	O
i	O
.	O
e	O
.,	O
healthy	O
worker	O
effect	O
)	O
[	O
116	O
].	O

Maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
transfers	O
to	O
the	O
fetus	O
by	O
the	O
placenta	O
.	O

Several	O
studies	O
have	O
reported	O
that	O
early	O
weaning	O
or	O
early	O
weaning	O
combined	O
with	O
a	O
high	O
-	O
grain	O
diet	O
increases	O
IMF	O
deposition	O
in	O
beef	O
cattle	O
.	O

However	B
,	O
no	O
differences	O
in	O
body	O
weight	O
between	O
CC	O
and	O
RC	O
females	O
were	O
found	O
.	O

Moreover	O
,	O
the	O
outcomes	O
of	O
the	O
present	O
study	O
enhance	O
the	O
importance	O
of	O
the	O
periconceptional	O
period	O
as	O
well	O
as	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
the	O
early	O
life	O
programming	O
,	O
due	O
to	O
the	O
fact	O
that	O
the	O
maternal	O
undernutrition	O
was	O
implemented	O
before	O
mating	O
and	O
offspring	O
were	O
raised	O
in	O
an	O
ad	O
libitum	O
standard	O
feeding	O
.	O

Nonetheless	O
,	O
in	O
our	O
study	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
lower	O
depression	O
scores	O
after	O
intervention	O
.	O

Maximum	O
starch	O
utilization	O
can	O
be	O
achieved	O
by	O
optimizing	O
fermentation	O
of	O
starch	O
in	O
the	O
rumen	O
to	O
produce	O
propionate	O
(	O
gluconeogenic	O
precursor	O
)	O
and	O
maximizing	O
starch	O
digestion	O
and	O
absorption	O
in	O
the	O
small	O
intestine	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

Maternal	O
anthropometric	O
measurements	O
Maternal	O
weight	O
and	O
mid	O
-	O
upperarm	O
circumference	O
(	O
MUAC	O
)	O
are	O
obtained	O
at	O
each	O
phase	O
(	O
1	O
to	O
8	O
),	O
and	O
height	O
only	O
at	O
phase	O
1	O
and	O
5	O
.	O

[	O
14	O
]	O
assessed	O
vitamin	O
D	O
status	O
in	O
healthy	O
Thai	O
elderly	O
women	O
and	O
found	O
that	O
two	O
-	O
thirds	O
had	O
vitamin	O
D	O
insufficiency	O
and	O
one	O
-	O
third	O
had	O
vitamin	O
D	O
deficiency	O
.	O

To	O
examine	O
similarities	O
in	O
the	O
genomic	O
context	O
of	O
the	O
CpGs	O
making	O
up	O
these	O
data	O
-	O
driven	O
RPMM	O
classes	O
,	O
we	O
examined	O
the	O
proportion	O
of	O
CpG	O
loci	O
associated	O
with	O
specific	O
DNA	O
sequence	O
features	O
within	O
each	O
class	O
,	O
including	O
location	O
within	O
a	O
repetitive	O
element	O
(	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
Alu	O
,	O
or	O
MIR	O
),	O
within	O
a	O
CGI	O
,	O
or	O
having	O
the	O
associated	O
gene	O
considered	O
a	O
PcG	O
protein	O
target	O
gene	O
(	O
Figure	O
2	O
).	O

Increases	O
in	O
stress	O
were	O
related	O
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	O
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

On	O
the	O
third	O
day	O
postpartum	O
,	O
the	O
diagnosis	O
of	O
gestational	O
diabetes	O
insipidus	O
was	O
suspected	O
and	O
the	O
patient	O
was	O
started	O
on	O
intranasal	O
DDAVP	O
spray	O
5	O
mcg	O
twice	O
a	O
day	O
,	O
after	O
an	O
initial	O
dose	O
of	O
10	O
mcg	O
.	O

These	O
were	O
divided	O
into	O
four	O
categories	O
and	O
concerned	O
knowledge	O
of	O
general	O
dietary	O
recommendations	O
during	O
pregnancy	O
,	O
the	O
sources	O
of	O
nutrients	O
,	O
the	O
roles	O
of	O
nutrients	O
during	O
pregnancy	O
,	O
and	O
the	O
importance	O
of	O
breastfeeding	O
.	O

Then	O
,	O
preadipocytes	O
can	O
differentiate	O
during	O
the	O
finishing	O
stage	O
when	O
they	O
fill	O
with	O
lipid	O
to	O
grow	O
into	O
visible	O
marbling	O
by	O
hypertrophy	O
.	O

Carbohydrate	O
should	O
be	O
restricted	O
to	O
35	O
%–	O
40	O
%	O
of	O
calories	O
.	O

These	O
processes	O
are	O
complex	O
and	O
normal	O
development	O
is	O
dependent	O
on	O
several	O
factors	O
.	O

It	O
should	O
be	O
noted	O
here	O
that	O
the	O
interactions	O
presented	O
in	O
the	O
networks	O
are	O
not	O
specific	O
for	O
porcine	O
liver	O
tissue	O
,	O
as	O
the	O
database	O
contains	O
literature	O
from	O
many	O
different	O
research	O
areas	O
.	O

For	O
laryngeal	O
spasm	O
,	O
intubation	O
and	O
,	O
in	O
rare	O
cases	O
,	O
tracheotomy	O
may	O
be	O
necessary	O
.	O

Human	O
variability	O
It	O
is	O
known	O
that	O
different	O
strains	O
of	O
laboratory	O
animals	O
can	O
respond	O
very	O
differently	O
to	O
the	O
same	O
environmental	O
exposure	O
.	O

Rojroongwasonkul	O
et	O
al	O
.	O

Birth	O
by	O
Cesarean	O
Delivery	O
The	O
delivery	O
of	O
a	O
baby	O
by	O
cesarean	O
delivery	O
has	O
been	O
suggested	O
to	O
be	O
associated	O
with	O
increased	O
risk	O
of	O
allergies	O
and	O
atopic	O
diseases	O
in	O
the	O
child	O
,	O
most	O
probably	O
because	O
of	O
a	O
lower	O
bacterial	O
exposure	O
for	O
the	O
child	O
.	O

The	O
nail	O
plate	O
was	O
subsequently	O
reflected	O
back	O
into	O
place	O
.	O

In	O
addition	O
,	O
studies	O
within	O
categories	O
1	O
and	O
2	O
may	O
also	O
enable	O
the	O
identification	O
of	O
markers	O
and	O
/	O
or	O
mechanisms	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
through	O
a	O
weight	O
of	O
evidence	O
approach	O
(	O
e	O
.	O
g	O
.	O

We	O
will	O
randomly	O
select	O
100	O
clusters	O
with	O
an	O
equal	O
number	O
of	O
clusters	O
in	O
each	O
arm	O
.	O

Higher	O
percentage	O
of	O
calories	O
from	O
protein	O
early	O
in	O
pregnancy	O
(	O
OR	O
=	O
0	O
.	O
38	O
(	O
0	O
.	O
19	O
,	O
0	O
.	O
78	O
);	O
P	O
=	O
0	O
.	O
04	O
)	O
was	O
also	O
a	O
significant	O
predictor	O
of	O
reduced	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
at	O
6	O
months	O
.	O

Postnatal	O
assessments	O
focus	O
mainly	O
on	O
offspring	O
health	O
and	O
development	O
at	O
6	O
weeks	O
,	O
6	O
months	O
,	O
7	O
.	O
5	O
months	O
(	O
6	O
months	O
+	O
6	O
weeks	O
)	O
and	O
12	O
months	O
’	O
postnatal	O
age	O
.	O

We	O
selected	O
a	O
95	O
%	O
confidence	O
level	O
and	O
an	O
assumed	O
prevalence	O
of	O
supplement	O
use	O
of	O
50	O
%,	O
informed	O
by	O
other	O
studies	O
[	O
15	O
-	O
19	O
,	O
22	O
],	O
due	O
to	O
the	O
lack	O
of	O
prior	O
data	O
in	O
our	O
region	O
.	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

However	O
,	O
thyroid	O
cancer	O
in	O
young	O
people	O
has	O
generally	O
an	O
excellent	O
prognosis	O
,	O
and	O
survival	O
among	O
women	O
with	O
thyroid	O
cancer	O
diagnosed	O
during	O
pregnancy	O
may	O
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	B
it	O
was	O
found	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

For	O
example	O
,	O
after	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
was	O
53	O
%	O
(	O
95	O
%	O
CI	O
,	O
30	O
-	O
69	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
all	O
types	O
of	O
fish	O
and	O
seafood	O
3	O
-	O
4	O
times	O
per	O
week	O
,	O
and	O
55	O
%	O
(	O
95	O
%	O
CI	O
,	O
46	O
-	O
68	O
%)	O
lower	O
for	O
women	O
who	O
ate	O
white	O
fish	O
two	O
times	O
per	O
week	O
,	O
compared	O
to	O
women	O
who	O
never	O
ate	O
fish	O
and	O
seafood	O
or	O
white	O
fish	O
(	O
Figure1	O
).	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
calorict	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
transcription	O
factors	O
(	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
)	O
regulating	O
the	O
expression	O
of	O
genes	O
implicated	O
in	O
lipid	O
and	O
carbohydrate	O
metabolism	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure6	O
).	O

This	O
paper	O
was	O
limited	O
to	O
the	O
six	O
randomised	O
and	O
quasi	O
-	O
randomised	O
trials	O
(	O
listed	O
inTable	O
1	O
)	O
on	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
,	O
which	O
met	O
at	O
least	O
one	O
of	O
the	O
following	O
inclusion	O
criteria	O
:	O
(	O
i	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
ii	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
routine	O
-	O
intermittent	O
(	O
weekly	O
and	O
twice	O
weekly	O
)	O
regimens	O
;	O
(	O
iii	O
)	O
comparison	O
between	O
intermittent	O
oral	O
iron	O
or	O
ironfolic	O
acid	O
supplementation	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
iv	O
)	O
comparison	O
between	O
intravenous	O
route	O
versus	O
oral	O
route	O
of	O
iron	O
supplementation	O
;	O
(	O
v	O
)	O
comparison	O
between	O
food	O
fortification	O
with	O
iron	O
and	O
no	O
fortification	O
/	O
placebo	O
.	O

Recommendations	O
are	O
individualized	O
after	O
a	O
dietary	O
assessment	O
of	O
each	O
patient	O
.	O

Discussion	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
that	O
occurs	O
in	O
4	O
out	O
of	O
100	O
,	O
000	O
pregnancies	O
as	O
discussed	O
by	O
Durr	O
[	O
1	O
].	O

All	O
nutrient	O
values	O
were	O
energy	O
-	O
adjusted	O
using	O
the	O
residuals	O
method	O
.	O

Cathelicidin	O
concentration	O
in	O
the	O
deficient	O
group	O
did	O
not	O
correlate	O
with	O
percent	O
fat	O
,	O
BMI	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
prior	O
to	O
delivery	O
,	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
,	O
child	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
,	O
or	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
.	O

Increased	O
age	O
and	O
male	O
gender	O
were	O
correlated	O
with	O
increased	O
cathelicidin	O
when	O
controlling	O
for	O
race	O
/	O
ethnicity	O
,	O
percent	O
fat	O
,	O
and	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
p	O
=	O
0	O
.	O
028	O
&	O
p	O
=	O
0	O
.	O
047	O
,	O
respectively	O
).	O

However	O
,	O
it	O
must	O
be	O
borne	O
in	O
mind	O
that	O
a	O
proportion	O
of	O
children	O
who	O
develop	O
atopic	O
manifestations	O
in	O
the	O
first	O
years	O
of	O
life	O
come	O
from	O
families	O
in	O
which	O
neither	O
parents	O
nor	O
siblings	O
are	O
atopic	O
.	O

In	O
recent	O
times	O
,	O
when	O
food	O
has	O
become	O
cheaper	O
and	O
more	O
widely	O
available	O
,	O
excessive	O
WAT	O
storage	O
contributed	O
to	O
the	O
worldwide	O
alarming	O
development	O
of	O
obesity	O
mentioned	O
above	O
(	O
World	O
Health	O
Organization	O
,	O
2009	O
).	O

For	O
example	O
,	O
glioma	O
risk	O
is	O
greater	O
for	O
males	O
than	O
females	O
[	O
2	O
],	O
yet	B
the	O
pattern	O
of	O
seasonal	O
influence	O
upon	O
handedness	O
does	O
not	O
vary	O
significantly	O
between	O
females	O
and	O
males	O
[	O
177	O
].	O

As	O
far	O
as	O
the	O
vacancy	O
status	O
is	O
concerned	O
,	O
almost	O
33	O
.	O
9	O
%,	O
35	O
%,	O
7	O
.	O
1	O
%,	O
and	O
7	O
.	O
2	O
%	O
of	O
CDPOs	O
,	O
Supervisors	O
,	O
Anganwadi	O
workers	O
and	O
Anganwadi	O
helpers	O
posts	O
are	O
still	O
vacant	O
in	O
the	O
country	O
.	O

Antihistamines	O
should	O
be	O
avoided	O
if	O
possible	O
,	O
but	O
if	O
required	O
,	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
may	O
be	O
used	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Frequency	O
of	O
distribution	O
of	O
health	O
topics	O
discussed	O
during	O
ANC	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
P	O
-	O
Value	O
of	O
the	O
different	O
service	O
satisfaction	O
rating	O
with	O
respect	O
to	O
the	O
educational	O
level	O
in	O
the	O
study	O
populationServicesFisher	O
'	O
s	O
exact	O
testp	O
-	O
valueReception0	O
.	O
091P	O
>	O
O	O
.	O
O5Sitting	O
area	O
comfort0	O
.	O
842Waiting	O
time4	O
.	O
357Staff	O
rapport1	O
.	O
838Competence	O
of	O
personnel0	O
.	O
672Health	O
talks5	O
.	O
43	O
Pregnancy	O
groups	O
There	O
was	O
a	O
statistically	O
significant	O
association	O
when	O
comparing	O
respondents	O
at	O
their	O
first	O
pregnancy	O
with	O
those	O
at	O
their	O
second	O
or	O
more	O
pregnancies	O
in	O
terms	O
of	O
their	O
satisfaction	O
ratings	O
;	O
the	O
sitting	O
area	O
comfort	O
(	O
F	O
=	O
7	O
.	O
052	O
;	O
P	O
=	O
0	O
.	O
04	O
),	O
competence	O
of	O
staff	O
(	O
F	O
=	O
8	O
.	O
92	O
,	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
health	O
talk	O
comprehensiveness	O
(	O
F	O
=	O
18	O
.	O
499	O
,	O
P	O
Number	O
of	O
Visits	O
at	O
the	O
time	O
of	O
study	O
There	O
was	O
no	O
statistically	O
significant	O
difference	O
when	O
the	O
service	O
rating	O
(	O
reception	O
,	O
sitting	O
area	O
comfort	O
,	O
waiting	O
time	O
,	O
staff	O
rapport	O
,	O
competence	O
of	O
personnel	O
and	O
health	O
talk	O
)	O
of	O
women	O
attending	O
their	O
second	O
visit	O
and	O
those	O
attending	O
subsequent	O
visits	O
was	O
compared	O
.	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

The	O
rationale	O
for	O
this	O
combination	O
is	O
to	O
meet	O
increased	O
folic	O
acid	O
requirements	O
in	O
pregnancy	O
brought	O
about	O
by	O
the	O
rapidly	O
dividing	O
cells	O
in	O
the	O
fetus	O
and	O
elevated	O
urinary	O
losses	O
[	O
7	O
].	O

Hypocalcemia	O
has	O
also	O
been	O
shown	O
to	O
occur	O
in	O
exclusively	O
breast	O
fed	O
babies	O
not	O
exposed	O
to	O
sunlight	O
and	O
in	O
infants	O
whose	O
mothers	O
are	O
deficient	O
in	O
vitamin	O
D	O
.[	O
1	O
]	O
Symptoms	O
of	O
hypocalcemia	O
in	O
children	O
include	O
lethargy	O
,	O
recurrent	O
respiratory	O
tract	O
infections	O
,	O
focal	O
clonic	O
seizures	O
,	O
jitteriness	O
,	O
carpopedal	O
spasm	O
and	O
rarely	O
stridor	O
due	O
to	O
laryngospasm	O
.	O

The	O
predominant	O
substrate	O
for	O
FA	O
synthesis	O
in	O
ruminants	O
is	O
acetate	O
,	O
which	O
is	O
mainly	O
derived	O
from	O
ruminal	O
fermentation	O
.	O

The	O
cattle	O
with	O
a	O
TT	O
genotype	O
(	O
approximately	O
6	O
.	O
15	O
%)	O
that	O
were	O
not	O
supplemented	O
with	O
vitamin	O
A	O
had	O
22	O
.	O
9	O
%	O
greater	O
IMF	O
compared	O
with	O
those	O
with	O
the	O
CC	O
genotype	O
(	O
approximately	O
4	O
.	O
95	O
%).	O

Lower	O
levels	O
of	O
PUFA	O
have	O
been	O
found	O
in	O
brain	O
content	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblast	O
among	O
patients	O
with	O
schizophrenia	O
,	O
compared	O
with	O
a	O
healthy	O
population	O
[	O
13	O
,	O
16	O
].	O

Differently	O
from	O
what	O
is	O
observed	O
in	O
other	O
pregnancy	O
-	O
associated	O
cancers	O
,	O
no	O
metastasis	O
of	O
DTC	O
to	O
placenta	O
or	O
foetus	O
has	O
been	O
reported	O
.	O

DNA	O
methylation	O
involves	O
the	O
addition	O
of	O
a	O
methyl	O
group	O
,	O
primarily	O
to	O
the	O
C5	O
of	O
cytosine	O
within	O
cytosine	O
–	O
phosphate	O
–	O
guanine	O
dinucelotides	O
(	O
CpGs	O
)	O
to	O
produce	O
5	O
-	O
methylcytosine	O
(	O
5mC	O
).	O

Indeed	O
,	O
over	O
the	O
last	O
decade	O
,	O
the	O
previous	O
gene	O
-	O
centric	O
dogma	O
,	O
central	O
to	O
molecular	O
biology	O
,	O
has	O
been	O
shown	O
to	O
be	O
incorrect	O
.	O

Fructose	O
,	O
which	O
is	O
a	O
major	O
component	O
of	O
added	O
sugars	O
,	O
and	O
is	O
present	O
naturally	O
in	O
fruit	O
juice	O
and	O
in	O
sweetened	O
drinks	O
as	O
added	O
sucrose	O
(	O
ratio	O
of	O
fructose	O
/	O
glucose	O
50	O
/	O
50	O
%)	O
or	O
isolated	O
fructose	O
,	O
has	O
been	O
mooted	O
as	O
driving	O
previous	O
cross	O
-	O
sectional	O
findings	O
linking	O
sugar	O
-	O
containing	O
beverage	O
consumption	O
to	O
asthma	O
in	O
children	O
[	O
7	O
,	O
8	O
].	O

Including	O
all	O
piglets	O
derived	O
from	O
the	O
complete	O
experiment	O
,	O
LP	O
offspring	O
was	O
growth	O
-	O
restricted	O
compared	O
to	O
AP	O
offspring	O
,	O
but	O
litter	O
size	O
did	O
not	O
differ	O
[	O
15	O
].	O

The	O
aim	O
is	O
to	O
achieve	O
normoglycemia	O
whilst	O
providing	O
the	O
required	O
nutrients	O
for	O
normal	O
fetal	O
growth	O
and	O
maternal	O
health	O
.	O

The	O
overall	O
client	O
satisfaction	O
was	O
compared	O
with	O
the	O
different	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
respondents	O
(	O
Table	O
4	O
).	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

Another	O
possible	O
explanation	O
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

Briefly	O
,	O
high	O
-	O
quality	O
forage	O
is	O
fed	O
ad	O
libitum	O
to	O
develop	O
the	O
rumen	O
during	O
the	O
growing	O
stage	O
(	O
7	O
to	O
12	O
months	O
of	O
age	O
),	O
and	O
the	O
concentrate	O
(	O
CP	O
15	O
%	O
to	O
16	O
%,	O
TDN	O
69	O
%	O
to	O
70	O
%)	O
is	O
restricted	O
to	O
1	O
.	O
5	O
%	O
to	O
1	O
.	O
6	O
%	O
of	O
body	O
weight	O
at	O
this	O
time	O
.	O

Investigators	O
have	O
shown	O
that	O
self	O
-	O
reported	O
snoring	O
correlates	O
well	O
with	O
objective	O
findings	O
from	O
nocturnal	O
polysomnography	O
,	O
especially	O
in	O
frequent	O
snorers	O
[	O
40	O
].	O

Certain	O
foods	O
and	O
the	O
chemicals	O
contained	O
in	O
these	O
foods	O
may	O
be	O
more	O
or	O
less	O
available	O
at	O
particular	O
times	O
of	O
the	O
year	O
due	O
to	O
crop	O
cycles	O
,	O
storage	O
capability	O
,	O
transportation	O
access	O
,	O
and	O
cost	O
;	O
and	O
the	O
use	O
of	O
preservatives	O
in	O
foods	O
also	O
may	O
vary	O
accordingly	O
.	O

However	O
,	O
routine	O
vitamin	O
D	O
supplementation	O
did	O
not	O
occur	O
during	O
the	O
time	O
period	O
the	O
women	O
in	O
the	O
current	O
study	O
were	O
recruited	O
.	O

After	O
staining	O
and	O
washing	O
steps	O
the	O
arrays	O
were	O
scanned	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

Results	O
were	O
expressed	O
as	O
fold	O
-	O
change	O
by	O
the	O
2	O
−	O
ΔΔCTmethod15and	O
analyzed	O
using	O
ABI	O
DataAssist	O
software	O
version	O
3	O
.	O
0	O
(	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
).	O

Pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
calculated	O
as	O
weight	O
in	O
kilograms	O
divided	O
by	O
height	O
in	O
meters	O
squared	O
.	O

To	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
preterm	O
delivery	O
from	O
15	O
%	O
in	O
control	O
compared	O
to	O
10	O
.	O
5	O
%	O
in	O
the	O
intervention	O
arm	O
,	O
assuming	O
80	O
%	O
power	O
,	O
5	O
%	O
level	O
of	O
significance	O
,	O
intracluster	O
correlation	O
of	O
0	O
.	O
012	O
for	O
small	O
birth	O
size	O
(	O
Bangladesh	O
DHS	O
data	O
),	O
would	O
require	O
a	O
sample	O
size	O
of	O
1300	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
64	O
clusters	O
.	O

Women	O
at	O
their	O
first	O
pregnancy	O
and	O
those	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
more	O
likely	O
to	O
be	O
unsatisfied	O
with	O
the	O
ANC	O
services	O
they	O
received	O
at	O
their	O
attending	O
health	O
centres	O
.	O

Also	O
,	O
vitamin	O
D	O
supplements	O
were	O
used	O
by	O
almost	O
half	O
of	O
the	O
women	O
but	O
most	O
(	O
88	O
%)	O
used	O
multivitamins	O
containing	O
5	O
–	O
10	O
μg	O
of	O
vitamin	O
D3	O
.	O

When	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
models	O
,	O
no	O
significant	O
relationship	O
between	O
any	O
of	O
the	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
and	O
cathelicidin	O
was	O
found	O
.	O

†	O
Studies	O
validating	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
.	O

Early	O
weaned	O
-	O
animals	O
showed	O
lighter	O
final	O
body	O
weight	O
,	O
and	O
tended	O
to	O
eat	O
less	O
than	O
conventionally	O
weaned	O
-	O
animals	O
.	O

Previous	O
findings	O
from	O
the	O
GraviD	O
study	O
show	O
lower	O
odds	O
of	O
preeclampsia	O
among	O
women	O
with	O
a	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
in	O
25OHD	O
[	O
3	O
].	O

Pre	O
-	O
intervention	O
,	O
only	O
one	O
of	O
the	O
91	O
women	O
with	O
GDM	O
seen	O
received	O
≥	O
1	O
dietetic	O
follow	O
-	O
up	O
appointment	O
.	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

3	O
.	O

All	O
the	O
studies	O
shown	O
here	O
demonstrated	O
associations	O
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
age	O
was	O
33	O
.	O
4	O
±	O
4	O
.	O
1	O
years	O
old	O
(	O
ranges	O
from	O
24	O
to	O
46	O
years	O
old	O
),	O
the	O
gestational	O
weeks	O
were	O
29	O
.	O
0	O
±	O
3	O
.	O
3	O
weeks	O
(	O
ranges	O
from	O
14	O
to	O
39	O
weeks	O
),	O
pre	O
-	O
pregnancy	O
BMI	O
was	O
23	O
.	O
0	O
±	O
3	O
.	O
7	O
(	O
ranges	O
from	O
15	O
.	O
6	O
to	O
37	O
.	O
2	O
)	O
kg	O
/	O
m2	O
.	O

However	O
,	O
there	O
were	O
elements	O
of	O
dissatisfaction	O
with	O
health	O
centre	O
services	O
,	O
poor	O
sitting	O
facilities	O
,	O
amenities	O
,	O
few	O
health	O
education	O
talks	O
and	O
poor	O
nursing	O
skills	O
.	O

Quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
First	O
-	O
strand	O
cDNA	O
was	O
synthesized	O
from	O
2	O
μg	O
of	O
total	O
RNA	O
(	O
n	O
=	O
14	O
per	O
diet	O
and	O
stage	O
)	O
using	O
random	O
primers	O
and	O
oligo	O
d	O
(	O
T	O
)	O
13VN	O
in	O
the	O
presence	O
of	O
Superscript	O
III	O
reverse	O
transcriptase	O
(	O
Invitrogen	O
,	O
Karlsruhe	O
,	O
Germany	O
).	O

The	O
FFQ	O
lacked	O
quantitative	O
information	O
on	O
soft	O
drink	O
consumption	O
and	O
this	O
will	O
have	O
led	O
to	O
underestimation	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
.	O

A	O
possible	O
connection	O
between	O
fetal	O
sex	O
,	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
complications	O
reveals	O
further	O
questions	O
and	O
encourages	O
continual	O
research	O
and	O
discussion	O
into	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
,	O
particularly	O
in	O
vitamin	O
D	O
replete	O
populations	O
.	O

Because	O
the	O
risk	O
of	O
developing	O
GDM	O
gradually	O
increases	O
in	O
overweight	O
and	O
obese	O
women	O
,	O
the	O
total	O
sample	O
was	O
divided	O
into	O
three	O
pre	O
-	O
pregnancy	O
BMI	O
groups	O
for	O
comparison	O
:	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
BMI	O
≥	O
25	O
kg	O
/	O
m2and	O
<	O
30	O
kg	O
/	O
m2and	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
.	O

Likewise	O
,	O
pharmaceutical	O
drug	O
-	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
has	O
also	O
been	O
reported	O
.	O

Furthermore	O
,	O
the	O
dietary	O
modifications	O
led	O
to	O
regulation	O
of	O
the	O
'	O
Wnt	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
involved	O
in	O
various	O
aspects	O
of	O
embryogenesis	O
,	O
including	O
cell	O
differentiation	O
and	O
cell	O
proliferation	O
[	O
38	O
].	O

The	O
activity	O
of	O
glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
,	O
a	O
biomarker	O
for	O
adipogenesis	O
,	O
decreases	O
in	O
bovine	O
preadipocytes	O
cultured	O
with	O
retinol	O
[	O
129	O
].	O

Feeding	O
high	O
-	O
oil	O
corn	O
(	O
1	O
.	O
3	O
%	O
more	O
total	O
lipid	O
than	O
typical	O
corn	O
)	O
enhanced	O
IMF	O
deposition	O
in	O
predominantly	O
Angus	O
finishing	O
crossbred	O
steers	O
[	O
94	O
].	O

The	O
goals	O
and	O
principles	O
of	O
management	O
for	O
acute	O
and	O
chronic	O
asthma	O
,	O
rhinitis	O
,	O
and	O
dermatologic	O
disorders	O
are	O
the	O
same	O
during	O
pregnancy	O
as	O
those	O
for	O
asthma	O
in	O
the	O
general	O
population	O
.	O

Maternal	O
skin	O
prick	O
tests	O
are	O
performed	O
by	O
a	O
medical	O
doctor	O
according	O
to	O
the	O
procedure	O
described	O
in	O
the	O
Allergy	O
Society	O
of	O
South	O
Africa	O
’	O
s	O
position	O
statement	O
on	O
skin	O
prick	O
testing	O
[	O
49	O
].	O

In	O
our	O
setting	O
,	O
family	O
planning	O
and	O
care	O
of	O
the	O
newborn	O
are	O
usually	O
discussed	O
in	O
Infant	O
Welfare	O
Clinic	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
the	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
(	O
Table	O
3	O
).	O

Study	O
has	O
found	O
that	O
the	O
prevalence	O
of	O
Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
66	O
–	O
96	O
%	O
[	O
7	O
].	O

Maternal	O
diet	O
was	O
assessed	O
by	O
self	O
-	O
report	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
it	O
is	O
possible	O
that	O
dietary	O
patterns	O
change	O
near	O
the	O
end	O
of	O
pregnancy	O
or	O
during	O
lactation	O
.	O

Treatment	O
of	O
reflux	O
during	O
pregnancy	O
should	O
focus	O
on	O
nonpharmacological	O
measures	O
,	O
such	O
as	O
avoiding	O
large	O
meals	O
shortly	O
before	O
bedtime	O
,	O
sleeping	O
with	O
the	O
upper	O
body	O
elevated	O
,	O
and	O
avoiding	O
extensive	O
consumption	O
of	O
coffee	O
,	O
sweets	O
,	O
and	O
fatty	O
foods	O
.	O

South	O
Africa	O
has	O
large	O
economic	O
disparities	O
and	O
20	O
%	O
of	O
the	O
population	O
are	O
living	O
in	O
extreme	O
poverty	O
,	O
indicating	O
they	O
cannot	O
afford	O
the	O
minimum	O
required	O
food	O
intake	O
[	O
17	O
].	O

Thus	O
,	O
the	O
impact	O
of	O
early	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
needs	O
confirmation	O
in	O
a	O
larger	O
scale	O
trial	O
.	O

studied	O
the	O
association	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
antenatal	O
depression	O
.	O

Thus	O
,	O
genes	O
and	O
pathways	O
identified	O
as	O
regulated	O
in	O
one	O
offspring	O
group	O
were	O
either	O
unregulated	O
or	O
showed	O
an	O
opposite	O
direction	O
of	O
regulation	O
in	O
the	O
corresponding	O
ontogenetic	O
period	O
within	O
the	O
other	O
dietary	O
group	O
.	O

Additionally	O
,	O
the	O
discordance	O
of	O
handedness	O
in	O
twin	O
studies	O
illustrates	O
that	O
genetics	O
alone	O
cannot	O
explain	O
the	O
development	O
of	O
handedness	O
[	O
202	O
–	O
207	O
].	O

Alternately	O
,	O
any	O
reduction	O
in	O
cellular	O
energetics	O
within	O
this	O
region	O
may	O
delay	O
the	O
integration	O
of	O
cortical	O
and	O
/	O
or	O
sub	O
-	O
cortical	O
inputs	O
.	O

On	O
the	O
other	O
hand	O
,	O
cytokines	O
are	O
messengers	O
produced	O
by	O
immune	O
cells	O
which	O
affect	O
all	O
tissues	O
,	O
including	O
brain	O
.	O

Those	O
interested	O
,	O
receive	O
a	O
study	O
information	O
leaflet	O
and	O
are	O
screened	O
for	O
eligibility	O
individually	O
in	O
a	O
private	O
space	O
upon	O
which	O
a	O
booking	O
date	O
is	O
supplied	O
if	O
eligible	O
.	O

In	O
addition	O
,	O
nutritional	O
restriction	O
during	O
early	O
and	O
mid	O
gestation	O
reduced	O
ovarian	O
characteristics	O
(	O
wet	O
ovary	O
weight	O
,	O
luteal	O
tissue	O
weight	O
)	O
of	O
heifers	O
,	O
indicating	O
negative	O
effects	O
of	O
fetal	O
programming	O
on	O
productive	O
efficiency	O
of	O
replacement	O
heifers	O
.	O

Canaries	O
in	O
the	O
Uranium	O
Mines	O
The	O
arrival	O
of	O
prospectors	O
signified	O
the	O
Navajo	O
Nation	O
’	O
s	O
entrance	O
into	O
the	O
modern	O
wage	O
economy	O
.	O
7Some	O
welcomed	O
the	O
potential	O
income	O
.	O

It	O
is	O
important	O
to	O
continue	O
supplementing	O
non	O
-	O
human	O
models	O
with	O
human	O
-	O
derived	O
data	O
,	O
incorporating	O
new	O
technologies	O
to	O
maximize	O
data	O
collection	O
,	O
and	O
updating	O
and	O
re	O
-	O
evaluating	O
current	O
conclusions	O
as	O
novel	O
information	O
becomes	O
available	O
.	O

The	O
selective	O
knock	O
-	O
out	O
of	O
SIRT1	O
in	O
hypothalamic	O
AgRP	O
neurons	O
diminished	O
response	O
to	O
hunger	O
-	O
inducing	O
hormone	O
ghrelin	O
,	O
reduced	O
food	O
intake	O
,	O
consequently	O
causing	O
decreased	O
lean	O
mass	O
and	O
body	O
weight	O
(	O
23	O
).	O

Methods	O
The	O
methods	O
and	O
primary	O
clinical	O
findings	O
of	O
the	O
LIMIT	O
randomised	O
trial	O
have	O
been	O
published	O
[	O
21	O
–	O
23	O
],	O
with	O
the	O
trial	O
registered	O
on	O
the	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

This	O
usually	O
means	O
the	O
commencement	O
of	O
insulin	O
.	O

The	O
effectiveness	O
of	O
calcium	O
supplementation	O
on	O
prevention	O
of	O
perinatal	O
depression	O
has	O
been	O
shown	O
in	O
a	O
previous	O
study	O
[	O
65	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
vitamin	O
D	O
status	O
in	O
pregnancy	O
with	O
birth	O
size	O
and	O
pregnancy	O
loss	O
(	O
adjusted	O
logistic	O
regression	O
analysis	O
)	O
Small	O
for	O
gestational	O
ageaPreterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
bLow	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
cPregnancy	O
lossdORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
ORCI	O
95	O
%	O
T1	O
25OHDe	O
Continuous	O
nmol	O
/	O
L1	O
.	O
0030	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9960	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
9990	O
.	O
99	O
–	O
1	O
.	O
010	O
.	O
989	O
*	O
0	O
.	O
98	O
–	O
1	O
.	O
00	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
91	O
.	O
0780	O
.	O
44	O
–	O
2	O
.	O
661	O
.	O
6470	O
.	O
63	O
–	O
4	O
.	O
332	O
.	O
5490	O
.	O
88	O
–	O
7	O
.	O
381	O
.	O
0300	O
.	O
44	O
–	O
2	O
.	O
41	O
50	O
–	O
74	O
.	O
91	O
.	O
6320	O
.	O
69	O
–	O
3	O
.	O
851	O
.	O
2600	O
.	O
47	O
–	O
3	O
.	O
362	O
.	O
2870	O
.	O
77	O
–	O
6	O
.	O
830	O
.	O
6880	O
.	O
29	O
–	O
1	O
.	O
62	O
75	O
–	O
99	O
-	O
91	O
.	O
2920	O
.	O
51	O
–	O
3	O
.	O
271	O
.	O
3320	O
.	O
48	O
–	O
3	O
.	O
731	O
.	O
6650	O
.	O
51	O
–	O
5	O
.	O
490	O
.	O
8090	O
.	O
33	O
–	O
1	O
.	O
96	O
≥	O
1001	O
.	O
2940	O
.	O
38	O
–	O
4	O
.	O
420	O
.	O
5020	O
.	O
09	O
–	O
2	O
.	O
721	O
.	O
2550	O
.	O
22	O
–	O
7	O
.	O
270	O
.	O
000fT3	O
25OHDe	O
<	O
30	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
30	O
–	O
49	O
.	O
90	O
.	O
7710	O
.	O
34	O
–	O
1	O
.	O
750	O
.	O
3020	O
.	O
08	O
–	O
1	O
.	O
140	O
.	O
071	O
*	O
0	O
.	O
01	O
–	O
0	O
.	O
63	O
50	O
–	O
74	O
.	O
90	O
.	O
6230	O
.	O
27	O
–	O
1	O
.	O
450	O
.	O
9330	O
.	O
31	O
–	O
2	O
.	O
790	O
.	O
5840	O
.	O
17	O
–	O
1	O
.	O
98	O
75	O
–	O
99	O
-	O
90	O
.	O
6570	O
.	O
27	O
–	O
1	O
.	O
610	O
.	O
6140	O
.	O
18	O
–	O
2	O
.	O
140	O
.	O
2370	O
.	O
06	O
–	O
1	O
.	O
01	O
≥	O
1000	O
.	O
318	O
*	O
0	O
.	O
11	O
–	O
0	O
.	O
900	O
.	O
4460	O
.	O
11	O
–	O
1	O
.	O
760	O
.	O
215	O
*	O
0	O
.	O
05	O
–	O
0	O
.	O
97Δ25OHDg	O
Large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
(	O
ref	O
)	O
1	O
.	O
01	O
.	O
01	O
.	O
0	O
Small	O
increase	O
(	O
0	O
–	O
30	O
nmol	O
/	O
L	O
)	O
2	O
.	O
564	O
*	O
1	O
.	O
16	O
–	O
5	O
.	O
672	O
.	O
905	O
*	O
1	O
.	O
01	O
–	O
8	O
.	O
343	O
.	O
1220	O
.	O
97	O
–	O
10	O
.	O
09	O
Decrease	O
(<	O
0	O
nmol	O
/	O
L	O
)	O
3	O
.	O
679	O
**	O
1	O
.	O
60	O
–	O
8	O
.	O
442	O
.	O
8940	O
.	O
95	O
–	O
8	O
.	O
854	O
.	O
722	O
*	O
1	O
.	O
37	O
–	O
16	O
.	O
28	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
*	O
p	O
<	O
0	O
.	O
05	O
**	O
p	O
<	O
0	O
.	O
01	O
aModels	O
include	O
92	O
(	O
T1	O
)	O
and	O
80	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
small	O
for	O
gestational	O
age	O
bModels	O
include	O
77	O
(	O
T1	O
)	O
and	O
43	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
preterm	O
delivery	O
cModels	O
include	O
57	O
(	O
T1	O
)	O
and	O
31	O
(	O
T3	O
and	O
Δ25OHD	O
)	O
cases	O
of	O
low	O
birth	O
weight	O
dModels	O
include	O
96	O
cases	O
of	O
pregnancy	O
loss	O
eAdjusted	O
for	O
education	O
,	O
origin	O
,	O
season	O
of	O
conception	O
and	O
BMI	O
at	O
T1	O
.	O

Medical	O
history	O
of	O
kidney	O
dysfunction	O
.	O

Given	O
that	O
this	O
is	O
the	O
first	O
study	O
to	O
be	O
conducted	O
among	O
pregnant	O
women	O
,	O
and	O
that	O
pre	O
-	O
pregnancy	O
BMI	O
may	O
reasonably	O
be	O
considered	O
a	O
confounder	O
or	O
a	O
covariate	O
along	O
the	O
causal	O
pathway	O
between	O
maternal	O
habitual	O
sleep	O
behaviors	O
and	O
GDM	O
,	O
we	O
were	O
careful	O
to	O
assess	O
the	O
potential	O
independent	O
contributions	O
of	O
the	O
sleep	O
variables	O
(	O
from	O
pre	O
-	O
pregnancy	O
BMI	O
).	O

In	O
final	O
adjusted	O
model	O
,	O
women	O
with	O
a	O
higher	O
adherence	O
to	O
western	O
dietary	O
pattern	O
had	O
4	O
.	O
88	O
times	O
larger	O
odds	O
for	O
having	O
an	O
infant	O
with	O
low	O
birth	O
head	O
circumference	O
than	O
those	O
with	O
a	O
lower	O
adherence	O
level	O
(	O
OR	O
:	O
4	O
.	O
88	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
79	O
-	O
30	O
.	O
19	O
P	O
=	O
0	O
.	O
35	O
).	O

2	O
.	O
3	O
.	O

Harper	O
and	O
Pethick	O
[	O
23	O
]	O
recommended	O
that	O
producers	O
focus	O
on	O
individuals	O
with	O
high	O
genetic	O
capacity	O
to	O
create	O
more	O
preadipocytes	O
within	O
animal	O
muscle	O
.	O

They	O
reported	O
that	O
the	O
average	O
breed	O
type	O
list	O
included	O
purebred	O
or	O
crossbred	O
Angus	O
,	O
Brahman	O
,	O
Simmental	O
,	O
Charolais	O
,	O
Hereford	O
,	O
Jersey	O
,	O
Korean	O
Brown	O
cattle	O
,	O
Maine	O
Anjou	O
,	O
Pinzgauer	O
,	O
Sahiwal	O
,	O
Salers	O
,	O
and	O
South	O
Devon	O
with	O
estimates	O
MS	O
heritability	O
of	O
0	O
.	O
37	O
(	O
range	O
0	O
.	O
30	O
to	O
0	O
.	O
57	O
).	O

Nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
these	O
supplements	O
,	O
regardless	O
of	O
the	O
frequency	O
of	O
prenatal	O
visits	O
or	O
socio	O
-	O
demographic	O
characteristics	O
.	O

According	O
to	O
these	O
results	O
,	O
visfatin	O
can	O
have	O
a	O
major	O
role	O
in	O
regulating	O
neonatal	O
obesity	O
after	O
birth	O
.	O

The	O
IMF	O
content	O
in	O
the	O
LM	O
of	O
the	O
high	O
-	O
concentrate	O
group	O
(	O
31	O
.	O
7	O
%	O
±	O
5	O
.	O
4	O
%)	O
was	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
(	O
22	O
.	O
9	O
%±	O
5	O
.	O
3	O
%).	O

It	O
is	O
also	O
possible	O
that	O
children	O
who	O
become	O
autistic	O
may	O
also	O
be	O
slow	O
to	O
deliver	O
that	O
the	O
prolonged	O
delivery	O
is	O
a	O
symptom	O
of	O
,	O
rather	O
than	O
a	O
cause	O
of	O
,	O
autism	O
.	O

We	O
will	O
use	O
physician	O
-	O
certified	O
verbal	O
autopsy	O
method	O
to	O
identify	O
cases	O
of	O
death	O
related	O
to	O
preterm	O
delivery	O
and	O
birth	O
asphyxia	O
using	O
the	O
hierarchical	O
assignment	O
of	O
causes	O
of	O
death	O
.	O

Mean	O
±	O
SD	O
SEI	O
of	O
the	O
Auckland	O
women	O
was	O
also	O
higher	O
compared	O
to	O
that	O
in	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Auckland	O
:	O
48	O
.	O
0	O
±	O
14	O
.	O
8	O
vs	O
.	O
Adelaide	O
:	O
27	O
.	O
7	O
±	O
10	O
.	O
5	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

She	O
clarified	O
the	O
study	O
’	O
s	O
goals	O
and	O
if	O
the	O
mothers	O
were	O
willing	O
to	O
participation	O
a	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
them	O
.	O

They	O
opined	O
that	O
sufficient	O
attention	O
should	O
be	O
paid	O
to	O
adolescent	O
girls	O
and	O
women	O
of	O
reproductive	O
age	O
long	O
before	O
pregnancy	O
and	O
suggested	O
intermittent	O
low	O
-	O
dose	O
iron	O
supplements	O
and	O
in	O
some	O
cases	O
,	O
combined	O
with	O
necessary	O
micronutrients	O
[	O
36	O
,	O
37	O
].	O

The	O
Vitamin	O
D	O
deficiency	O
level	O
identified	O
in	O
this	O
study	O
was	O
20	O
.	O
4	O
%,	O
which	O
is	O
lower	O
than	O
those	O
identified	O
in	O
the	O
studies	O
discussed	O
previously	O
.	O

In	O
addition	O
,	O
we	O
analysed	O
13	O
infants	O
treated	O
by	O
our	O
department	O
for	O
idiopathic	O
infantile	O
hypercalcaemia	O
(	O
IIH	O
)	O
from	O
2011	O
-	O
2013	O
.	O

In	O
the	O
same	O
study	O
,	O
LM	O
area	O
also	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
.	O

Pregnant	O
women	O
(<	O
18	O
weeks	O
’	O
gestation	O
)	O
(	O
n	O
=	O
250	O
)	O
are	O
being	O
recruited	O
from	O
primary	O
healthcare	O
clinics	O
in	O
Johannesburg	O
and	O
are	O
followed	O
-	O
up	O
at	O
a	O
provincial	O
hospital	O
.	O

Categorical	O
variables	O
Children	O
were	O
further	O
classified	O
,	O
post	O
hoc	O
,	O
according	O
to	O
their	O
asthmatic	O
/	O
atopic	O
status	O
,	O
thus	O
defining	O
a	O
four	O
-	O
category	O
variable	O
(	O
no	O
atopy	O
or	O
asthma	O
,	O
atopy	O
only	O
,	O
nonatopic	O
asthma	O
and	O
atopic	O
asthma	O
),	O
and	O
according	O
to	O
their	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
(	O
n	O
=	O
0	O
,	O
1	O
and	O
≥	O
2	O
).	O

Current	O
understanding	O
suggests	O
that	O
hypoxia	O
is	O
one	O
of	O
the	O
complications	O
of	O
prolonged	O
labor	O
,	O
along	O
with	O
infection	O
,	O
or	O
head	O
trauma	O
from	O
extended	O
pressure	O
.	O

To	O
conclude	O
,	O
the	O
ICDS	O
scheme	O
is	O
a	O
comprehensive	O
approach	O
for	O
delivering	O
an	O
integrated	O
package	O
of	O
services	O
to	O
bring	O
about	O
a	O
significant	O
improvement	O
in	O
the	O
child	O
related	O
health	O
,	O
care	O
,	O
and	O
nutrition	O
practices	O
of	O
the	O
community	O
.	O

Depression	O
was	O
reported	O
in	O
8	O
.	O
6	O
%	O
of	O
European	O
mothers	O
,	O
in	O
19	O
.	O
5	O
%	O
of	O
Middle	O
Eastern	O
mothers	O
,	O
and	O
in	O
17	O
.	O
5	O
%	O
of	O
South	O
Asian	O
mothers	O
.	O

Although	B
potentially	O
complex	O
,	O
the	O
use	O
of	O
a	O
systems	O
biology	O
approach	O
,	O
incorporating	O
genome	O
-	O
wide	O
analysis	O
at	O
multiple	O
levels	O
(	O
histone	O
code	O
,	O
methylome	O
,	O
non	O
-	O
coding	O
RNA	O
expression	O
,	O
transcriptome	O
,	O
proteome	O
and	O
metabolome	O
)	O
would	O
provide	O
comprehensive	O
analysis	O
of	O
epigenetic	O
changes	O
and	O
associated	O
phenotypic	O
outcomes	O
.	O

The	O
overall	O
response	O
rate	O
was	O
72	O
%,	O
and	O
34	O
415	O
answered	O
the	O
follow	O
-	O
up	O
questionnaire	O
and	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
measured	O
(	O
outcome	O
under	O
study	O
).	O

Only	B
6	O
%	O
of	O
women	O
started	O
visits	O
in	O
the	O
first	O
trimester	O
while	B
14	O
.	O
5	O
%	O
began	O
in	O
the	O
third	O
trimester	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Recommendations	O
for	O
Treatment	O
of	O
Asthma	O
and	O
Allergies	O
in	O
PregnancyDrugs	O
preferred	O
for	O
use	O
during	O
pregnancy	O
Anti	O
-	O
inflammatory	O
:	O
cromolyn	O
beclomethasone	O
,	O
prednisone	O
Bronchodilator	O
:	O
inhaled	O
β2	O
-	O
adrenergic	O
agonist	O
,	O
theophylline	O
Antihistamine	O
:	O
chlorpheniramine	O
,	O
tripelennamine	O
Decongestant	O
:	O
pseudoephedrine	O
,	O
oxymetazoline	O
Cough	O
:	O
guaifenesin	O
,	O
dextromethorphan	O
Antibiotic	O
:	O
amoxicillinDrugs	O
that	O
generally	O
should	O
be	O
avoided	O
during	O
pregnancy	O
α	O
-	O
Adrenergic	O
compounds	O
(	O
other	O
than	O
pseudoephedrine	O
)	O
Epinephrine	O
(	O
other	O
than	O
for	O
anaphylaxis	O
)	O
Iodides	O
Sulfonamides	O
(	O
in	O
late	O
pregnancy	O
)	O
Tetracyclines	O
Quinolones	O
Adapted	O
from	O
the	O
NAEPP	O
expert	O
group	O
report	O
[	O
21	O
].	O

Our	O
exclusion	O
criteria	O
were	O
families	O
expecting	O
to	O
move	O
to	O
another	O
town	O
within	O
18	O
months	O
,	O
diagnosis	O
of	O
rickets	O
or	O
treatment	O
with	O
vitamin	O
D	O
in	O
the	O
previous	O
3	O
months	O
,	O
and	O
clinical	O
diagnosis	O
of	O
Kwashiorkor	O
or	O
Marasmus	O
.	O

The	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
was	O
increased	O
in	O
RC	O
male	O
hypothalamus	O
,	O
but	O
a	O
down	O
-	O
expression	O
of	O
most	O
eCBs	O
-	O
metabolizing	O
enzymes	O
(	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
and	O
several	O
key	O
regulators	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1b	O
,	O
Acox1	O
),	O
mitochondrial	O
respiration	O
(	O
Cox4i1	O
),	O
and	O
lipid	O
flux	O
(	O
Ppar	O
γ	O
)	O
was	O
found	O
in	O
their	O
PAT	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
depression	O
scores	O
in	O
nulliparous	O
and	O
multiparous	O
subgroupsVariables	O
Mean	O
(	O
sd	O
)	O
NulliparousMultiparousVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
valueVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
13	O
.	O
13	O
(	O
6	O
.	O
91	O
)	O
13	O
.	O
25	O
(	O
6	O
.	O
55	O
)	O
41	O
/	O
510	O
.	O
9312	O
.	O
49	O
(	O
9	O
.	O
08	O
)	O
9	O
.	O
31	O
(	O
5	O
.	O
34	O
)	O
34	O
/	O
270	O
.	O
1525	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
18	O
.	O
40	O
(	O
11	O
.	O
38	O
)	O
12	O
.	O
49	O
(	O
6	O
.	O
29	O
)	O
33	O
/	O
430	O
.	O
0116	O
.	O
58	O
(	O
8	O
.	O
54	O
)	O
11	O
.	O
36	O
(	O
5	O
.	O
47	O
)	O
28	O
/	O
250	O
.	O
02Depression	O
score	O
at	O
baseline8	O
.	O
41	O
(	O
3	O
.	O
52	O
)	O
8	O
.	O
73	O
(	O
3	O
.	O
57	O
)	O
41	O
/	O
510	O
.	O
678	O
.	O
47	O
(	O
4	O
.	O
35	O
)	O
8	O
.	O
48	O
(	O
4	O
.	O
30	O
)	O
34	O
/	O
270	O
.	O
99Depression	O
score	O
at	O
38	O
-	O
40w	O
gestation6	O
.	O
47	O
(	O
3	O
.	O
43	O
)	O
7	O
.	O
98	O
(	O
3	O
.	O
74	O
)	O
38	O
/	O
460	O
.	O
065	O
.	O
80	O
(	O
3	O
.	O
62	O
)	O
7	O
.	O
44	O
(	O
4	O
.	O
28	O
)	O
30	O
/	O
270	O
.	O
12Depression	O
score	O
at	O
postpartum	O
(	O
4w	O
)	O
4	O
.	O
59	O
(	O
3	O
.	O
24	O
)	O
7	O
.	O
27	O
(	O
4	O
.	O
04	O
)	O
34	O
/	O
450	O
.	O
0024	O
.	O
60	O
(	O
3	O
.	O
40	O
)	O
7	O
.	O
52	O
(	O
4	O
.	O
70	O
)	O
30	O
/	O
270	O
.	O
01Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
18	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
24	O
(	O
3	O
.	O
79	O
)	O
34	O
/	O
450	O
.	O
0014	O
.	O
20	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
07	O
(	O
4	O
.	O
37	O
)	O
30	O
/	O
270	O
.	O
01	O
*	O
Mann	O
–	O
Whitney	O
U	O
test	O
We	O
examined	O
the	O
correlation	O
between	O
change	O
in	O
vitamin	O
D	O
concentrations	O
and	O
change	O
in	O
depression	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

As	O
nodal	O
spread	O
is	O
relatively	O
common	O
,	O
initial	O
surgical	O
exploration	O
should	O
include	O
careful	O
examination	O
of	O
the	O
central	O
compartment	O
nodes	O
(	O
paratracheal	O
and	O
tracheoesophageal	O
)	O
as	O
well	O
as	O
dissection	O
of	O
clinically	O
suspicious	O
nodes	O
for	O
frozen	O
section	O
examination	O
.	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

Notably	B
,	O
in	O
the	O
aforementioned	O
study	O
examining	O
localized	O
cathelicidin	O
concentrations	O
in	O
saliva	O
,	O
the	O
female	O
gender	O
was	O
found	O
to	O
positively	O
correlate	O
with	O
cathelicidin	O
[	O
30	O
].	O

proposed	O
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	O
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

These	O
features	O
were	O
also	O
linked	O
to	O
an	O
impairment	O
of	O
the	O
browning	O
process	O
of	O
the	O
white	O
adipose	O
tissue	O
(	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

This	O
Zinc	O
-	O
finger	O
transcription	O
factor	O
induces	O
differentiation	O
of	O
brown	O
adipocytes	O
(	O
Seale	O
et	O
al	O
.,	O
2011	O
).	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

Data	O
processing	O
and	O
statistical	O
analysis	O
We	O
identified	O
open	O
reference	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
using	O
QIIME	O
version	O
1	O
.	O
9	O
.	O
1	O
[	O
35	O
]	O
with	O
the	O
UCLUST	O
algorithm	O
and	O
97	O
%	O
similarity	O
[	O
36	O
].	O

1	O
.	O

Sleep	O
was	O
assessed	O
using	O
the	O
General	O
Sleep	O
Disturbance	O
questionnaire	O
[	O
30	O
].	O

This	O
review	O
will	O
examine	O
the	O
pharmacological	O
options	O
for	O
the	O
management	O
of	O
gestational	O
diabetes	O
,	O
as	O
well	O
as	O
the	O
evidence	O
for	O
blood	O
glucose	O
monitoring	O
,	O
dietary	O
and	O
exercise	O
therapy	O
.	O

Vitamin	O
C	O
or	O
L	O
-	O
ascorbic	O
acid	O
has	O
several	O
roles	O
including	O
in	O
oxidation	O
–	O
reduction	O
reactions	O
and	O
collagen	O
synthesis	O
[	O
147	O
].	O

A	O
difference	O
in	O
nature	O
of	O
antenatal	O
depression	O
compared	O
to	O
postnatal	O
depression	O
can	O
reflect	O
another	O
possible	O
reason	O
for	O
achieving	O
this	O
result	O
.	O

Statistical	O
analyses	O
were	O
performed	O
using	O
SAS	O
9	O
.	O
3	O
.	O

For	O
this	O
reason	O
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	O
biochemical	O
markers	O
that	O
reflect	O
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	O
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

[	O
24	O
]	O
found	O
that	O
seafood	O
consumption	O
that	O
excluded	O
fish	O
intake	O
had	O
a	O
detrimental	O
effect	O
on	O
neurodevelopment	O
,	O
while	O
fish	O
intake	O
alone	O
led	O
to	O
improved	O
outcomes	O
.	O

These	O
groups	O
were	O
chosen	O
to	O
study	O
whether	O
vitamin	O
D	O
insufficiency	O
(	O
30	O
–	O
50	O
nmol	O
/	O
L	O
),	O
sufficiency	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
or	O
high	O
status	O
(≥	O
75	O
or	O
≥	O
100	O
nmol	O
/	O
L	O
)	O
was	O
associated	O
with	O
the	O
outcomes	O
studied	O
,	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

*	O
Studies	O
demonstrating	O
environmentally	O
-	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
.	O

Cold	O
stress	O
causes	O
white	O
fat	O
depot	O
lipolysis	O
in	O
rats	O
[	O
102	O
].	O

Cost	O
-	O
effectiveness	O
analysis	O
The	O
economic	O
evaluation	O
will	O
take	O
a	O
societal	O
perspective	O
.	O

Authors	O
'	O
contributions	O
CQ	O
and	O
MAW	O
had	O
full	O
access	O
to	O
all	O
the	O
data	O
in	O
the	O
study	O
and	O
take	O
responsibility	O
for	O
the	O
integrity	O
of	O
the	O
data	O
,	O
the	O
accuracy	O
of	O
the	O
data	O
analysis	O
,	O
and	O
the	O
decision	O
to	O
submit	O
for	O
publication	O
.	O

In	O
light	O
of	O
the	O
inflammatory	O
nature	O
of	O
depression	O
and	O
the	O
strong	O
role	O
of	O
vitamin	O
D	O
as	O
an	O
anti	O
-	O
inflammatory	O
and	O
immunomodulator	O
,	O
inflammation	O
may	O
mediate	O
the	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
depression	O
during	O
pregnancy	O
[	O
73	O
,	O
74	O
].	O

Additionally	O
,	O
the	O
diagnosis	O
of	O
GDM	O
indicates	O
that	O
the	O
mother	O
has	O
a	O
predisposition	O
to	O
diabetes	O
.	O

All	O
studies	O
were	O
found	O
to	O
be	O
either	O
positive	O
or	O
neutral	O
in	O
regards	O
to	O
quality	O
rating	O
.	O

Additionally	O
,	O
genome	O
-	O
wide	O
and	O
spermatic	O
methylation	O
studies	O
were	O
performed	O
.	O

In	O
total	O
,	O
18	O
of	O
the	O
40	O
studies	O
shown	O
inTable	O
2validated	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
;	O
thereby	O
demonstrating	O
a	O
definitive	O
causal	O
link	O
between	O
exposure	O
(	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
cadmium	O
,	O
methylmercury	O
,	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetra	O
-	O
chloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
),	O
urethane	O
,	O
vinyl	O
carbamate	O
,	O
alcohol	O
,	O
caffeine	O
,	O
overnutrition	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
4	O
-(	O
methyl	O
-	O
nitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
),	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

Food	O
consumption	O
frequency	O
of	O
food	O
rich	O
in	O
Vitamin	O
D	O
Participants	O
filled	O
dietary	O
records	O
for	O
7	O
–	O
232	O
days	O
,	O
with	O
an	O
average	O
of	O
31	O
.	O
7	O
days	O
.	O

Finally	O
,	O
the	O
candidates	O
were	O
referred	O
to	O
the	O
lab	O
in	O
order	O
to	O
provide	O
blood	O
samples	O
for	O
determining	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

Access	O
to	O
data	O
All	O
collected	O
data	O
will	O
be	O
accessible	O
by	O
the	O
study	O
investigators	O
.	O

Meta	O
-	O
analysis	O
[	O
8	O
]	O
and	O
prospective	O
follow	O
-	O
up	O
studies	O
indicates	O
that	O
up	O
to	O
75	O
-	O
90	O
%	O
of	O
developmental	O
psychotic	O
experiences	O
are	O
transitory	O
.	O

In	O
contrast	O
,	O
when	O
bred	O
under	O
thermoneutral	O
conditions	O
(	O
29	O
°	O
C	O
),	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
enhanced	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
(	O
Feldmann	O
et	O
al	O
.,	O
2009	O
).	O

After	O
DNase	O
treatment	O
a	O
column	O
-	O
based	O
purification	O
using	O
the	O
RNeasy	O
Mini	O
Kit	O
(	O
Qiagen	O
,	O
Hilden	O
,	O
Germany	O
)	O
was	O
done	O
.	O

The	O
offspring	O
of	O
overweight	O
mothers	O
were	O
larger	O
at	O
birth	O
but	O
,	O
by	O
6	O
-	O
months	O
,	O
did	O
not	O
significantly	O
differ	O
from	O
those	O
of	O
normal	O
weight	O
mothers	O
.	O

Bell	O
and	O
Greenwood	O
[	O
158	O
]	O
also	O
suggest	O
that	O
effects	O
of	O
fetal	O
programming	O
during	O
early	O
-	O
mid	O
-	O
gestation	O
on	O
postnatal	O
growth	O
or	O
composition	O
are	O
generally	O
minor	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

After	O
adjusting	O
for	O
the	O
total	O
number	O
of	O
prenatal	O
visits	O
,	O
we	O
noted	B
independent	O
effects	O
of	O
area	O
of	O
residence	O
and	O
level	O
of	O
education	O
on	O
the	O
use	O
of	O
supplements	O
:	O
women	O
from	O
urban	O
areas	O
and	O
those	O
with	O
more	O
than	O
9	O
years	O
of	O
formal	O
education	O
were	O
more	O
likely	O
to	O
have	O
used	O
folic	O
acid	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
1	O
.	O
5	O
;	O
9	O
–	O
12	O
years	O
of	O
education	O
:	O
aOR	O
,	O
4	O
.	O
8	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
3	O
-	O
10	O
.	O
0	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
8	O
.	O
1	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
7	O
-	O
18	O
.	O
0	O
)	O
and	O
multivitamin	O
supplements	O
(	O
urban	O
area	O
:	O
aOR	O
,	O
1	O
.	O
7	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
2	O
.	O
7	O
;	O
>	O
12	O
years	O
of	O
school	O
:	O
aOR	O
,	O
3	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
7	O
-	O
7	O
.	O
4	O
)	O
(	O
Table	O
5	O
).	O

Associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
and	O
pregnancy	O
loss	O
were	O
also	O
studied	O
.	O

Confirmatory	O
allergy	O
tests	O
for	O
folic	O
acid	O
were	O
not	O
available	O
for	O
any	O
of	O
the	O
cases	O
.	O

Autism	O
spectrum	O
disorders	O
in	O
childhood	O
have	O
also	O
been	O
observed	O
and	O
diagnosed	O
more	O
frequently	O
among	O
children	O
born	O
to	O
women	O
with	O
metabolic	O
conditions	O
identified	O
during	O
pregnancy	O
,	O
including	O
diabetes	O
and	O
obesity	O
[	O
47	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
plasma	O
levels	O
of	O
leptin	O
,	O
metabolites	O
,	O
alkaline	O
phosphatase	O
,	O
and	O
hepatic	O
transaminases	O
in	O
adult	O
offspring	O
Two	O
-	O
way	O
ANOVA	O
showed	O
an	O
effect	O
of	O
prenatal	O
diet	O
on	O
the	O
plasma	O
levels	O
of	O
glucose	O
,	O
the	O
lipid	O
profile	O
(	O
triglycerides	O
,	O
HDL	O
,	O
LDL	O
,	O
and	O
VLDL	O
)	O
and	O
urea	O
(	O
Table1	O
).	O

For	O
instance	O
,	O
environmental	O
pollutants	O
such	O
as	O
polychlorinated	O
biphenyls	O
(	O
PCB	O
)	O
and	O
dioxins	O
are	O
known	O
to	O
accumulate	O
in	O
fatty	O
fish	O
[	O
38	O
].	O

However	B
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

The	O
diagnosis	O
is	O
made	O
with	O
an	O
oral	O
glucose	O
tolerance	O
test	O
,	O
though	B
the	O
criteria	O
vary	O
around	O
the	O
world	O
(	O
Table	O
1	O
).	O

2007	O
;	O
Sinclair	O
et	O
al	O
.	O

Harmon	O
and	O
McLeod	O
[	O
111	O
]	O
reported	O
that	O
starch	O
digestion	O
is	O
more	O
efficient	O
in	O
the	O
small	O
intestine	O
than	O
during	O
fermentation	O
in	O
the	O
rumen	O
:	O
the	O
total	O
energetic	O
efficiency	O
of	O
rumen	O
-	O
fermented	O
starch	O
was	O
about	O
73	O
%	O
that	O
of	O
small	O
intestine	O
-	O
digested	O
starch	O
.	O

For	O
1	O
hospital	O
(	O
n	O
=	O
23	O
women	O
)	O
certain	O
questions	O
(	O
mainly	O
nationality	O
,	O
ethnicity	O
,	O
education	O
level	O
)	O
needed	O
to	O
be	O
omitted	O
from	O
the	O
questionnaire	O
upon	O
decision	O
of	O
the	O
ethical	O
committee	O
of	O
this	O
particular	O
hospital	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Geographical	O
distribution	O
of	O
the	O
55	O
hospitals	O
visited	O
in	O
Belgium	O
and	O
the	O
number	O
of	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
investigated	O
by	O
site	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
Belgium	O
2010	O
–	O
2011	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
pregnant	O
women	O
by	O
region	O
,	O
trimester	O
and	O
age	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O
RegionsBrussels	O
**	O
Flanders	O
**	O
WalloniaAge	O
(	O
years	O
)	O
1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15	O
–	O
20721110211721	O
–	O
2534277751567326	O
–	O
304139108149765831	O
–	O
3534536975494536	O
–	O
4014142319132441	O
–	O
45231332Total132138289307218219	O
6	O
missing	O
data	O
for	O
age	O
.	O

MH	O
prepared	O
the	O
manuscript	O
in	O
collaboration	O
with	O
ML	O
.	O

For	O
all	O
women	O
included	O
in	O
the	O
study	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
obtained	O
from	O
weight	O
and	O
height	O
recorded	O
by	O
the	O
gynaecologist	O
during	O
the	O
first	O
prenatal	O
consultation	O
in	O
the	O
beginning	O
of	O
the	O
first	O
trimester	O
of	O
pregnancy	O
.	O

Our	O
findings	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
impact	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
on	O
early	O
infant	O
neurodevelopment	O
.	O

While	O
this	O
large	O
body	O
of	O
work	O
also	O
provides	O
some	O
comprehensive	O
evidence	O
for	O
,	O
and	O
specific	O
mechanisms	O
of	O
,	O
epigenetic	O
toxicity	O
,	O
it	O
was	O
considered	O
outside	O
the	O
scope	O
of	O
this	O
review	O
.	O

Of	O
these	O
,	O
423	O
probe	O
-	O
sets	O
showed	O
an	O
increased	O
mRNA	O
expression	O
.	O

Assignment	O
of	O
treatments	O
An	O
investigator	O
remote	O
from	O
the	O
field	O
area	O
will	O
assign	O
the	O
interventions	O
to	O
eligible	O
clusters	O
using	O
a	O
fixed	O
randomisation	O
scheme	O
with	O
a	O
uniform	O
allocation	O
ratio	O
of	O
treatments	O
,	O
stratified	O
by	O
subdistrict	O
or	O
Upazila	O
.	O

Male	O
offspring	O
from	O
the	O
HV	O
dams	O
weaned	O
to	O
the	O
RV	O
diet	O
had	O
5	O
%	O
higher	O
72	O
h	O
food	O
intake	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
03	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
4	O
),	O
8	O
%	O
higher	O
weight	O
gain	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
0006	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
3	O
)	O
and	O
36	O
%	O
higher	O
glucose	O
response	O
to	O
glucose	O
gavage	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
compared	O
to	O
those	O
from	O
the	O
RV	O
dams	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
2	O
,	O
3	O
,	O
4	O
).	O

Interestingly	B
,	O
very	O
low	O
birth	O
weight	O
has	O
been	O
associated	O
with	O
left	O
-	O
or	O
mix	O
-	O
handedness	O
[	O
175	O
,	O
176	O
],	O
a	O
factor	O
associated	O
in	O
some	O
studies	O
with	O
season	O
of	O
birth	O
[	O
177	O
]	O
and	O
reduced	O
glioma	O
risk	O
[	O
178	O
].	O

In	O
Romania	O
it	O
is	O
not	O
clear	O
whether	O
there	O
is	O
a	O
relationship	O
between	O
socio	O
-	O
demographic	O
factors	O
or	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
iron	O
,	O
folic	O
acid	O
and	O
multivitamins	O
in	O
pregnancy	O
.	O

At	O
6	O
months	O
,	O
no	O
significant	O
effects	O
were	O
seen	O
for	O
GWG	O
on	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
P	O
=	O
.	O
11	O
)	O
or	O
average	O
z	O
-	O
scores	O
(	O
P	O
=	O
.	O
16	O
)	O
at	O
6	O
months	O
.	O

Gestational	O
and	O
neonatal	O
data	O
were	O
retrieved	O
from	O
medical	O
records	O
.	O

However	O
,	O
such	O
a	O
relation	O
has	O
not	O
yet	O
been	O
confirmed	O
.	O

Thus	O
,	O
preeclampsia	O
does	O
not	O
seem	B
to	O
mediate	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
trajectory	O
and	O
neonatal	O
birth	O
size	O
or	O
preterm	O
birth	O
.	O

Additionally	O
,	O
while	O
one	O
study	O
examined	O
the	O
levels	O
of	O
maternal	O
and	O
neonatal	O
vitamin	O
D	O
and	O
cathelicidin	O
concentrations	O
in	O
healthy	O
children	O
at	O
delivery	O
,	O
there	O
is	O
a	O
lack	O
of	O
research	O
to	O
determine	O
correlations	O
between	O
vitamin	O
D	O
status	O
and	O
cathelicidin	O
among	O
healthy	O
children	O
over	O
time	O
[	O
20	O
],	O
as	O
well	O
as	O
which	O
factors	O
such	O
as	O
age	O
of	O
the	O
child	O
,	O
gender	O
,	O
and	O
body	O
composition	O
may	O
independently	O
impact	O
cathelicidin	O
concentrations	O
.	O

Taken	O
together	O
,	O
policy	O
makers	O
should	O
implement	O
changes	O
in	O
the	O
health	O
care	O
delivery	O
system	O
taking	O
into	O
account	O
the	O
users	O
’	O
opinion	O
,	O
more	O
so	O
in	O
the	O
light	O
of	O
increasing	O
female	O
education	O
in	O
Cameroon	O
.	O

Compared	O
with	O
lean	O
women	O
non	O
-	O
snorers	O
,	O
those	O
women	O
who	O
were	O
both	O
overweight	O
and	O
who	O
snored	O
had	O
a	O
statistically	O
significant	O
6	O
.	O
91	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
6	O
.	O
91	O
;	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
)	O
(	O
Table3	O
).	O

Also	O
,	O
maternal	O
25OHD	O
<	O
28	O
nmol	O
/	O
L	O
in	O
late	O
,	O
but	O
not	O
early	O
,	O
pregnancy	O
have	O
been	O
associated	O
with	O
lower	O
infant	O
birth	O
size	O
and	O
shorter	O
gestational	O
length	O
in	O
a	O
smaller	O
longitudinal	O
study	O
[	O
8	O
].	O

The	O
informed	O
consent	O
form	O
is	O
given	O
to	O
the	O
participant	O
to	O
read	O
,	O
consider	O
and	O
discuss	O
with	O
her	O
partner	O
and	O
/	O
or	O
family	O
.	O

Initial	O
research	O
efforts	O
,	O
which	O
were	O
embarked	O
upon	O
during	O
the	O
1950s	O
,	O
assert	O
that	O
complications	O
in	O
a	O
given	O
pregnancy	O
,	O
the	O
birthing	O
process	O
,	O
and	O
the	O
incidence	O
of	O
autism	O
are	O
linked	O
.	O

Herb	O
use	O
among	O
low	O
income	O
women	O
at	O
an	O
urban	O
tertiary	O
care	O
center	O
and	O
their	O
communications	O
with	O
prenatal	O
care	O
providers	O
Purpose	O
Little	O
is	O
known	O
about	O
the	O
use	O
of	O
herbs	O
in	O
low	O
income	O
underserved	O
mothers	O
and	O
patterns	O
of	O
communication	O
about	O
herb	O
use	O
to	O
prenatal	O
providers	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
feeding	O
response	O
to	O
AM251	O
in	O
adult	O
offspring	O
The	O
feeding	O
behavior	O
to	O
AM251	O
(	O
chocolate	O
and	O
total	O
caloric	O
intake	O
)	O
was	O
evaluated	O
for	O
4	O
h	O
in	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
13	O
–	O
14	O
(	O
Figures3E	O
–	O
H	O
).	O

While	O
in	O
a	O
study	O
by	O
Cassidy	O
-	O
Bushrow	O
et	O
al	O
.,	O
in	O
African	O
-	O
American	O
women	O
,	O
an	O
inverse	O
relationship	O
was	O
observed	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
the	O
early	O
stages	O
of	O
pregnancy	O
and	O
antenatal	O
depression	O
.	O

The	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
this	O
cohort	O
is	O
comparable	O
to	O
several	O
other	O
European	O
populations	O
[	O
58	O
].	O

Finally	O
,	O
to	O
make	O
our	O
search	O
inclusive	O
of	O
those	O
studies	O
in	O
which	O
season	O
of	O
birth	O
was	O
a	O
secondary	O
factor	O
we	O
checked	O
the	O
tables	O
of	O
every	O
article	O
known	O
to	O
us	O
that	O
examined	O
risk	O
factors	O
for	O
brain	O
tumors	O
.	O

In	O
general	O
,	O
the	O
term	O
obesity	O
applies	O
to	O
both	O
the	O
obese	O
and	O
the	O
overweight	O
subjects	O
.	O

Maternal	O
serum	O
T1	O
and	O
T3	O
samples	O
were	O
analysed	O
in	O
sequence	O
.	O

(	O
2014	O
)	O
Nickel	O
(	O
Ni	O
)	O
LifetimeAdulthood	O
↓	O
NSCLC	O
overall	O
and	O
relapse	O
free	O
survivalmiRNAsChiou	O
et	O
al	O
.	O

It	O
has	O
been	O
suggested	O
that	O
intrauterine	O
growth	O
patterns	O
improved	O
prediction	O
of	O
childhood	O
anthropometry	O
,	O
above	O
and	O
beyond	O
birth	O
weight	O
alone	O
.	O

The	O
lowest	O
odds	O
of	O
SGA	O
and	O
LBW	O
are	O
found	O
among	O
women	O
with	O
the	O
largest	O
increments	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
).	O

Prenatal	O
diet	O
influences	O
the	O
risk	O
of	O
infant	O
and	O
child	O
allergy	O
.	O

It	O
was	O
demonstrated	O
that	O
when	O
the	O
serotonin	O
levels	O
were	O
altered	O
by	O
SSRIs	O
during	O
early	O
development	O
of	O
brain	O
structure	O
,	O
the	O
functions	O
were	O
altered	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpc	O
vs	O
.	O
1	O
dpn	O
AP	O
AMPK	O
signalingup6	O
.	O
96	O
*	O
E	O
-	O
38AKT2	O
,	O
INSR	O
,	O
PIK3C2A	O
,	O
PIK3R1	O
,	O
PPM1B	O
,	O
PRKAA1	O
,	O
PRKACB	O
,	O
RAC1	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown3	O
.	O
25	O
*	O
E	O
-	O
47CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
KIF11	O
,	O
PLK4	O
,	O
PTTG1	O
AP	O
Pyrimidine	O
metabolismdown2	O
.	O
52	O
*	O
E	O
-	O
310CAD	O
,	O
DCTD	O
,	O
DKC1	O
,	O
POLQ	O
,	O
POLR3E	O
,	O
POLR3K	O
,	O
RFC5	O
,	O
RRM1	O
,	O
TYMS	O
,	O
UCK2	O
AP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown2	O
.	O
04	O
*	O
E	O
-	O
46CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
UBC	O
,	O
YWHAE	O
LP	O
Purine	O
metabolismup9	O
.	O
20	O
*	O
E	O
-	O
312DDX39	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
RUVBL1	O
,	O
RUVBL2	O
LP	O
Pyrimidine	O
metabolismup6	O
.	O
15	O
*	O
E	O
-	O
714CTPS	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
PUS1	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
TXNRD1	O
,	O
TYMS	O
,	O
UCK2	O
LP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinaseup7	O
.	O
55	O
*	O
E	O
-	O
57ANAPC4	O
,	O
CDC27	O
,	O
CDK1	O
,	O
ESPL1	O
,	O
FZR1	O
,	O
PPP2R1B	O
,	O
PTTG1	O
LP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationup3	O
.	O
09	O
*	O
E	O
-	O
23CDK1	O
,	O
CHEK1	O
,	O
YWHAZ	O
LP	O
Wnt	O
signalingdown4	O
.	O
02	O
*	O
E	O
-	O
29AKT3	O
,	O
FZD5	O
,	O
MMP7	O
,	O
NLK	O
,	O
SOX4	O
,	O
TCF3	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5A1	O
dpn	O
vs	O
.	O
28	O
dpn	O
AP	O
AMPK	O
signalingup4	O
.	O
26	O
*	O
E	O
-	O
38AK1	O
,	O
CPT1A	O
,	O
EIF4EBP1	O
,	O
HMGCR	O
,	O
MAPK14	O
,	O
NOS3	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
mTOR	O
signalingup1	O
.	O
89	O
*	O
E	O
-	O
27EIF3F	O
,	O
EIF3G	O
,	O
EIF4EBP1	O
,	O
FNBP1	O
,	O
GNB1L	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationdown6	O
.	O
40	O
*	O
E	O
-	O
36ACAD8	O
,	O
ACADL	O
,	O
ACADSB	O
,	O
BCAT1	O
,	O
DBT	O
,	O
MCCC2	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup7	O
.	O
12	O
*	O
E	O
-	O
811ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
GCDH	O
,	O
HMGCL	O
,	O
HMGCS1	O
,	O
MCCC2	O
,	O
MCEE	O
LP	O
Fatty	O
acid	O
metabolismup3	O
.	O
23	O
*	O
E	O
-	O
38ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
CYP51A1	O
,	O
GCDH	O
,	O
PECI	O
LP	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
76	O
*	O
E	O
-	O
65ACAT1	O
,	O
ACAT2	O
,	O
BDH2	O
,	O
HMGCL	O
,	O
HMGCS1	O
LP	O
Biosynthesis	O
of	O
steroidsup3	O
.	O
27	O
*	O
E	O
-	O
45CYP24A1	O
,	O
FDPS	O
,	O
HMGCR	O
,	O
IDI1	O
,	O
SC5DL	O
LP	O
Glucocorticoid	O
receptor	O
signalingup3	O
.	O
57	O
*	O
E	O
-	O
312CDKN1C	O
,	O
CXCL3	O
,	O
IL10	O
,	O
MAP3K1	O
,	O
NCOA2	O
,	O
NFKBIB	O
,	O
NR3C1	O
,	O
POLR2B	O
,	O
PRKACB	O
,	O
RRAS2	O
,	O
SLPI	O
,	O
SMARCA4	O
LP	O
G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
22	O
*	O
E	O
-	O
24CCNE1	O
,	O
CDC25A	O
,	O
CDKN1A	O
,	O
E2F328	O
dpn	O
vs	O
.	O
188	O
dpn	O
AP	O
AMPK	O
signalingup1	O
.	O
50	O
*	O
E	O
-	O
310INSR	O
,	O
MAPK12	O
,	O
PPAT	O
,	O
PPM1A	O
,	O
PPP2CA	O
,	O
PPP2R3A	O
,	O
PRKAA2	O
,	O
SMARCA2	O
,	O
SRC	O
,	O
STK11	O
AP	O
Fatty	O
acid	O
metabolismup1	O
.	O
28	O
*	O
E	O
-	O
28ACADSB	O
,	O
ALDH1A1	O
,	O
CYP1B1	O
,	O
CYP2D6	O
,	O
CYP3A4	O
,	O
CYP4A11	O
,	O
CYP4B1	O
,	O
PECI	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown8	O
.	O
33	O
*	O
E	O
-	O
37ANAPC5	O
,	O
CDK1	O
,	O
PLK1	O
,	O
PLK2	O
,	O
PPP2R1B	O
,	O
SLK	O
,	O
WEE1	O
AP	O
VEGF	O
signalingdown7	O
.	O
3	O
*	O
E	O
-	O
39AKT3	O
,	O
BCL2	O
,	O
KDR	O
,	O
NOS3	O
,	O
PRKCB	O
,	O
RAC2	O
,	O
RRAS	O
,	O
VCL	O
,	O
VEGFC	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup1	O
.	O
07	O
*	O
E	O
-	O
27ACAA1	O
,	O
ACAT1	O
,	O
ALDH1B1	O
,	O
AUH	O
,	O
ECH1	O
,	O
IVD	O
,	O
IWS1	O
LP	O
Fatty	O
acid	O
elongation	O
in	O
mitochondriaup2	O
.	O
05	O
*	O
E	O
-	O
23ACAA1	O
,	O
AUH	O
,	O
ECH1	O
LP	O
mTOR	O
signalingup2	O
.	O
65	O
*	O
E	O
-	O
210AKT3	O
,	O
DDIT4	O
,	O
EIF4B	O
,	O
EIF4G3	O
,	O
PPP2R1B	O
,	O
PRKAB2	O
,	O
PRKAG1	O
,	O
PRKAG2	O
,	O
TSC1	O
,	O
VEGFA	O
LP	O
Actin	O
cytoskeleton	O
signalingdown7	O
.	O
99	O
*	O
E	O
-	O
524ACTB	O
,	O
ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CD14	O
,	O
CFL1	O
,	O
F2R	O
,	O
FGD1	O
,	O
LBP	O
,	O
MAP2K1	O
,	O
MYH9	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
TMSB4X	O
,	O
TMSL3	O
,	O
WASF1	O
LP	O
RhoA	O
signalingdow5	O
.	O
05	O
*	O
E	O
-	O
3n12ACTB	O
,	O
ACTR2	O
,	O
ARHGAP1	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
WASF1	O
LP	O
Rac	O
signalingdown4	O
.	O
34	O
*	O
E	O
-	O
312ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
MAP2K1	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
WASF1	O
LP	O
Complement	O
systemdown2	O
.	O
17	O
*	O
E	O
-	O
25C2	O
,	O
C7	O
,	O
C9	O
,	O
CFB	O
,	O
MBL2	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

This	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Tarbiat	O
Modares	O
University	O
(	O
registration	O
number	O
:	O
IR	O
.	O
TMU	O
.	O
REC	O
.	O
1394	O
.	O
120	O
).	O

Vitamin	O
D	O
is	O
likely	O
safe	O
during	O
pregnancy	O
and	O
breast	O
feeding	O
when	O
taken	O
by	O
mouth	O
in	O
recommended	O
amounts	O
,	O
that	O
is	O
10	O
mcg	O
(	O
400	O
USP	O
units	O
)	O
of	O
vitamin	O
D	O
daily	O
in	O
normal	O
pregnancy	O
.	O

Assessing	O
cognitive	O
development	O
differences	O
in	O
infancy	O
and	O
childhood	O
is	O
fraught	O
with	O
difficulties	O
due	O
to	O
the	O
nature	O
of	O
childhood	O
development	O
and	O
the	O
accurate	O
measurement	O
of	O
such	O
.	O

Sustained	O
advocacy	O
in	O
tackling	O
micronutrient	O
deficiencies	O
at	O
national	O
and	O
international	O
policy	O
levels	O
is	O
also	O
a	O
prerequisite	O
to	O
the	O
attainment	O
of	O
Millennium	O
Development	O
Goals	O
4	O
and	O
5	O
.	O

Interestingly	B
,	O
epidemiological	O
studies	O
in	O
women	O
showed	O
that	O
maternal	O
malnutrition	O
during	O
pregnancy	O
can	O
result	O
in	O
fetal	O
growth	O
retardation	O
[	O
11	O
,	O
12	O
].	O

Critics	O
of	O
these	O
genetic	O
predisposition	O
argued	O
that	O
since	O
many	O
genes	O
are	O
involved	O
in	O
the	O
etiology	O
of	O
autism	O
,	O
the	O
role	O
of	O
any	O
single	O
gene	O
polymorphism	O
in	O
causing	O
autism	O
is	O
small	O
.	O

Results	O
Demographic	O
and	O
underlying	O
variables	O
from	O
the	O
two	O
groups	O
are	O
presented	O
inTable	O
1	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Levels	O
of	O
adiposity	O
in	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
of	O
rat	O
adult	O
offspring	O
at	O
postnatal	O
weeks	O
21	O
–	O
23	O
†	O
.	O
MaleFemaleTwo	O
-	O
way	O
ANOVACC	O
(	O
n	O
=	O
12	O
)	O
RC	O
(	O
n	O
=	O
15	O
)	O
CC	O
(	O
n	O
=	O
11	O
)	O
RC	O
(	O
n	O
=	O
17	O
)	O
InteractionPrenatal	O
dietSex	O
Perirenal	O
fat	O
(	O
g	O
)	O
8	O
.	O
90	O
±	O
0	O
.	O
4112	O
.	O
30	O
±	O
0	O
.	O
64	O
***	O
4	O
.	O
82	O
±	O
0	O
.	O
36	O
***	O
5	O
.	O
73	O
±	O
0	O
.	O
69	O
$$$	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
214	O
,	O
P	O
=	O
0	O
.	O
045	O
F	O
(	O
1	O
,	O
51	O
)=	O
12	O
.	O
542	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
76	O
.	O
281	O
,	O
P	O
<	O
0	O
.	O
001Perirenal	O
fat	O
/	O
BW	O
(%)	O
1	O
.	O
97	O
±	O
0	O
.	O
082	O
.	O
47	O
±	O
0	O
.	O
12	O
*	O
1	O
.	O
80	O
±	O
0	O
.	O
122	O
.	O
06	O
±	O
0	O
.	O
19	O
$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
106	O
,	O
P	O
=	O
0	O
.	O
017nsPerigonadal	O
fat	O
(	O
g	O
)	O
9	O
.	O
32	O
±	O
0	O
.	O
6111	O
.	O
32	O
±	O
0	O
.	O
70	O
*	O
6	O
.	O
14	O
±	O
0	O
.	O
67	O
**	O
7	O
.	O
2	O
±	O
0	O
.	O
49	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
059	O
,	O
P	O
=	O
0	O
.	O
049	O
F	O
(	O
1	O
,	O
51	O
)=	O
34	O
.	O
261	O
,	O
P	O
<	O
0	O
.	O
001Perigonadal	O
fat	O
/	O
BW	O
(%)	O
2	O
.	O
06	O
±	O
0	O
.	O
122	O
.	O
27	O
±	O
0	O
.	O
132	O
.	O
29	O
±	O
0	O
.	O
212	O
.	O
66	O
±	O
0	O
.	O
14nsNs	O
F	O
(	O
1	O
,	O
51	O
)=	O
4	O
.	O
111	O
,	O
P	O
=	O
0	O
.	O
048Abdominal	O
fat	O
(	O
g	O
)	O
18	O
.	O
22	O
±	O
0	O
.	O
9423	O
.	O
63	O
±	O
1	O
.	O
14	O
**	O
10	O
.	O
96	O
±	O
0	O
.	O
96	O
***	O
12	O
.	O
95	O
±	O
1	O
.	O
11	O
$$$	O
ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
11	O
.	O
302	O
,	O
P	O
=	O
0	O
.	O
001	O
F	O
(	O
1	O
,	O
51	O
)=	O
66	O
.	O
545	O
,	O
P	O
<	O
0	O
.	O
001Abdominal	O
fat	O
/	O
BW	O
(%)	O
4	O
.	O
03	O
±	O
0	O
.	O
184	O
.	O
74	O
±	O
0	O
.	O
204	O
.	O
15	O
±	O
0	O
.	O
284	O
.	O
72	O
±	O
0	O
.	O
30ns	O
F	O
(	O
1	O
,	O
51	O
)=	O
6	O
.	O
163	O
,	O
P	O
=	O
0	O
.	O
016ns	O
CC	O
,	O
offspring	O
from	O
control	O
-	O
fed	O
dams	O
;	O
RC	O
,	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
.	O

Ursodeoxycholic	O
acid	O
,	O
which	O
is	O
a	O
bile	O
acid	O
,	O
is	O
synthesized	O
chemically	O
from	O
cholic	O
acid	O
.	O

This	O
positive	O
correlation	O
between	O
cathelicidin	O
and	O
age	O
was	O
also	O
shown	O
in	O
the	O
oral	O
environment	O
when	O
examining	O
cathelicidin	O
concentrations	O
in	O
saliva	O
in	O
healthy	O
children	O
aged	O
2	O
to	O
18	O
years	O
[	O
30	O
].	O

of	O
education	O
or	O
less	O
and	O
23	O
(	O
30	O
.	O
3	O
%)	O
had	O
11	O
yrs	O
.	O

The	O
study	O
investigates	O
the	O
indicated	O
variables	O
from	O
early	O
pregnancy	O
to	O
infants	O
up	O
to	O
12	O
months	O
.	O

These	O
genes	O
display	O
diet	O
-	O
dependent	O
longitudinal	O
transcriptomic	O
regulation	O
(	O
Figure1	O
).	O

The	O
HV	O
pup	O
diet	O
brought	O
BDNF	O
expression	O
to	O
control	O
levels	O
but	O
the	O
HFol	O
pup	O
diet	O
only	O
attenuated	O
the	O
decrease	O
in	O
expression	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
(	O
Figure	O
5a	O
).	O

Intranasal	O
cromolyn	O
,	O
intranasal	O
steroids	O
,	O
and	O
montelukast	O
are	O
the	O
preferred	O
drugs	O
for	O
the	O
treatment	O
of	O
rhinitis	O
because	O
of	O
the	O
low	O
risk	O
of	O
systemic	O
effects	O
.	O

Although	B
no	O
causality	O
was	O
found	O
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

All	O
authors	O
have	O
interpreted	O
the	O
results	O
,	O
reviewed	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

The	O
mitochondria	O
of	O
BAT	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
uncoupling	O
protein	O
-	O
1	O
(	O
UCP1	O
)	O
in	O
the	O
inner	O
mitochondrial	O
membrane	O
.	O

Also	O
,	O
impaired	O
fetal	O
growth	O
,	O
in	O
particular	O
in	O
head	O
circumference	O
,	O
is	O
associated	O
with	O
nonoptimal	O
neurodevelopmental	O
outcome	O
[	O
4	O
].	O

Some	O
sires	O
may	O
have	O
high	O
breeding	O
value	O
for	O
both	O
IMF	O
and	O
YG	O
,	O
and	O
selection	O
of	O
such	O
sires	O
is	O
likely	O
to	O
be	O
beneficial	O
for	O
increasing	O
IMF	O
deposition	O
without	O
decreasing	O
YG	O
.	O

Consequently	O
,	O
these	O
studies	O
are	O
rarely	O
considered	O
acceptable	O
to	O
many	O
regulatory	O
authorities	O
and	O
are	O
not	O
specifically	O
requested	O
for	O
ethical	O
reasons	O
,	O
the	O
numbers	O
of	O
animals	O
needed	O
to	O
ensure	O
appropriate	O
statistical	O
power	O
would	O
be	O
both	O
unworkable	O
,	O
and	O
unethical	O
.	O

Overall	O
,	O
a	O
woman	O
requires	O
about	O
2	O
–	O
2	O
.	O
8	O
mg	O
of	O
iron	O
per	O
day	O
during	O
pregnancy	O
[	O
17	O
].	O

Bindon	O
[	O
115	O
]	O
suggested	O
that	O
maize	O
produces	O
increased	O
glucose	O
from	O
digestion	O
in	O
the	O
small	O
intestine	O
and	O
that	O
steam	O
flaking	O
increases	O
digestion	O
in	O
both	O
the	O
rumen	O
and	O
small	O
intestine	O
.	O

These	O
associations	O
were	O
not	O
confounded	O
by	O
intake	O
of	O
sugar	O
in	O
early	O
childhood	O
,	O
which	O
was	O
unrelated	O
to	O
these	O
outcomes	O
.	O

First	O
,	O
our	O
determination	O
of	O
maternal	O
sleep	O
duration	O
and	O
snoring	O
was	O
based	O
on	O
reports	O
made	O
early	O
during	O
pregnancy	O
,	O
so	O
reporting	O
was	O
not	O
conditional	O
on	O
pregnancy	O
outcomes	O
or	O
on	O
signs	O
and	O
symptoms	O
of	O
GDM	O
.	O

Although	B
a	O
recent	O
pilot	O
randomized	O
trial	O
[	O
39	O
]	O
found	O
no	O
significant	O
impact	O
of	O
a	O
low	O
glycemic	O
index	O
diet	O
on	O
the	O
offspring	O
weight	O
of	O
overweight	O
/	O
obese	O
mothers	O
,	O
future	O
,	O
larger	O
randomized	O
trials	O
and	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
diet	O
in	O
pregnancy	O
are	O
needed	O
to	O
untangle	O
the	O
relationship	O
between	O
weight	O
status	O
,	O
time	O
in	O
pregnancy	O
of	O
nutrient	O
exposures	O
,	O
and	O
offspring	O
weight	O
outcomes	O
.	O

Participants	O
are	O
asked	O
according	O
to	O
the	O
~	O
140	O
food	O
items	O
listed	O
in	O
the	O
QFFQ	O
,	O
the	O
type	O
/	O
brand	O
,	O
cooking	O
methods	O
,	O
frequency	O
and	O
the	O
amount	O
of	O
all	O
food	O
and	O
drink	O
consumed	O
in	O
the	O
past	O
4	O
weeks	O
.	O

In	O
contrast	O
,	O
a	O
reduction	O
or	O
inhibition	O
of	O
Nampt	O
leads	O
to	O
reduced	O
NAD	O
+	O
concentration	O
and	O
SIRT1	O
activity	O
,	O
resulting	O
in	O
inhibition	O
of	O
osteocyte	O
differentiation	O
.	O

The	O
literature	O
also	O
contains	O
many	O
in	O
vitro	O
studies	O
investigating	O
the	O
role	O
of	O
specific	O
epigenetic	O
mechanisms	O
in	O
adverse	O
outcomes	O
induced	O
by	O
environmental	O
exposures	O
.	O

These	O
include	O
a	O
restriction	O
in	O
fat	O
and	O
simple	O
carbohydrate	O
intake	O
,	O
regular	O
distribution	O
of	O
meals	O
,	O
carbohydrate	O
foods	O
favoring	O
those	O
with	O
low	O
glycemic	O
index	O
,	O
and	O
caloric	O
restriction	O
for	O
those	O
who	O
are	O
obese	O
.	O

Summary	O
and	O
conclusions	O
Gestational	O
diabetes	O
is	O
a	O
common	O
disorder	O
which	O
in	O
the	O
majority	O
of	O
cases	O
,	O
should	O
initially	O
be	O
managed	O
by	O
dietary	O
measures	O
.	O

Depression	O
scores	O
were	O
divided	O
into	O
three	O
categories	O
,	O
<	O
9	O
,	O
9	O
–	O
13	O
,	O
and	O
>	O
13	O
,	O
and	O
using	O
the	O
Fisher	O
’	O
s	O
exact	O
test	O
,	O
the	O
comparisons	O
between	O
the	O
two	O
groups	O
were	O
conducted	O
.	O

Conclusions	O
Iron	O
deficiency	O
remains	O
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

We	O
will	O
conduct	O
analyses	O
at	O
the	O
infant	O
level	O
adjusted	O
for	O
the	O
cluster	O
randomisation	O
.	O

During	O
pregnancy	O
.	O

Characterizing	O
normal	O
variation	O
within	O
the	O
epigenome	O
between	O
non	O
-	O
disease	O
states	O
would	O
provide	O
valuable	O
data	O
to	O
begin	O
establishing	O
limits	O
of	O
epignetic	O
change	O
above	O
which	O
cellular	O
homeostasis	O
fails	O
and	O
epigenetic	O
toxicity	O
is	O
induced	O
.	O

This	O
data	O
-	O
driven	O
clustering	O
allowed	O
us	O
to	O
define	O
stable	O
classes	O
of	O
CpG	O
loci	O
demonstrating	O
similar	O
patterns	O
of	O
methylation	O
,	O
which	O
we	O
used	O
to	O
examine	O
associations	O
between	O
methylation	O
of	O
these	O
classes	O
of	O
CpGs	O
and	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
.	O

Maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
infants	O
belonging	O
to	O
the	O
high	O
Clostridium	O
cluster	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
36	O
(	O
1	O
.	O
05	O
,	O
5	O
.	O
30	O
)).	O

The	O
study	O
protocol	O
has	O
been	O
described	O
previously	O
[	O
11	O
,	O
12	O
]	O
and	O
further	O
information	O
can	O
be	O
found	O
atwww	O
.	O
alspac	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
,	O
which	O
contains	O
details	O
of	O
all	O
the	O
data	O
that	O
are	O
available	O
(	O
www	O
.	O
bris	O
.	O
ac	O
.	O
uk	O
/	O
alspac	O
/	O
researchers	O
/	O
data	O
-	O
access	O
/	O
data	O
-	O
dictionary	O
/).	O

Applying	O
a	O
single	O
factor	O
(	O
e	O
.	O
g	O
.,	O
nutritional	O
or	O
genetic	O
)	O
may	O
not	O
be	O
adequate	O
to	O
increase	O
IMF	O
deposition	O
.	O

The	O
fact	O
that	O
anaemia	O
frequently	O
does	O
occur	O
in	O
pregnancy	O
among	O
women	O
in	O
developing	O
countries	O
is	O
an	O
indication	O
that	O
preexisting	O
iron	O
stores	O
are	O
often	O
inadequate	O
and	O
physiological	O
adaptations	O
to	O
pregnancy	O
are	O
insufficient	O
to	O
meet	O
the	O
increased	O
requirements	O
[	O
4	O
].	O

Household	O
pets	O
were	O
assessed	O
during	O
pregnancy	O
and	O
serum	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
)	O
in	O
cord	O
blood	O
was	O
used	O
as	O
the	O
measure	O
of	O
vitamin	O
D	O
and	O
a	O
marker	O
of	O
maternal	O
level	O
.	O

We	O
found	O
the	O
lowest	O
odds	O
of	O
SGA	O
among	O
women	O
with	O
the	O
highest	O
T3	O
25OHD	O
concentration	O
,	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

The	O
main	O
groups	O
of	O
PUFA	O
are	O
omega	O
-	O
6	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
of	O
which	O
some	O
need	O
to	O
be	O
supplied	O
through	O
the	O
diet	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Schematic	O
representation	O
of	O
the	O
main	O
factors	O
described	O
in	O
the	O
review	O
,	O
which	O
modulate	O
UCP1	O
activity	O
.	O

However	O
these	O
socio	O
-	O
demographic	O
factors	O
were	O
not	O
independent	O
determinants	O
of	O
the	O
use	O
of	O
iron	O
supplements	O
.	O

Also	O
,	O
future	O
adequately	O
powered	O
randomized	O
clinical	O
trials	O
are	O
needed	O
to	O
determine	O
whether	O
modifying	O
maternal	O
prenatal	O
behaviors	O
and	O
GWG	O
can	O
prevent	O
offspring	O
obesity	O
.	O

Thus	O
,	O
optimal	O
asthma	O
treatment	O
is	O
crucial	O
,	O
as	O
the	O
risk	O
of	O
preeclampsia	O
,	O
premature	O
birth	O
,	O
low	O
birth	O
weight	O
,[	O
19	O
]	O
and	O
maternal	O
and	O
neonatal	O
hypoxia	O
and	O
morbidity	O
[	O
10	O
,	O
20	O
]	O
posed	O
by	O
undertreated	O
asthma	O
may	O
be	O
greater	O
than	O
that	O
from	O
the	O
use	O
of	O
oral	O
steroids	O
for	O
the	O
treatment	O
of	O
asthma	O
.	O

Introduction	O
Autism	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
method	O
of	O
prevention	O
;	O
thus	O
there	O
is	O
a	O
need	O
for	O
research	O
to	O
identify	O
its	O
possible	O
causative	O
factors	O
.	O

PubMed	O
Central	O
:	O

We	O
assessed	O
violation	O
of	O
the	O
proportionality	O
assumption	O
with	O
Schoenfeld	O
residuals	O
.	O

To	O
account	O
for	O
differences	O
in	O
baseline	O
and	O
trajectories	O
of	O
infant	O
gut	O
microbial	O
profiles	O
,	O
we	O
stratified	O
analyses	O
by	O
delivery	O
mode	O
.	O

During	O
exposure	O
to	O
sunlight	O
,	O
ultraviolet	O
B	O
(	O
UVB	O
)	O
(	O
wavelength	O
290	O
–	O
305	O
nm	O
)	O
penetrates	O
the	O
skin	O
and	O
converts	O
7	O
-	O
dehydrocholesterol	O
to	O
previtamin	O
D3	O
.	O

Animals	O
,	O
housing	O
,	O
mating	O
,	O
and	O
feeding	O
Adolescent	O
female	O
Wistar	O
rats	O
(	O
Harlan	O
,	O
Barcelona	O
,	O
Spain	O
)	O
weighing	O
191	O
.	O
7	O
±	O
2	O
.	O
6	O
g	O
were	O
individually	O
housed	O
in	O
standard	O
cages	O
and	O
maintained	O
in	O
controlled	O
room	O
conditions	O
at	O
21	O
±	O
1	O
°	O
C	O
room	O
temperature	O
,	O
40	O
±	O
5	O
%	O
relative	O
humidity	O
and	O
a	O
12	O
-	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
off	O
8	O
:	O
00	O
p	O
.	O
m	O
.).	O

Regular	O
supply	O
of	O
IFA	O
supplements	O
and	O
counselling	O
Upon	O
receiving	O
the	O
consent	O
icddr	O
,	O
b	O
study	O
staff	O
(	O
Field	O
Implementers	O
or	O
FI	O
)	O
will	O
hand	O
over	O
the	O
first	O
two	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
capsules	O
,	O
each	O
containing	O
60	O
mg	O
of	O
elemental	O
iron	O
and	O
400μg	O
of	O
folic	O
acid	O
.	O

A	O
significant	O
interaction	O
was	O
detected	O
between	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
genotype	O
and	O
vitamin	O
A	O
supplementation	O
for	O
IMF	O
content	O
in	O
the	O
LM	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
relationship	O
between	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
and	O
to	O
assess	O
the	O
influence	O
of	O
socio	O
-	O
demographic	O
factors	O
and	O
prenatal	O
care	O
.	O

As	O
mentioned	O
earlier	O
,	O
there	O
are	O
a	O
number	O
of	O
loci	O
within	O
PGCs	O
that	O
escape	O
the	O
two	O
global	O
DNA	O
demethylation	O
re	O
-	O
programing	O
events	O
.	O

There	O
is	O
limited	O
evidence	O
about	O
the	O
optimal	O
timing	O
of	O
IFA	O
supplementation	O
in	O
pregnancy	O
.	O

Concerning	O
hyperphagia	O
,	O
several	O
studies	O
have	O
reported	O
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	O
been	O
proposed	O
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Conclusions	O
Developmental	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
subtle	O
changes	O
in	O
protein	O
expression	O
in	O
the	O
nucleus	O
accumbens	O
.	O

Improved	O
human	O
exposure	O
data	O
could	O
be	O
collected	O
and	O
used	O
to	O
facilitate	O
the	O
use	O
of	O
more	O
relevant	O
doses	O
,	O
routes	O
of	O
administration	O
,	O
metabolites	O
and	O
mixtures	O
.	O

BAT	O
activation	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
or	O
thyroid	O
hormone	O
treatment	O
was	O
shown	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
(	O
Cawthorne	O
et	O
al	O
.,	O
1984	O
;	O
Forest	O
et	O
al	O
.,	O
1987	O
;	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

There	O
was	O
no	O
association	O
between	O
alcohol	O
intake	O
and	O
psychotic	O
symptoms	O
among	O
women	O
in	O
the	O
middle	O
and	O
low	O
psychotic	O
-	O
like	O
symptoms	O
groups	O
(	O
data	O
not	O
shown	O
).	O

Further	O
,	O
the	O
various	O
chapters	O
in	O
the	O
book	O
explain	O
the	O
basic	O
principles	O
in	O
nutrition	O
coupled	O
with	O
applications	O
in	O
different	O
clinical	O
conditions	O
.	O

Furthermore	O
,	O
adult	O
fracture	O
-	O
outcome	O
supplementation	O
studies21show	O
no	O
benefit	O
from	O
adding	O
calcium	O
.	O

The	O
hypernatremia	O
and	O
the	O
acute	O
kidney	O
injury	O
corrected	O
over	O
a	O
course	O
of	O
several	O
days	O
with	O
continued	O
fluid	O
administration	O
.	O

Additionally	O
,	O
differences	O
in	O
breast	O
milk	O
composition	O
due	O
to	O
maternal	O
diet	O
may	O
contribute	O
to	O
the	O
infant	O
gut	O
microbiome	O
in	O
breastfed	O
infants	O
.	O

These	O
proteins	O
are	O
essential	O
for	O
clathrin	O
-	O
mediated	O
endocytosis	O
,	O
a	O
role	O
of	O
particular	O
importance	O
in	O
neurons	O
for	O
neurotransmitter	O
release	O
[	O
31	O
].	O

Although	B
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
had	O
similar	O
effects	O
on	O
food	O
intake	O
,	O
weight	O
gain	O
and	O
blood	O
glucose	O
response	O
by	O
preventing	O
the	O
negative	O
consequences	O
of	O
the	O
HV	O
gestational	O
diet	O
,	O
they	O
differed	O
in	O
their	O
impact	O
on	O
expression	O
in	O
food	O
intake	O
regulatory	O
genes	O
in	O
the	O
hypothalamus	O
.	O

With	O
the	O
approval	O
from	O
the	O
IRB	O
,	O
pregnant	O
women	O
aged	O
less	O
than	O
the	O
legal	O
age	O
of	O
consent	O
in	O
Cameroon	O
(	O
21	O
years	O
)	O
and	O
attending	O
antenatal	O
care	O
services	O
were	O
considered	O
emancipated	O
minors	O
and	O
thus	O
allowed	O
to	O
provide	O
consent	O
for	O
themselves	O
.	O

Researchers	O
at	O
the	O
University	O
of	O
Texas	O
M	O
.	O
D	O
.	O

These	O
four	O
miRNAs	O
are	O
miR	O
-	O
124a	O
,	O
miR	O
-	O
142	O
-	O
3p	O
,	O
miR	O
-	O
30	O
and	O
miR	O
-	O
204	O
,	O
the	O
miRNAs	O
binding	O
sites	O
on	O
the	O
3	O
′	O
UTR	O
of	O
GR	O
were	O
shown	O
inFig	O
.	O

In	O
this	O
respect	O
,	O
government	O
recommendations	O
must	O
be	O
carefully	O
worded	O
,	O
as	O
1	O
study	O
found	O
that	O
avoidance	O
of	O
peanuts	O
was	O
overdone	O
among	O
pregnant	O
women	O
:	O
although	B
such	O
avoidance	O
was	O
recommended	O
only	O
for	O
women	O
with	O
atopy	O
risk	O
,	O
65	O
%	O
of	O
all	O
pregnant	O
women	O
had	O
avoided	O
peanuts	O
during	O
pregnancy	O
(	O
42	O
%	O
of	O
all	O
women	O
who	O
responded	O
had	O
heard	O
about	O
the	O
advice	O
,	O
eg	O
,	O
from	O
their	O
midwives	O
,	O
and	O
50	O
%	O
subsequently	O
changed	O
their	O
diet	O
)	O
[	O
101	O
].	O

While	O
some	O
evidence	O
suggests	O
that	O
meconium	O
aspiration	O
syndrome	O
may	O
have	O
a	O
link	O
as	O
a	O
contributing	O
factor	O
,	O
more	O
studies	O
are	O
needed	O
.	O

Therefore	O
,	O
the	O
definition	O
used	O
in	O
this	O
study	O
is	O
likely	O
to	O
be	O
relevant	O
.	O

IIH	O
was	O
associated	O
with	O
significant	O
morbidity	O
,	O
including	O
symptomatic	O
hypercalcaemia	O
and	O
nephrocalcinosis	O
.	O

values94	O
dpc	O
CCND20	O
.	O
022	O
-	O
1	O
.	O
25down0	O
.	O
0001	O
-	O
1	O
.	O
83down0	O
.	O
47	O
*	O
NCAPG0	O
.	O
019	O
-	O
1	O
.	O
73down0	O
.	O
003	O
-	O
1	O
.	O
58down0	O
.	O
47	O
*	O
MGMT0	O
.	O
031	O
+	O
1	O
.	O
12up0	O
.	O
011	O
+	O
1	O
.	O
32up0	O
.	O
53	O
**	O
GADD45B0	O
.	O
669	O
-	O
1	O
.	O
08n	O
.	O
r	O
.	O
0	O
.	O
522	O
+	O
1	O
.	O
17n	O
.	O
r0	O
.	O
68	O
***	O
1	O
dpn	O
SDHB0	O
.	O
0006	O
-	O
1	O
.	O
19down0	O
.	O
028	O
-	O
1	O
.	O
30down0	O
.	O
71	O
***	O
CCND20	O
.	O
711	O
-	O
1	O
.	O
06n	O
.	O
r	O
.	O
0	O
.	O
651	O
-	O
1	O
.	O
09n	O
.	O
r	O
.	O
0	O
.	O
46	O
*	O
PPARGC1A0	O
.	O
745	O
-	O
1	O
.	O
03n	O
.	O
r	O
.	O
0	O
.	O
761	O
-	O
1	O
.	O
04n	O
.	O
r	O
.	O
0	O
.	O
67	O
***	O
188	O
dpn	O
PRKAA10	O
.	O
0004	O
-	O
1	O
.	O
68down0	O
.	O
027	O
-	O
1	O
.	O
40down0	O
.	O
77	O
***	O
PRKAA20	O
.	O
009	O
-	O
1	O
.	O
36down0	O
.	O
095	O
-	O
1	O
.	O
25down0	O
.	O
10PPARGC1A0	O
.	O
126	O
-	O
1	O
.	O
35n	O
.	O
r	O
.	O
0	O
.	O
105	O
-	O
1	O
.	O
36n	O
.	O
r	O
.	O
0	O
.	O
86	O
***	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
*	O
calculated	O
by	O
factorial	O
normalisation	O
on	O
RPL10	O
expression	O
values	O
;	O
**	O
p	O
-	O
value	O
of	O
pamn	O
'	O
rho	O
;	O
n	O
.	O
r	O
.	O

Examples	O
include	O
the	O
occurrence	O
of	O
generalized	O
eczema	O
requiring	O
identification	O
of	O
the	O
cause	O
before	O
treatment	O
or	O
a	O
suspected	O
allergy	O
to	O
a	O
drug	O
needed	O
for	O
therapy	O
of	O
the	O
mother	O
(	O
eg	O
,	O
penicillin	O
for	O
treating	O
syphilis	O
)	O
[	O
50	O
].	O

Regarding	O
formal	O
education	O
,	O
25	O
.	O
5	O
%	O
had	O
completed	O
less	O
than	O
8	O
years	O
of	O
school	O
,	O
whereas	O
34	O
.	O
0	O
%	O
had	O
a	O
university	O
degree	O
.	O

If	O
the	O
proportion	O
of	O
non	O
-	O
urbanized	O
participants	O
was	O
high	O
in	O
the	O
study	O
population	O
this	O
could	O
have	O
confounded	O
our	O
results	O
,	O
nevertheless	O
this	O
is	O
not	O
the	O
case	O
in	O
the	O
Swedish	O
population	O
.	O

CC	O
and	O
RC	O
females	O
showed	O
a	O
lower	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
than	O
those	O
of	O
the	O
respective	O
CC	O
and	O
RC	O
males	O
.	O

Over	O
the	O
past	O
several	O
decades	O
,	O
continuing	O
research	O
has	O
been	O
conducted	O
,	O
and	O
much	O
literature	O
has	O
been	O
published	O
that	O
has	O
supported	O
the	O
existence	O
of	O
the	O
links	O
between	O
autism	O
and	O
factors	O
that	O
relate	O
to	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
research	O
council	O
(	O
research	O
project	O
number	O
:	O
193053	O
)	O
and	O
ethics	O
committee	O
(	O
research	O
ethics	O
number	O
:	O
IR	O
.	O
MUI	O
.	O
REC193053	O
).	O

The	O
latter	O
tend	O
to	O
live	O
and	O
work	O
in	O
a	O
more	O
closed	O
indoor	O
environment	O
and	O
thus	O
suffer	O
greater	O
exposure	O
to	O
indoor	O
pollutants	O
(	O
e	O
.	O
g	O
.,	O
polychlorinated	O
biphenyls	O
,	O
phthalates	O
,	O
phenols	O
,	O
flame	O
retardants	O
)	O
[	O
29	O
].	O

In	O
the	O
first	O
dimension	O
,	O
rehydrated	O
strips	O
were	O
focused	O
using	O
an	O
ElectrophoretIQ3	O
isoelectric	O
focusing	O
system	O
(	O
Proteome	O
Systems	O
)	O
for	O
a	O
total	O
of	O
120	O
kVh	O
.	O

RNA	O
was	O
quantified	O
by	O
spectrometry	O
with	O
a	O
NanoDrop	O
ND	O
-	O
1000	O
spectrophotometer	O
(	O
PEQLAB	O
,	O
Erlangen	O
,	O
Germany	O
).	O

Indeed	O
,	O
for	O
the	O
risk	O
of	O
GDM	O
an	O
opposite	O
effect	O
of	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
observed	O
depending	O
on	O
fetal	O
sex	O
.	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

It	O
is	O
also	O
relevant	O
to	O
note	O
that	O
Hibbeln	O
et	O
al	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	B
interest	B
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

Both	O
the	O
tails	O
and	O
globular	O
domains	O
of	O
histones	O
can	O
undergo	O
multiple	O
posttranslational	O
modifications	O
,	O
including	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ADP	O
ribosylation	O
,	O
ubiquitination	O
and	O
sumoylation	O
,	O
giving	O
rise	O
to	O
the	O
so	O
-	O
called	O
histone	O
code	O
(	O
Strahl	O
&	O
Allis2000	O
;	O
Turner2000	O
;	O
Jenuwein	O
&	O
Allis2001	O
;	O
Bhaumik	O
et	O
al	O
.	O
2007	O
;	O
Kouzarides2007	O
;	O
Suganuma	O
&	O
Workman2011	O
).	O

Also	O
,	O
the	O
dietary	O
intake	O
of	O
PUFA	O
was	O
negatively	O
correlated	O
with	O
the	O
severity	O
of	O
psychotic	O
symptoms	O
in	O
patients	O
with	O
schizophrenia	O
[	O
15	O
].	O

However	O
,	O
it	O
is	O
important	O
not	O
to	O
put	O
the	O
mother	O
on	O
a	O
rigid	O
elimination	O
diet	O
because	O
this	O
could	O
negatively	O
influence	O
the	O
nutrition	O
of	O
both	O
the	O
mother	O
and	O
the	O
growing	O
infant	O
[	O
48	O
].	O

The	O
fattening	O
period	O
can	O
be	O
divided	O
into	O
early	O
and	O
late	O
periods	O
,	O
during	O
which	O
the	O
concentrate	O
is	O
mainly	O
fed	O
with	O
a	O
small	O
portion	O
of	O
roughage	O
.	O

Obesogenic	O
phenotype	O
of	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
multivitamin	O
diet	O
is	O
prevented	O
by	O
a	O
post	O
-	O
weaning	O
high	O
multivitamin	O
or	O
high	O
folate	O
diet	O
Abstract	O
Background	O
High	O
multivitamin	O
(	O
10	O
-	O
fold	O
AIN	O
-	O
93G	O
,	O
HV	O
)	O
diets	O
fed	O
during	O
pregnancy	O
to	O
Wistar	O
rats	O
increase	O
characteristics	O
of	O
metabolic	O
syndrome	O
in	O
offspring	O
when	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Adequacy	O
of	O
energy	O
intake	O
in	O
total	O
sample	O
and	O
stratified	O
by	O
the	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
PPBMI	O
)	O
classification	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
gestational	O
diabetes	O
mellitus	O
.	O

However	B
,	O
when	O
each	O
pregnancy	O
complication	O
was	O
analysed	O
separately	O
,	O
a	O
53	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
with	O
high	O
vitamin	O
D	O
status	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
status	O
(	O
aRR	O
:	O
0	O
.	O
47	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
23	O
,	O
0	O
.	O
96	O
).	O

The	O
perinatal	O
mortality	O
rate	O
was	O
2	O
.	O
6	O
%	O
in	O
these	O
women	O
with	O
‘	O
mild	O
GDM	O
’	O
in	O
the	O
1970s	O
,	O
compared	O
to	O
0	O
.	O
7	O
%,	O
in	O
the	O
1980s	O
after	O
routine	O
treatment	O
had	O
been	O
introduced	O
for	O
this	O
group	O
.	O

Assuming	O
a	O
crude	O
birth	O
rate	O
of	O
23	O
per	O
1000	O
people	O
,	O
10	O
%	O
loss	O
of	O
pregnancies	O
before	O
birth	O
and	O
15	O
%	O
loss	O
to	O
follow	O
up	O
each	O
cluster	O
will	O
yield	O
300	O
births	O
over	O
15	O
months	O
,	O
and	O
this	O
will	O
be	O
sufficient	O
to	O
reach	O
the	O
desired	O
sample	O
size	O
.	O

The	O
primary	O
outcome	O
variable	O
was	O
a	O
composite	O
of	O
neonatal	O
hypoglycemia	O
,	O
respiratory	O
distress	O
,	O
need	O
for	O
phototherapy	O
,	O
birth	O
trauma	O
,	O
Apgar	O
score	O
less	O
than	O
7	O
,	O
or	O
prematurity	O
.	O

(	O
2006	O
)],	O
presence	O
within	O
1	O
kb	O
of	O
at	O
least	O
one	O
of	O
258	O
computationally	O
predicted	O
transcription	O
factor	O
binding	O
site	O
(	O
TFBS	O
)	O
sequences	O
obtained	O
from	O
the	O
tfbsConsSites	O
track	O
of	O
the	O
University	O
of	O
California	O
–	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genomes	O
Browser	O
site	O
(	O
TFBS	O
z	O
-	O
score	O
>	O
2	O
)	O
(	O
Kent	O
et	O
al	O
.	O

Different	O
factors	O
can	O
partially	O
explain	O
the	O
discrepancies	O
found	O
in	O
food	O
preferences	O
.	O

According	O
to	O
USDA	O
nutrition	O
data	O
,	O
the	O
main	O
food	O
sources	O
of	O
Vitamin	O
D	O
are	O
cheese	O
(	O
7	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
egg	O
yolk	O
(	O
5	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
canned	O
sardine	O
(	O
4	O
.	O
8	O
μg	O
/	O
100	O
g	O
),	O
butter	O
(	O
1	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
and	O
animal	O
organs	O
and	O
meat	O
products	O
(	O
less	O
than	O
1	O
%)	O
[	O
5	O
].	O

In	O
a	O
population	O
-	O
based	O
Swedish	O
study	O
of	O
2	O
,	O
668	O
men	O
followed	O
for	O
10	O
-	O
years	O
,	O
investigators	O
reported	O
that	O
the	O
multivariable	O
adjusted	O
relative	O
risk	O
for	O
incident	O
type	O
2	O
diabetes	O
was	O
highest	O
for	O
obese	O
snorers	O
(	O
OR	O
=	O
7	O
.	O
0	O
;	O
95	O
%	O
CI	O
2	O
.	O
9	O
-	O
16	O
.	O
9	O
)	O
than	O
for	O
lean	O
non	O
-	O
snorers	O
[	O
38	O
].	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
10	O
.	O
1186	O
/	O
s40168	O
-	O
018	O
-	O
0490	O
-	O
8	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Methods	O
We	O
conducted	O
a	O
follow	O
up	O
study	O
of	O
infants	O
born	O
to	O
women	O
who	O
participated	O
in	O
the	O
LIMIT	O
trial	O
during	O
pregnancy	O
.	O

The	O
fieldworkers	O
obtained	O
written	O
informed	O
consent	O
from	O
the	O
mother	O
,	O
father	O
,	O
or	O
another	O
senior	O
family	O
member	O
before	O
recruitment	O
;	O
allocated	O
the	O
unique	O
identification	O
number	O
(	O
sequentially	O
);	O
and	O
gave	O
the	O
first	O
dose	O
of	O
vitamin	O
D3or	O
placebo	O
.	O

Most	O
marbling	O
fat	O
is	O
deposited	O
between	O
muscle	O
fibre	O
bundles	O
in	O
the	O
perimysial	O
connective	O
tissue	O
in	O
beef	O
cattle	O
[	O
4	O
].	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Box	O
1	O
.	O

Wang	O
et	O
al	O
[	O
144	O
]	O
suggested	O
that	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
competes	O
with	O
PPARG	O
for	O
binding	O
to	O
the	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
).	O

Interestingly	B
,	O
increased	O
FDG	O
uptake	O
was	O
also	O
noted	O
in	O
the	O
subcutaneous	O
fat	O
,	O
in	O
particular	O
in	O
the	O
pelvic	O
area	O
and	O
over	O
the	O
lower	O
extremities	O
.	O

Identifying	O
and	O
understanding	O
environmentally	O
induced	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
may	O
lead	O
to	O
adverse	O
outcomes	O
is	O
vital	O
for	O
protecting	O
public	O
health	O
.	O

The	O
"	O
high	O
level	O
symptoms	O
group	O
"	O
included	O
women	O
with	O
frequent	O
experiences	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(≥	O
3	O
"	O
almost	O
always	O
"	O
or	O
"	O
often	O
"	O
answers	O
).	O

At	O
the	O
end	O
of	O
each	O
interview	O
,	O
the	O
data	O
collector	O
will	O
store	O
the	O
data	O
on	O
the	O
local	O
device	O
and	O
then	O
upload	O
the	O
data	O
to	O
the	O
central	O
server	O
after	O
the	O
end	O
of	O
a	O
day	O
’	O
s	O
work	O
.	O

Distinct	O
species	O
and	O
model	O
systems	O
metabolize	O
xenobiotics	O
differently	O
depending	O
on	O
their	O
specific	O
enzymatic	O
profiles	O
.	O

Results	O
Geographical	O
accessibility	O
and	O
perceived	O
quality	O
of	O
care	O
were	O
the	O
predominant	O
reasons	O
for	O
choosing	O
or	O
changing	O
a	O
site	O
for	O
ANC	O
.	O

2011	O
;	O
Lester	O
and	O
Padbury	O
2009	O
).	O

The	O
supernatant	O
was	O
reduced	O
and	O
alkylated	O
in	O
5	O
mM	O
tributylphosphine	O
(	O
TBP	O
)	O
and	O
1M	O
acrylamide	O
monomer	O
at	O
room	O
temperature	O
for	O
2	O
hr	O
.	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

Lesions	O
of	O
testis	O
and	O
epididymis	O
associated	O
with	O
prenatal	O
diethylstilbestrol	O
exposure	O
.	O

Rodent	O
models	O
The	O
deleterious	O
effects	O
of	O
exposures	O
to	O
environmental	O
factors	O
in	O
human	O
cohorts	O
have	O
stimulated	O
investigations	O
of	O
environmentally	O
induced	O
toxicity	O
in	O
rodent	O
models	O
.	O

However	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
requires	O
an	O
additional	O
hydroxylation	O
in	O
the	O
kidneys	O
to	O
form	O
the	O
biologically	O
active	O
form	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
.	O

Conclusion	O
.	O

Furthermore	O
,	O
IMF	O
has	O
a	O
higher	O
expression	O
of	O
glucose	O
transporter	O
4	O
,	O
which	O
is	O
responsible	O
for	O
uptake	O
of	O
glucose	O
in	O
adipose	O
tissues	O
,	O
compared	O
to	O
subcutaneous	O
fat	O
(	O
reviewed	O
in	O
[	O
90	O
]).	O

Understanding	O
the	O
factors	O
affecting	O
IMF	O
deposition	O
and	O
the	O
mechanisms	O
responsible	O
for	O
its	O
deposition	O
is	O
important	O
when	O
manipulating	O
IMF	O
deposition	O
.	O

Across	O
binding	O
sites	O
of	O
transcription	O
factors	O
overrepresented	O
within	O
1	O
kb	O
of	O
loci	O
,	O
we	O
compared	O
the	O
distribution	O
of	O
statistics	O
representing	O
the	O
association	O
between	O
CpG	O
-	O
specific	O
average	O
β	O
-	O
value	O
and	O
each	O
repetitive	O
element	O
methylation	O
markers	O
.	O

2	O
Data	O
collection	O
per	O
phase	O
during	O
the	O
NuPED	O
study	O
.	O

Protein	O
spots	O
that	O
were	O
significantly	O
altered	O
were	O
excised	O
for	O
identification	O
by	O
mass	O
spectrometry	O
.	O

We	O
also	O
collected	O
samples	O
at	O
other	O
times	O
(	O
appendix	O
)	O
from	O
a	O
different	O
set	O
of	O
randomly	O
selected	O
children	O
to	O
check	O
fluctuations	O
in	O
serum	O
concentrations	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

Measurement	O
data	O
were	O
presented	O
as	O
mean	O
±	O
for	O
standard	O
deviation	O
.	O

Hence	O
,	O
pre	O
-	O
pregnancy	O
BMI	O
appears	B
to	I
be	I
a	O
determining	O
factor	O
in	O
creating	O
the	O
difference	O
and	O
the	O
amount	O
of	O
maternal	O
plasma	O
visfatin	O
during	O
pregnancy	O
,	O
which	O
can	O
predict	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
and	O
maternal	O
outcomes	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
case	O
is	O
the	O
first	O
report	O
of	O
AAOC	O
in	O
pregnancy	O
.	O

The	O
EPA	O
has	O
mapped	O
521	O
abandoned	O
uranium	O
mines	O
on	O
the	O
reservation	O
,	O
ranging	O
from	O
small	O
holes	O
dug	O
by	O
a	O
single	O
prospector	O
into	O
the	O
side	O
of	O
a	O
mesa	O
to	O
large	O
commercial	O
mining	O
operations	O
.	O
1The	O
Navajo	O
people	O
did	O
not	O
have	O
a	O
word	O
for	O
“	O
radioactivity	O
”	O
when	O
mining	O
outfits	O
looking	O
for	O
vanadium2and	O
uranium3began	O
moving	O
onto	O
their	O
land	O
in	O
the	O
1940s	O
,	O
and	O
they	O
did	O
not	O
understand	O
that	O
radiation	O
could	O
be	O
dangerous	O
.	O

Buffy	O
coats	O
are	O
stored	O
in	O
1	O
:	O
1	O
vol	O
:	O
vol	O
RNA	O
later	O
(	O
Ambion	O
).	O

These	O
neuroendocrine	O
cells	O
are	O
believed	O
to	O
be	O
of	O
neural	O
crest	O
origin	O
,	O
thus	O
having	O
a	O
separate	O
lineage	O
from	O
the	O
endoderm	O
-	O
derived	O
follicular	O
thyroid	O
cells	O
.	O

We	O
consider	O
this	O
risk	O
,	O
and	O
the	O
impact	O
on	O
the	O
validity	O
of	O
our	O
findings	O
to	O
be	O
low	O
.	O

Forty	O
participants	O
in	O
this	O
study	O
had	O
plasma	O
samples	O
collected	O
at	O
two	O
subsequent	O
yearly	O
visits	O
,	O
spaced	O
roughly	O
twelve	O
months	O
apart	O
.	O

Briefly	O
,	O
they	O
proposed	O
that	O
mesenchymal	O
stem	O
cells	O
are	O
first	O
committed	O
to	O
the	O
myogenic	O
and	O
adipogenic	O
–	O
fibrogenic	O
cell	O
lineages	O
during	O
fetal	O
muscle	O
development	O
[	O
16	O
].	O

Each	O
participant	O
is	O
requested	O
to	O
recall	O
all	O
foods	O
and	O
drinks	O
consumed	O
the	O
previous	O
day	O
from	O
when	O
she	O
woke	O
up	O
until	O
the	O
next	O
day	O
the	O
same	O
time	O
.	O

A	O
novel	O
observation	B
of	O
our	O
study	O
is	O
that	O
the	O
hypothalamic	O
feeding	O
pathways	O
respond	O
to	O
the	O
vitamin	O
content	O
of	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Frequent	O
review	O
and	O
titration	O
of	O
the	O
insulin	O
dosage	O
is	O
recommended	O
.	O

For	O
this	O
purpose	O
,	O
we	O
searched	O
the	O
current	O
literature	O
on	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
and	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
epidemiological	O
cohorts	O
and	O
rodent	O
models	O
in	O
PubMed	O
using	O
the	O
terms	O
in	O
Supplementary	O
Table	O
1	O
;	O
defining	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
as	O
environmental	O
factors	O
(	O
chemicals	O
,	O
radiation	O
and	O
lifestyle	O
factors	O
(	O
including	O
alcohol	O
,	O
nutrition	O
and	O
smoking	O
))	O
that	O
induce	O
adverse	O
effects	O
(	O
growth	O
retardation	O
,	O
fertility	O
problems	O
,	O
hormonal	O
changes	O
,	O
reproductive	O
and	O
/	O
or	O
other	O
organ	O
-	O
and	O
system	O
-	O
specific	O
abnormalities	O
(	O
including	O
immune	O
disorders	O
,	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
))	O
and	O
are	O
associated	O
with	O
epigenetic	O
mechanisms	O
(	O
histone	O
modifications	O
,	O
DNA	O
methylation	O
,	O
non	O
-	O
coding	O
RNAs	O
(	O
ncRNAs	O
)	O
and	O
other	O
epigenetic	O
machinery	O
(	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
)).	O

The	O
remaining	O
piglets	O
were	O
cross	O
-	O
fostered	O
to	O
non	O
-	O
experimental	O
sows	O
of	O
2ndto	O
4thparities	O
,	O
which	O
were	O
on	O
the	O
AP	O
diet	O
during	O
gestation	O
.	O

Description	O
of	O
covariates	O
At	O
the	O
time	O
of	O
enrollment	O
in	O
the	O
study	O
,	O
a	O
45	O
to	O
60	O
-	O
minute	O
structured	O
questionnaire	O
was	O
administered	O
by	O
a	O
trained	O
interviewer	O
.	O

Another	O
factor	O
possibly	O
associated	O
with	O
pet	O
ownership	O
is	O
increased	O
Vitamin	O
D	O
among	O
family	O
members	O
as	O
pet	O
keeping	O
may	O
be	O
correlated	O
with	O
lifestyles	O
involving	O
increased	O
outdoor	O
exposure	O
,	O
such	O
as	O
dog	O
walking	O
.	O

Modest	O
limitations	O
of	O
this	O
study	O
include	O
the	O
use	O
of	O
data	O
from	O
medical	O
records	O
,	O
which	O
may	O
have	O
reduced	O
the	O
quality	O
of	O
covariate	O
data	O
used	O
in	O
this	O
study	O
.	O

This	O
statistical	O
pooling	O
of	O
several	O
studies	O
,	O
taking	O
into	O
account	O
the	O
size	O
of	O
individual	O
studies	O
,	O
confers	O
more	O
power	O
to	O
detect	O
a	O
potential	O
association	O
,	O
and	O
quantitative	O
meta	O
-	O
analyses	O
are	O
often	O
put	O
at	O
the	O
top	O
of	O
evidence	O
hierarchies	O
.	O

Conclusion	O
We	O
found	O
that	O
healthier	O
maternal	O
dietary	O
patterns	O
during	O
early	O
pregnancy	O
might	O
be	O
associated	O
with	O
lower	O
risk	O
of	O
low	O
birth	O
weight	O
.	O

Overall	O
,	O
handedness	O
appears	B
to	I
be	I
a	O
surrogate	O
marker	O
for	O
an	O
underlying	O
but	O
unidentified	O
risk	O
factor	O
that	O
interacts	O
with	O
seasonality	O
and	O
other	O
factors	O
to	O
possibly	O
explain	O
glioma	O
risk	O
.	O

Finally	O
,	O
visfatin	O
levels	O
were	O
compared	O
using	O
data	O
from	O
maternal	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Alternatively	O
,	O
higher	O
eggs	O
and	O
poultry	O
consumption	O
may	O
also	O
explain	O
the	O
high	O
detection	O
rate	O
.	O

Women	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
had	O
moved	O
and	O
their	O
medical	O
records	O
could	O
not	O
be	O
retrieved	O
.	O

Studies	O
have	O
shown	O
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
is	O
associated	O
with	O
psychological	O
symptoms	O
like	O
anxiety	O
,	O
depression	O
and	O
reduced	O
cognitive	O
function	O
[	O
26	O
,	O
27	O
].	O

Much	O
of	O
the	O
animal	O
studies	O
to	O
date	O
on	O
environmental	O
chemicals	O
have	O
involved	O
administration	O
of	O
high	O
doses	O
,	O
many	O
orders	O
of	O
magnitude	O
above	O
likely	O
exposures	O
in	O
real	O
human	O
populations	O
.	O

Several	O
studies	O
have	O
shown	O
that	O
fetal	O
nutritional	O
programming	O
affects	O
growth	O
and	O
/	O
or	O
beef	O
quality	O
,	O
including	O
marbling	O
.	O

The	O
proteins	O
with	O
calcium	O
-	O
related	O
functions	O
are	O
annotated	O
(	O
Fx	O
).	O

In	O
an	O
additional	O
analysis	O
of	O
the	O
association	O
between	O
alcohol	O
intake	O
and	O
psychotic	O
-	O
like	O
symptoms	O
,	O
we	O
categorized	O
women	O
into	O
never	O
drinkers	O
or	O
drinkers	O
,	O
and	O
used	O
drinkers	O
as	O
the	O
reference	O
category	O
.	O

A	O
study	O
by	O
Oken	O
et	O
al	O
.	O

Here	O
,	O
the	O
perception	O
of	O
the	O
past	O
users	O
is	O
the	O
only	O
driving	O
tool	O
to	O
refer	O
.	O

This	O
concept	O
of	O
phenotypic	O
plasticity	O
,	O
particularly	B
as	O
a	O
consequence	O
of	O
different	O
environments	O
in	O
early	O
life	O
,	O
implicates	O
epigenetic	O
mechanisms	O
and	O
has	O
fueled	O
research	O
into	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

The	O
MS	O
and	O
IMF	O
content	O
in	O
Angus	O
steers	O
increases	O
in	O
a	O
linear	O
fashion	O
with	O
increasing	O
HCW	O
from	O
208	O
to	O
380	O
kg	O
[	O
72	O
].	O

Of	B
note	I
,	O
one	O
of	O
these	O
children	O
was	O
obese	O
,	O
one	O
had	O
seasonal	O
allergies	O
treated	O
with	O
a	O
long	O
-	O
term	O
steroid	O
nasal	O
spray	O
,	O
and	O
the	O
third	O
had	O
a	O
history	O
of	O
febrile	O
seizures	O
.	O

From	O
the	O
final	O
analysis	O
ten	O
questionnaires	O
were	O
excluded	O
representing	O
drop	O
-	O
outs	O
(	O
refusals	O
after	O
the	O
initial	O
moment	O
of	O
the	O
study	O
or	O
incomplete	O
questionnaires	O
).	O

Thus	O
a	O
study	O
with	O
80	O
%	O
power	O
and	O
95	O
%	O
significance	O
needed	O
22	O
079	O
child	O
-	O
months	O
per	O
group	O
(	O
total	O
of	O
2454	O
children	O
for	O
18	O
months	O
follow	O
-	O
up	O
).	O

Discussion	O
This	O
systematic	O
review	O
of	O
observational	O
cohort	O
studies	O
demonstrates	O
an	O
association	O
between	O
consumption	O
of	O
one	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
during	O
pregnancy	O
and	O
better	O
offspring	O
neurodevelopment	O
outcomes	O
.	O

Data	O
include	O
date	O
and	O
country	O
of	O
birth	O
,	O
marital	O
status	O
,	O
educational	O
level	O
,	O
home	O
language	O
,	O
employment	O
status	O
,	O
household	O
income	O
,	O
number	O
of	O
members	O
in	O
the	O
household	O
,	O
and	O
beneficiaries	O
of	O
social	O
grants	O
.	O

Body	O
weight	O
and	O
caloric	O
intake	O
of	O
offspring	O
were	O
monitored	O
from	O
birth	O
(	O
PND0	O
)	O
to	O
adulthood	O
(	O
postnatal	O
weeks	O
21	O
–	O
23	O
).	O

investigated	O
the	O
role	O
of	O
supplemental	O
folate	O
,	O
zinc	O
and	O
antioxidants	O
(	O
vitamins	O
C	O
,	O
E	O
,	O
and	O
β	O
-	O
carotene	O
)	O
on	O
spermatocyte	O
aneuploidy	O
.	O

This	O
study	O
is	O
one	O
of	O
the	O
first	O
to	O
prospectively	O
examine	O
impacts	O
of	O
prenatal	O
diet	O
,	O
physical	O
activity	O
,	O
and	O
psychosocial	O
exposures	O
on	O
offspring	O
weight	O
outcomes	O
in	O
a	O
diverse	O
sample	O
.	O

This	O
variable	O
had	O
a	O
median	O
value	O
of	O
11	O
.	O
20	O
and	O
mode	O
value	O
of	O
4	O
.	O

The	O
different	O
epigenetic	O
pathways	O
converge	O
and	O
interact	O
to	O
regulate	O
gene	O
expression	O
at	O
multiple	O
levels	O
(	O
Figure	O
2	O
).	O

A	O
self	O
-	O
report	O
,	O
food	O
frequency	O
questionnaire	O
was	O
used	O
,	O
which	O
is	O
useful	O
in	O
ranking	O
nutrient	O
intakes	O
of	O
individual	O
subjects	O
but	O
can	O
be	O
subject	O
to	O
bias	O
,	O
particularly	O
in	O
obese	O
individuals	O
[	O
52	O
].	O

It	O
is	O
associated	O
with	O
inadequate	O
invasion	O
of	O
extravillous	O
trophoblasts	O
and	O
inadequate	O
angiogenesis	O
,	O
with	O
insufficient	O
conversion	O
of	O
arterial	O
spiral	O
arteries	O
in	O
the	O
decidua	O
[	O
1	O
].	O

The	O
statistical	O
calculation	O
involved	O
is	O
the	O
linear	O
multiple	O
regression	O
:	O
fixed	O
model	O
,	O
single	O
regression	O
coefficient	O
.	O

However	O
,	O
there	O
is	O
insufficient	O
evidence	O
to	O
implicate	O
any	O
one	O
perinatal	O
or	O
neonatal	O
factor	O
in	O
autism	O
etiology	O
,	O
although	B
there	O
is	O
some	O
evidence	O
to	O
suggest	O
that	O
exposure	O
to	O
a	O
broad	O
class	O
of	O
conditions	O
reflecting	O
general	O
compromises	O
to	O
perinatal	O
and	O
neonatal	O
health	O
may	O
increase	O
the	O
risk	O
.	O

Serum	O
vitamin	O
D3	O
level	O
was	O
found	O
to	O
be	O
low	O
(	O
4	O
.	O
7	O
ng	O
/	O
ml	O
).	O

Although	B
previous	O
small	O
surveys	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
common	O
in	O
Europe	O
[	O
29	O
],[	O
30	O
],	O
there	O
are	O
no	O
reliable	O
country	O
-	O
wide	O
estimates	O
of	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
European	O
countries	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
difference	O
between	O
the	O
two	O
groups	O
was	O
meaningful	O
concerning	O
over	O
-	O
time	O
reduction	O
of	O
depression	O
.	O

In	O
the	O
study	O
,	O
steers	O
from	O
dams	O
fed	O
a	O
corn	O
-	O
based	O
diet	O
during	O
late	O
gestation	O
had	O
a	O
lower	O
MS	O
compared	O
with	O
progeny	O
from	O
dams	O
fed	O
diets	O
low	O
in	O
starch	O
(	O
grass	O
hay	O
or	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
).	O

furthered	O
our	O
understanding	O
of	O
the	O
effects	O
of	O
paternal	O
folate	O
deficiency	O
[	O
6	O
].	O

Four	O
large	O
cohort	O
studies	O
conducted	O
across	O
Sweden	O
,	O
Australia	O
,	O
and	O
Denmark	O
found	O
that	O
an	O
Apgar	O
score	O
of	O
7	O
has	O
a	O
strong	O
predictive	O
value	O
of	O
autism	O
[	O
18	O
,	O
54	O
–	O
56	O
];	O
similar	O
findings	O
were	O
reported	O
by	O
Garderner	O
et	O
al	O
.	O

In	O
a	O
study	O
by	O
Kazemi	O
et	O
al	O
.,	O
in	O
67	O
mothers	O
with	O
term	O
birth	O
in	O
Zanjan	O
,	O
86	O
%	O
in	O
the	O
winter	O
and	O
46	O
%	O
in	O
the	O
summer	O
had	O
vitamin	O
D	O
levels	O
lower	O
than	O
25	O
ng	O
/.	O

Mechanisms	O
leading	O
to	O
aortic	O
dissection	O
involve	O
a	O
weakening	O
of	O
the	O
layers	O
of	O
the	O
aorta	O
allowing	O
blood	O
to	O
enter	O
the	O
media	O
and	O
separate	O
the	O
intimal	O
and	O
adventitial	O
layers	O
creating	O
a	O
false	O
lumen	O
.	O

For	O
these	O
patients	O
,	O
surgery	O
could	O
be	O
safely	O
performed	O
during	O
the	O
mid	O
-	O
trimester	O
or	O
delayed	O
until	O
delivery	O
without	O
worsening	O
prognosis3034	O
.	O

Our	O
findings	O
are	O
consistent	O
with	O
some	O
studies	O
in	O
nonpregnant	O
adults	O
and	O
children	O
showing	O
a	O
connection	O
between	O
higher	O
intake	O
of	O
sweets	O
and	O
soft	O
drinks	O
and	O
increased	O
weight	O
status	O
[	O
32	O
],	O
but	O
conflicting	O
results	O
have	O
been	O
reported	O
in	O
association	O
with	O
GWG	O
[	O
33	O
].	O

Glucose	O
response	O
to	O
a	O
glucose	O
load	O
was	O
measured	O
at	O
18	O
weeks	O
post	O
-	O
weaning	O
.	O

Such	O
findings	O
will	O
be	O
used	O
to	O
implement	O
informative	O
interventional	O
programs	O
to	O
control	O
impaired	O
fetal	O
growth	O
and	O
develop	O
practical	O
policies	O
to	O
improve	O
the	O
diet	O
quality	O
among	O
pregnant	O
women	O
.	O

Similar	O
studies	O
using	O
a	O
Swedish	O
medical	O
birth	O
registry	O
observed	O
different	O
factors	O
that	O
affected	O
autism	O
spectrum	O
disorders	O
.	O

One	O
paediatric	O
trial	O
showed	O
16	O
%	O
higher	O
rates	O
of	O
tuberculosis	O
symptom	O
resolution	O
,	O
29an	O
adult	O
trial	O
showed	O
23	O
%	O
greater	O
sputum	O
conversion	O
rate	O
at	O
6	O
months	O
,	O
30another	O
trial	O
showed	O
20	O
%	O
greater	O
restriction	O
of	O
BCG	O
-	O
lux	O
growth	O
in	O
blood	O
,	O
31another	O
trial	O
found	O
accelerated	O
sputum	O
conversion	O
only	O
in	O
a	O
certain	O
genotype	O
of	O
the	O
sample	O
,	O
20whereas	O
yet	B
another	O
found	O
no	O
significant	O
difference	O
in	O
sputum	O
conversion32in	O
the	O
intervention	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Due	O
to	O
the	O
normal	O
dietary	O
conditions	O
at	O
juvenile	O
and	O
adult	O
stages	O
the	O
alterations	O
found	O
here	O
can	O
be	O
regarded	O
as	O
fetal	O
nutritional	O
programming	O
.	O

Eligibility	O
criteria	O
included	O
nonsmoking	O
,	O
adults	O
(	O
age	O
>	O
18	O
years	O
),	O
fluency	O
in	O
English	O
,	O
access	O
to	O
telephone	O
,	O
gestational	O
age	O
between	O
10	O
and	O
16	O
weeks	O
,	O
singleton	O
pregnancy	O
,	O
no	O
current	O
or	O
history	O
of	O
eating	O
disorders	O
,	O
and	O
without	O
major	O
psychiatric	O
illness	O
(	O
i	O
.	O
e	O
.,	O
schizophrenia	O
,	O
bipolar	O
disorder	O
,	O
and	O
panic	O
/	O
anxiety	O
disorder	O
)	O
or	O
major	O
medical	O
problems	O
,	O
including	O
diabetes	O
,	O
stroke	O
,	O
and	O
cancer	O
.	O

Study	O
Limitations	O
This	O
study	O
provides	O
useful	O
data	O
of	O
the	O
relationship	O
between	O
serum	O
visfatin	O
and	O
the	O
children	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

Most	O
sleep	O
studies	O
,	O
however	O
,	O
have	O
excluded	O
pregnant	O
women	O
;	O
hence	O
very	O
little	O
is	O
known	O
about	O
how	O
insufficient	O
sleep	O
and	O
sleep	O
disordered	O
breathing	O
during	O
gestation	O
contribute	O
to	O
increased	O
risks	O
of	O
medical	O
complications	O
of	O
pregnancy	O
including	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

Although	B
,	O
laboratories	O
at	O
the	O
health	O
facilities	O
in	O
developing	O
countries	O
usually	O
lack	O
the	O
capacity	O
to	O
conduct	O
quality	O
blood	O
test	O
,	O
they	O
could	O
be	O
strengthened	O
to	O
provide	O
reliable	O
estimations	O
of	O
red	O
blood	O
cell	O
indices	O
such	O
as	O
haemoglobin	O
,	O
haematocrit	O
,	O
mean	O
cell	O
volume	O
,	O
mean	O
cell	O
haemoglobin	O
,	O
and	O
mean	O
cell	O
haemoglobin	O
concentration	O
.	O

The	O
intersection	O
of	O
commonly	O
regulated	O
genes	O
between	O
those	O
comparisons	O
was	O
discarded	O
because	O
regulation	O
of	O
these	O
genes	O
was	O
likely	O
due	O
to	O
physiologically	O
developmental	O
processes	O
.	O

1	O
Flow	O
chart	O
of	O
the	O
study	O
inclusion	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
and	O
their	O
infants	O
at	O
birthMeanSDBirth	O
weight	O
(	O
grams	O
)	O
a3542537	O
.	O
7Birth	O
length	O
(	O
cm	O
)	O
a502	O
.	O
3Gestational	O
age	O
at	O
delivery	O
(	O
days	O
)	O
28012	O
.	O
4Gestational	O
age	O
T1	O
(	O
days	O
)	O
7613	O
.	O
8Gestational	O
age	O
T3	O
(	O
days	O
)	O
23412	O
.	O
9Maternal	O
s	O
-	O
25OHD	O
T1	O
(	O
nmol	O
/	O
L	O
)	O
6424	O
.	O
4Maternal	O
s	O
-	O
25OHD	O
T3	O
(	O
nmol	O
/	O
L	O
)	O
7534	O
.	O
4N	O
(%)	O
Male	O
gender	O
of	O
infanta976	O
(	O
49	O
.	O
8	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
weight	O
or	O
length	O
)	O
93	O
(	O
4	O
.	O
5	O
)	O
Low	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
58	O
(	O
2	O
.	O
8	O
)	O
Preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
78	O
(	O
3	O
.	O
8	O
)	O
Spontaneous	O
preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
55	O
(	O
2	O
.	O
7	O
)	O
Pregnancy	O
loss97	O
(	O
4	O
.	O
7	O
)	O
Intrauterine	O
fetal	O
death	O
(≥	O
22	O
weeks	O
)	O
9	O
(	O
0	O
.	O
5	O
)	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
aLive	O
born	O
infants	O
only	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
The	O
pregnant	O
women	O
’	O
s	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
(	O
T1	O
)	O
and	O
third	O
(	O
T3	O
)	O
trimester	O
of	O
pregnancy	O
,	O
and	O
their	O
characteristics	O
(	O
mean	O
or	O
percent	O
)	O
grouped	O
by	O
25OHD	O
concentration	O
in	O
(	O
T1	O
)	O
T1	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N198291788565125	O
%	O
10	O
.	O
114	O
.	O
840	O
.	O
128	O
.	O
76	O
.	O
4BMI	O
T1	O
(	O
kg	O
/	O
m2	O
)	O
25	O
.	O
124	O
.	O
924	O
.	O
423	O
.	O
924	O
.	O
4Age	O
T1	O
(	O
years	O
)	O
29	O
.	O
430	O
.	O
931	O
.	O
632	O
.	O
032	O
.	O
4Born	O
in	O
Sweden	O
(%)	O
14	O
.	O
154	O
.	O
683	O
.	O
387	O
.	O
893	O
.	O
5Tobacco	O
use	O
T1	O
(%)	O
6	O
.	O
84	O
.	O
64	O
.	O
04	O
.	O
61	O
.	O
6Nulliparous	O
T1	O
(%)	O
34	O
.	O
842	O
.	O
042	O
.	O
643	O
.	O
142	O
.	O
7Vitamin	O
D	O
supplement	O
use	O
T1	O
(%)	O
10	O
.	O
628	O
.	O
245	O
.	O
256	O
.	O
662	O
.	O
9University	O
level	O
education	O
(%)	O
32	O
.	O
354	O
.	O
961	O
.	O
367	O
.	O
366	O
.	O
1Small	O
for	O
gestational	O
age	O
(%)	O
5	O
.	O
74	O
.	O
25	O
.	O
34	O
.	O
14	O
.	O
0Preterm	O
delivery	O
(%)	O
4	O
.	O
15	O
.	O
23	O
.	O
83	O
.	O
91	O
.	O
6Low	O
birth	O
weight	O
(%)	O
3	O
.	O
04	O
.	O
53	O
.	O
12	O
.	O
11	O
.	O
6Pregnancy	O
loss	O
(%)	O
6	O
.	O
35	O
.	O
64	O
.	O
55	O
.	O
10T3	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N163330473409443	O
%	O
9	O
.	O
018	O
.	O
226	O
.	O
022	O
.	O
524	O
.	O
4Small	O
for	O
gestational	O
age	O
(%)	O
7	O
.	O
55	O
.	O
54	O
.	O
74	O
.	O
62	O
.	O
3Preterm	O
delivery	O
(%)	O
4	O
.	O
31	O
.	O
23	O
.	O
62	O
.	O
21	O
.	O
6Low	O
birth	O
weight	O
(%)	O
4	O
.	O
30	O
.	O
32	O
.	O
71	O
.	O
21	O
.	O
4	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
Birth	O
size	O
and	O
preterm	O
delivery	O
In	O
total	O
,	O
93	O
(	O
4	O
.	O
5	O
%)	O
infants	O
were	O
born	O
SGA	O
.	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

Construction	O
validity	O
was	O
also	O
found	B
to	I
be	I
satisfactory	O
(	O
ANOVA	O
F	O
statistic	O
=	O
39	O
.	O
9	O
,	O
p	O
<	O
.	O
001	O
),	O
and	O
post	O
hoc	O
testing	O
revealed	O
statistically	O
significant	O
differences	O
between	O
the	O
mean	O
score	O
of	O
the	O
questionnaire	O
according	O
to	O
each	O
category	O
of	O
formal	O
education	O
(	O
4	O
.	O
9	O
for	O
1	O
–	O
4	O
years	O
of	O
formal	O
education	O
;	O
8	O
.	O
35	O
for	O
5	O
–	O
8	O
years	O
of	O
education	O
;	O
10	O
.	O
8	O
for	O
9	O
–	O
12	O
years	O
of	O
education	O
;	O
and	O
13	O
.	O
7	O
for	O
more	O
than	O
12	O
years	O
;	O
p	O
<	O
.	O
001	O
).	O

Comparable	O
results	O
were	O
documented	O
with	O
dietary	O
supplements	O
containing	O
iron	O
and	O
ironfortified	O
milk	O
[	O
30	O
,	O
31	O
].	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

Strengths	O
of	O
this	O
study	O
are	O
that	O
the	O
GraviD	O
cohort	O
is	O
representative	O
of	O
the	O
general	O
pregnant	O
population	O
in	O
terms	O
of	O
origin	O
,	O
education	O
,	O
parity	O
,	O
BMI	O
and	O
tobacco	O
use	O
[	O
25	O
],	O
which	O
increases	O
the	O
external	O
validity	O
of	O
the	O
findings	O
.	O

Hod	O
et	O
al	O
.	O

It	O
was	O
a	O
possible	O
reason	O
that	O
we	O
did	O
not	O
observe	O
any	O
relationship	O
between	O
antenatal	O
depression	O
score	O
and	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
.	O

Hypervitaminosis	O
D	O
is	O
thought	O
to	O
be	O
associated	O
with	O
a	O
rare	O
infant	O
disease	O
with	O
supravalvular	O
aortic	O
stenosis	O
,	O
elfin	O
facies	O
and	O
mental	O
retardation	O
.	O

In	O
contrast	O
,	O
LP	O
fetuses	O
showed	O
an	O
increased	O
expression	O
of	O
transcripts	O
associated	O
with	O
cell	O
division	O
within	O
the	O
corresponding	O
developmental	O
period	O
.	O

Analysis	O
of	O
Samples	O
Approximately	O
5	O
ml	O
whole	O
blood	O
was	O
collected	O
by	O
venipuncture	O
in	O
a	O
non	O
-	O
heparinized	O
tube	O
.	O

Supplements	O
containing	O
vitamin	O
D	O
were	O
used	O
by	O
43	O
%	O
in	O
T1	O
and	O
39	O
%	O
in	O
T3	O
-	O
mainly	O
multivitamins	O
[	O
19	O
].	O

We	O
also	O
hypothesised	O
that	O
the	O
early	O
start	O
to	O
IFA	O
supplements	O
would	O
not	O
increase	O
iron	O
-	O
related	O
side	O
effects	O
,	O
e	O
.	O
g	O
.	O

Further	O
,	O
analyses	O
were	O
based	O
on	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
follow	O
-	O
up	O
(	O
96	O
.	O
6	O
%	O
of	O
those	O
randomised	O
)	O
by	O
using	O
multiple	O
imputation	O
to	O
address	O
missing	O
data	O
for	O
infants	O
who	O
were	O
not	O
assessed	O
at	O
6	O
months	O
.	O

Similarly	O
,	O
dietary	O
forage	O
level	O
affected	O
MS	O
.	O
Jersey	O
steers	O
fed	O
a	O
low	O
forage	O
diet	O
(	O
6	O
%	O
Sudan	O
grass	O
,	O
6	O
%	O
alfalfa	O
hay	O
and	O
63	O
.	O
15	O
%	O
steam	O
-	O
flaked	O
corn	O
,	O
dry	O
matter	O
[	O
DM	O
]	O
basis	O
)	O
in	O
a	O
feedlot	O
finishing	O
diet	O
had	O
greater	O
MS	O
in	O
the	O
strip	O
loin	O
than	O
did	O
animals	O
fed	O
a	O
high	O
forage	O
level	O
diet	O
(	O
12	O
%	O
Sudan	O
grass	O
,	O
12	O
%	O
alfalfa	O
hay	O
and	O
51	O
.	O
20	O
%	O
steam	O
-	O
flaked	O
corn	O
)	O
[	O
121	O
].	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	O
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	B
to	I
be	I
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

All	O
these	O
mechanisms	O
play	O
critical	O
roles	O
throughout	O
normal	O
mammalian	O
development	O
,	O
particularly	O
during	O
early	O
embryo	O
and	O
germ	O
cell	O
development	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Beaujean2014	O
;	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Luk	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Mukherjee	O
et	O
al	O
.	O
2014	O
;	O
O	O
'	O
Doherty	O
&	O
McGettigan2014	O
;	O
Grote	O
&	O
Herrmann2015	O
;	O
Hogg	O
&	O
Western2015	O
;	O
Marcho	O
et	O
al	O
.	O
2015	O
).	O

Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
[	O
25	O
].	O

showing	O
“	O
hyperlocomotion	O
”)[	O
9	O
],[	O
10	O
].	O

Further	O
studies	O
should	O
be	O
performed	O
to	O
clarify	O
the	O
role	O
of	O
the	O
endocannabinoid	O
system	O
and	O
other	O
homeostatic	O
mechanisms	O
implicated	O
in	O
the	O
process	O
of	O
nutritional	O
programming	O
.	O

The	O
smoking	O
evidence	O
is	O
particularly	B
compelling	O
as	O
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	O
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

This	O
suggests	O
that	O
our	O
microarray	O
data	O
are	O
reliable	O
.	O

While	O
a	O
similar	O
robust	O
,	O
dose	O
-	O
dependent	O
relationship	O
is	O
also	O
crucial	O
to	O
facilitate	O
the	O
development	O
of	O
testing	O
methods	O
for	O
hazard	O
assessment	O
,	O
relevant	O
environmental	O
regulation	O
and	O
/	O
or	O
appropriate	O
medical	O
intervention	O
,	O
establishing	O
causality	O
is	O
not	O
necessarily	O
essential	O
.	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

Objectives	O
:	O
We	O
examined	O
associations	O
between	O
in	O
utero	O
exposures	O
,	O
infant	O
growth	O
,	O
and	O
methylation	O
of	O
repetitive	O
elements	O
and	O
gene	O
-	O
associated	O
DNA	O
in	O
human	O
term	O
placenta	O
tissue	O
samples	O
.	O

Gestational	O
age	O
was	O
calculated	O
based	O
on	O
the	O
first	O
day	O
of	O
the	O
last	O
menstruation	O
(	O
LMP	O
),	O
or	O
the	O
first	O
trimester	O
ultrasound	O
(	O
if	O
uncertain	O
about	O
LMP	O
).	O

Concurrent	O
changes	O
in	O
rates	O
of	O
hyper	O
and	O
hypo	O
-	O
calcaemia	O
suggest	O
antenatal	O
vitamin	O
D3supplementation	O
as	O
an	O
aetiological	O
factor	O
.	O

Researchers	O
can	O
determine	O
which	O
women	O
are	O
taking	O
their	O
vitamins	O
by	O
who	O
refills	O
their	O
prescription	O
.	O

The	O
expression	O
of	O
214	O
probe	O
-	O
sets	O
was	O
increased	O
in	O
the	O
LP	O
offspring	O
compared	O
with	O
AP	O
offspring	O
.	O

Control	O
We	O
used	O
usual	O
iron	O
supplementation	O
program	O
as	O
the	O
comparator	O
.	O

However	O
,	O
a	O
recent	O
multi	O
-	O
centered	O
international	O
case	O
-	O
control	O
study	O
of	O
adult	O
diet	O
and	O
brain	O
tumor	O
risk	O
found	O
no	O
evidence	O
of	O
confounding	O
or	O
effect	O
modification	O
by	O
vitamin	O
supplementation	O
,	O
especially	O
in	O
the	O
association	O
between	O
consumption	O
of	O
cured	O
meats	O
(	O
containing	O
high	O
levels	O
of	O
nitrates	O
)	O
and	O
gliomas	O
[	O
167	O
].	O

Lack	O
of	O
engagement	O
may	O
be	O
a	O
consequence	O
of	O
insufficient	O
involvement	O
of	O
policy	O
makers	O
,	O
issues	O
regarding	O
distribution	O
and	O
costs	O
and	O
difficulties	O
in	O
training	O
the	O
educators	O
,	O
or	O
the	O
beliefs	O
and	O
cultural	O
practices	O
of	O
the	O
target	O
population	O
and	O
the	O
characteristics	O
and	O
side	O
effects	O
of	O
supplements	O
[	O
11	O
,	O
14	O
].	O

For	O
example	O
,	O
researchers	O
have	O
reported	O
a	O
common	O
occurrence	O
of	O
unbooked	O
pregnancies	O
[	O
49	O
,	O
50	O
]	O
and	O
a	O
wide	O
range	O
(	O
60	O
%	O
to	O
90	O
%)	O
of	O
antenatal	O
care	O
utilization	O
rates	O
(	O
i	O
.	O
e	O
.,	O
antenatal	O
care	O
clinic	O
attendance	O
of	O
at	O
least	O
once	O
during	O
most	O
recent	O
pregnancy	O
)	O
[	O
51	O
–	O
53	O
].	O

Because	O
it	O
is	O
possible	O
to	O
consume	O
fish	O
and	O
seafood	O
safely	O
during	O
pregnancy	O
,	O
through	O
following	O
recommendations	O
to	O
limit	O
high	O
mercury	O
species	O
,	O
it	O
is	O
prudent	O
to	O
recommend	O
that	O
pregnant	O
women	O
consume	O
these	O
foods	O
,	O
rather	O
than	O
rely	O
on	O
supplementation	O
,	O
in	O
order	O
to	O
maximise	O
infant	O
neurodevelopment	O
outcomes	O
.	O

Using	O
the	O
Institute	O
of	O
Medicine	O
’	O
s	O
definition	O
of	O
sufficiency	O
(	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
)	O
[	O
25	O
],	O
the	O
cohort	O
also	O
was	O
divided	O
into	O
two	O
groups	O
based	O
on	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
,	O
with	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
50	O
.	O
0	O
nmol	O
/	O
L	O
)	O
defined	O
as	O
deficient	O
.	O

The	O
impact	O
of	O
short	O
sleep	O
duration	O
on	O
the	O
risk	O
of	O
diabetes	O
has	O
been	O
shown	O
in	O
several	O
epidemiological	O
studies	O
,	O
with	O
significant	O
increases	O
in	O
the	O
incidence	O
of	O
diabetes	O
among	O
individuals	O
who	O
report	O
habitual	O
short	O
sleep	O
duration	O
and	O
those	O
who	O
report	O
having	O
difficulty	O
maintaining	O
sleep	O
[	O
4	O
,	O
9	O
-	O
11	O
].	O

Samples	O
were	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
(	O
approximately	O
500	O
mg	O
),	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

Phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
ten	O
(	O
PTEN	O
),	O
a	O
well	O
-	O
known	O
tumor	O
suppressor	O
is	O
a	O
phosphatase	O
that	O
specifically	O
catalyzes	O
the	O
dephosphorylation	O
of	O
phosphatidylinositol	O
-	O
3	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
PIP3	O
),	O
in	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
diphosphate	O
PIP2	O
(	O
Cantley	O
and	O
Neel	O
,	O
1999	O
).	O

This	O
observation	O
is	O
similar	O
to	O
studies	O
carried	O
out	O
in	O
Kenya	O
[	O
13	O
]	O
and	O
South	O
Africa	O
[	O
14	O
]	O
where	O
women	O
started	O
clinic	O
late	O
because	O
of	O
perceived	O
lack	O
of	O
benefit	O
,	O
limited	O
facility	O
access	O
,	O
uncertainty	O
about	O
pregnancy	O
and	O
“	O
laziness	O
”	O
to	O
go	O
for	O
many	O
visits	O
.	O

Maternal	O
diet	O
during	O
pregnancy	O
is	O
related	O
with	O
the	O
infant	O
stool	O
microbiome	O
in	O
a	O
delivery	O
mode	O
-	O
dependent	O
manner	O
Abstract	O
Background	O
The	O
gut	O
microbiome	O
has	O
an	O
important	O
role	O
in	O
infant	O
health	O
and	O
immune	O
development	O
and	O
may	O
be	O
affected	O
by	O
early	O
-	O
life	O
exposures	O
.	O

An	O
elevated	O
risk	O
remained	O
after	O
adjustment	O
for	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
1	O
.	O
54	O
;	O
95	O
%	O
CI	O
0	O
.	O
71	O
-	O
3	O
.	O
35	O
).	O

After	O
delivery	O
,	O
study	O
personnel	O
abstracted	O
data	O
from	O
participants	O
'	O
hospital	O
labor	O
and	O
delivery	O
medical	O
records	O
and	O
clinic	O
records	O
.	O

Oral	O
Supplements	O
Prenatal	O
supplements	O
are	O
an	O
important	O
component	O
of	O
a	O
healthy	O
pregnancy	O
.	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

Iron	O
deficiency	O
is	I
not	B
only	I
the	I
most	I
prevalent	I
but	I
also	I
the	I
most	O
neglected	O
nutrient	O
deficiency	O
in	O
the	O
world	O
,	O
particularly	B
among	O
pregnant	O
women	O
and	O
children	O
in	O
developing	O
countries	O
[	O
7	O
].	O

In	O
general	O
,	O
treatment	O
of	O
asthma	O
and	O
allergic	O
diseases	O
does	O
not	O
differ	O
from	O
that	O
in	O
nonpregnant	O
women	O
.	O

However	O
,	O
meta	O
-	O
analysis	O
of	O
the	O
4	O
case	O
-	O
control	O
studies	O
revealed	O
a	O
significantly	O
increased	O
risk	O
of	O
oral	O
clefts	O
in	O
infants	O
of	O
corticosteroid	O
-	O
treated	O
mothers	O
(	O
odds	O
ratio	O
,	O
3	O
.	O
35	O
;	O
confidence	O
interval	O
1	O
.	O
97	O
-	O
5	O
.	O
69	O
)	O
[	O
12	O
].	O

In	O
children	O
,	O
high	O
birth	O
weight	O
has	O
been	O
associated	O
with	O
increased	O
risk	O
for	O
astrocytoma	O
and	O
medulloblastoma	O
/	O
primitive	O
neuroectodermal	O
tumors	O
(	O
PNET	O
)	O
[	O
173	O
].	O

These	O
results	O
are	O
in	O
keeping	O
with	O
data	O
showing	O
a	O
physiological	O
role	O
of	O
BAT	O
in	O
whole	O
-	O
body	O
energy	O
expenditure	O
,	O
glucose	O
homeostasis	O
,	O
and	O
insulin	O
sensitivity	O
in	O
humans	O
during	O
prolonged	O
cold	O
exposure	O
(	O
Chondronikola	O
et	O
al	O
.,	O
2014	O
).	O

The	O
TSH	O
concentration	O
generally	O
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

Major	O
Maternal	O
Dietary	O
Patterns	O
during	O
Early	O
Pregnancy	O
and	O
Their	O
Association	O
with	O
Neonatal	O
Anthropometric	O
Measurement	O
Abstract	O
Background	O
Anthropometric	O
measurements	O
of	O
newborn	O
infant	O
are	O
widely	O
assessed	O
as	O
determinants	O
of	O
maternal	O
nutrition	O
.	O

Dosage	O
in	O
excess	O
of	O
50	O
mcg	O
(	O
2000	O
units	O
)	O
per	O
day	O
are	O
not	O
recommended	O
,	O
thus	O
the	O
treatment	O
of	O
postsurgical	O
hypoparatithyroid	O
patient	O
calcium	O
supplementation	O
may	O
be	O
required	O
at	O
dosage	O
as	O
high	O
as	O
4	O
g	O
/	O
day	O
together	O
with	O
D	O
vitamin	O
.	O

Newborn	O
weight	O
is	O
measured	O
with	O
a	O
calibrated	O
digital	O
infant	O
scale	O
to	O
the	O
nearest	O
10	O
g	O
.	O
In	O
order	O
to	O
minimize	O
intra	O
-	O
observer	O
variability	O
all	O
circumferences	O
and	O
CHL	O
are	O
measured	O
with	O
an	O
inelastic	O
tape	O
to	O
the	O
nearest	O
0	O
.	O
5	O
cm	O
(	O
metal	O
measuring	O
tape	O
not	O
used	O
to	O
prevent	O
possible	O
lacerations	O
).	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

While	O
statistically	O
significant	O
,	O
the	O
clinical	O
significance	O
of	O
such	O
a	O
small	O
difference	O
is	O
questionable	O
,	O
the	O
findings	O
also	O
consistent	O
with	O
a	O
chance	O
occurrence	O
,	O
particularly	O
as	O
this	O
was	O
a	O
secondary	O
outcome	O
,	O
and	O
no	O
other	O
statistically	O
significant	O
differences	O
were	O
identified	O
between	O
the	O
treatment	O
groups	O
in	O
infant	O
BMI	O
,	O
abdominal	O
circumference	O
,	O
or	O
the	O
remainder	O
of	O
infant	O
anthropometric	O
measures	O
obtained	O
.	O

For	O
each	O
pathway	O
,	O
scores	O
are	O
calculated	O
as	O
the	O
negative	O
base	O
-	O
10	O
logarithm	O
of	O
the	O
P	O
value	O
,	O
indicating	O
the	O
likelihood	O
that	O
the	O
dysregulated	O
proteins	O
would	O
be	O
found	O
in	O
a	O
given	O
network	O
by	O
chance	O
.	O

Frequency	O
of	O
the	O
type	O
of	O
food	O
eaten	O
during	O
the	O
past	O
month	O
can	O
be	O
reported	O
by	O
the	O
mother	O
as	O
every	O
day	O
;	O
most	O
days	O
(	O
not	O
every	O
day	O
,	O
but	O
at	O
least	O
4	O
times	O
per	O
week	O
);	O
once	O
a	O
week	O
(	O
less	O
than	O
4	O
times	O
per	O
week	O
,	O
but	O
at	O
least	O
once	O
per	O
week	O
)	O
or	O
never	O
.	O

The	O
Guidelines	O
for	O
maternity	O
care	O
in	O
South	O
Africa	O
[	O
26	O
]	O
therefore	O
recommend	O
routine	O
nutritional	O
assessment	O
–	O
such	O
as	O
measuring	O
mid	O
-	O
upper	O
arm	O
circumference	O
and	O
haemoglobin	O
levels	O
–	O
and	O
daily	O
supplementation	O
of	O
200	O
mg	O
ferrous	O
sulphate	O
,	O
1000	O
mg	O
calcium	O
and	O
5	O
mg	O
folic	O
acid	O
.	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	O
to	O
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

“	O
We	O
’	O
ve	O
pretty	O
much	O
been	O
clear	O
from	O
the	O
beginning	O
that	O
if	O
we	O
see	O
something	O
that	O
’	O
s	O
wrong	O
,	O
we	O
’	O
re	O
not	O
going	O
to	O
let	O
it	O
stick	O
around	O
just	O
to	O
preserve	O
the	O
data	O
,”	O
Lewis	O
says	O
.	O

The	O
DVD	O
adult	O
rat	O
is	O
also	O
more	O
sensitive	O
to	O
haloperidol	O
,	O
a	O
dopamine	O
(	O
DA	O
)	O
D2	O
receptor	O
antagonist	O
[	O
10	O
],	O
that	O
is	O
a	O
widely	O
used	O
antipsychotic	O
medication	O
used	O
to	O
treat	O
schizophrenia	O
.	O

Interpretation	O
of	O
the	O
findings	O
with	O
respect	O
to	O
mechanistic	O
connections	O
between	O
environmental	O
factors	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
effects	O
in	O
the	O
target	O
organ	O
/	O
tissue	O
can	O
therefore	O
be	O
challenging	O
.	O

If	O
an	O
environmental	O
exposure	O
is	O
truly	O
transgenerational	O
,	O
then	O
:	O
(	O
1	O
)	O
following	O
an	O
in	O
utero	O
exposure	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	O
least	O
the	O
F3generation	O
(	O
great	O
-	O
great	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
mother	O
and	O
F3represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
;	O
or	O
(	O
2	O
)	O
following	O
an	O
ex	O
utero	O
exposure	O
in	O
childhood	O
/	O
adulthood	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	O
least	O
the	O
F2generation	O
(	O
the	O
great	O
-	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
generation	O
and	O
F2represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
.	O

Conclusion	O
About	O
one	O
third	O
of	O
pregnant	O
women	O
in	O
our	O
study	O
population	O
attended	O
an	O
ANC	O
site	O
different	O
from	O
their	O
local	O
catchment	O
area	O
despite	B
the	O
availability	O
of	O
ANC	O
in	O
their	O
residential	O
area	O
.	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

We	O
will	O
estimate	O
incremental	O
cost	O
-	O
effectiveness	O
ratios	O
as	O
incremental	O
cost	O
per	O
neonate	O
death	O
avoided	O
;	O
per	O
low	O
birth	O
weight	O
infant	O
avoided	O
and	O
per	O
life	O
-	O
year	O
saved	O
.	O

The	O
persistence	O
of	O
the	O
relationship	O
between	O
postpartum	O
maternal	O
serum	O
visfatin	O
levels	O
and	O
anthropometric	O
indicators	O
can	O
be	O
attributed	O
to	O
excretion	O
of	O
visfatin	O
in	O
mother	O
’	O
s	O
milk	O
,	O
which	O
was	O
confirmed	O
by	O
Bienertová	O
-	O
Vašků	O
et	O
al	O
.(	O
25	O
).	O

In	O
adipose	O
tissue	O
,	O
it	O
appears	B
that	O
PPARγ	O
transcriptionally	O
controls	O
FGF21	O
,	O
which	O
then	O
acts	O
as	O
an	O
autocrine	O
or	O
paracrine	O
way	O
to	O
increase	O
PPARγ	O
transcriptional	O
activity	O
in	O
a	O
feed	O
-	O
forward	O
loop	O
system	O
(	O
Wang	O
et	O
al	O
.,	O
2008	O
;	O
Dutchak	O
et	O
al	O
.,	O
2012	O
).	O

Laboratory	O
evaluation	O
of	O
the	O
infant	O
showed	O
serum	O
sodium	O
of	O
177	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
4	O
mEq	O
/	O
L	O
,	O
chloride	O
140	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
14	O
mEq	O
/	O
L	O
,	O
BUN	O
49	O
mEq	O
/	O
L	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
glucose	O
30	O
mg	O
/	O
dL	O
,	O
and	O
calcium	O
8	O
.	O
3	O
mEq	O
/	O
L	O
.	O

Thus	O
,	O
the	O
reversibility	O
of	O
environmentally	O
induced	O
changes	O
is	O
also	O
critically	O
important	O
when	O
determining	O
the	O
true	O
potential	O
adversity	O
of	O
an	O
environmental	O
exposure	O
.	O

Visfatin	O
as	O
a	O
predictor	O
for	O
growth	O
of	O
fetus	O
and	O
infant	O
Abstract	O
Objective	O
:	O
Visfatin	O
is	O
an	O
adipocytokine	O
that	O
functions	O
as	O
an	O
enzyme	O
and	O
a	O
growth	O
factor	O
to	O
investigate	O
the	O
relationship	O
between	O
serum	O
visfatin	O
and	O
the	O
fetus	O
’	O
s	O
anthropometric	O
markers	O
up	O
to	O
a	O
year	O
after	O
birth	O
.	O

In	O
this	O
study	O
,	O
they	O
selected	O
mothers	O
who	O
needed	O
antidepressant	O
drugs	O
after	O
childbirth	O
as	O
the	O
case	O
group	O
.	O

None	O
of	O
the	O
other	O
variables	O
listed	O
in	O
Table1were	O
found	O
to	O
be	I
confounders	O
.	O

Study	O
Design	O
and	O
Participants	O
The	O
current	O
prospective	O
observational	O
study	O
was	O
conducted	O
among	O
pregnant	O
women	O
during	O
the	O
first	O
trimester	O
,	O
who	O
were	O
being	O
attended	O
at	O
health	O
centers	O
across	O
Isfahan	O
city	O
in	O
the	O
central	O
part	O
of	O
Iran	O
during	O
2015	O
-	O
2016	O
.	O

Vinter	O
and	O
colleagues	O
[	O
18	O
]	O
conducted	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
participants	O
6	O
-	O
months	O
after	O
birth	O
,	O
in	O
which	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
was	O
provided	O
to	O
overweight	O
and	O
obese	O
women	O
[	O
15	O
].	O

Daily	O
consumption	O
of	O
vegetables	O
,	O
fruits	O
,	O
legumes	O
,	O
soy	O
,	O
and	O
nuts	O
,	O
whole	O
grains	O
,	O
fish	O
and	O
seafood	O
,	O
and	O
monounsaturated	O
to	O
saturated	O
fat	O
ratio	O
(	O
MUFA	O
:	O
SFA	O
)	O
above	O
the	O
median	O
is	O
considered	O
healthful	O
and	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

Furthermore	O
,	O
better	O
overall	O
diet	O
quality	O
has	O
been	O
associated	O
with	O
a	O
lower	O
risk	O
for	O
maternal	O
perinatal	O
depression	O
and	O
gestational	O
weight	O
gain	O
,	O
which	O
in	O
turn	O
are	O
risk	O
factors	O
for	O
suboptimal	O
offspring	O
development	O
[	O
14	O
–	O
16	O
].	O

All	O
data	O
are	O
collected	O
either	O
by	O
health	O
professionals	O
on	O
site	O
or	O
by	O
trained	O
fieldworkers	O
.	O

Regarding	O
the	O
timing	O
of	O
restriction	O
,	O
protein	O
deficiency	O
during	O
early	O
pregnancy	O
induces	O
a	O
less	O
preference	O
to	O
a	O
high	O
-	O
fat	O
diet	O
in	O
the	O
female	O
offspring	O
(	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
),	O
whereas	O
a	O
high	O
preference	O
was	O
obtained	O
when	O
restriction	O
was	O
applied	O
through	O
other	O
gestational	O
periods	O
(	O
Bellinger	O
et	O
al	O
.,	O
2004	O
;	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
).	O

Moreover	O
,	O
by	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
DNA	O
methylation	O
and	O
genomewide	O
(	O
array	O
)	O
gene	O
-	O
associated	O
methylation	O
,	O
this	O
work	O
suggests	O
potential	O
epigenetic	O
mechanisms	O
underlying	O
changes	O
to	O
placental	O
function	O
that	O
may	O
lead	O
to	O
altered	O
fetal	O
development	O
and	O
programming	O
.	O

Predictors	O
included	O
both	O
baseline	O
and	O
pregnancy	O
changes	O
over	O
time	O
(	O
between	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
).	O

At	O
middle	O
or	O
late	O
term	O
of	O
pregnancy	O
;	O
3	O
).	O

Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
file	O
PubMed	O
Central	O
:	O

Furthermore	O
,	O
seasonal	O
variation	O
in	O
immune	O
function	O
may	O
increase	O
host	O
susceptibility	O
to	O
infections	O
at	O
certain	O
times	O
of	O
the	O
year	O
[	O
143	O
,	O
144	O
].	O

Further	O
filtering	O
based	O
on	O
the	O
variability	O
of	O
expression	O
of	O
probe	O
-	O
sets	O
revealed	O
7	O
,	O
937	O
probe	O
-	O
sets	O
for	O
further	O
analysis	O
at	O
stage	O
94	O
dpc	O
(	O
1	O
dpn	O
:	O
9	O
,	O
099	O
;	O
28	O
dpn	O
:	O
8	O
,	O
250	O
;	O
188	O
dpn	O
:	O
8	O
,	O
943	O
).	O

MTCs	O
,	O
like	O
other	O
neuroendocrine	O
tumours	O
,	O
can	O
express	O
somatostatin	O
receptors	O
.	O

Bell	O
-	O
Jefferson	O
and	O
her	O
brother	O
Peterson	O
Bell	O
played	O
in	O
and	O
around	O
the	O
mines	O
,	O
splashing	O
and	O
swimming	O
in	O
pools	O
of	O
radioactive	O
water	O
that	O
had	O
been	O
pumped	O
out	O
of	O
the	O
mines	O
and	O
then	O
collected	O
on	O
their	O
property	O
.	O

The	O
survey	O
findings	O
also	O
suggest	O
a	O
positive	O
association	O
between	O
natural	O
iron	O
content	O
in	O
groundwater	O
and	O
iron	O
status	O
of	O
women	O
[	O
6	O
].	O

Alarmingly	B
,	O
in	O
the	O
birth	O
cohort	O
study	O
from	O
the	O
Isle	O
of	O
Wight	O
,	O
about	O
43	O
%	O
of	O
children	O
had	O
been	O
exposed	O
to	O
environmental	O
tobacco	O
smoke	O
during	O
their	O
first	O
year	O
of	O
life	O
[	O
38	O
].	O

From	O
the	O
infants	O
,	O
a	O
2	O
–	O
5	O
ml	O
urine	O
sample	O
is	O
collected	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
using	O
adhesive	O
paediatric	O
urine	O
collection	O
bags	O
.	O

In	O
the	O
1980s	O
,	O
with	O
routine	O
treatment	O
for	O
women	O
with	O
mild	O
GDM	O
,	O
their	O
outcomes	O
were	O
not	O
different	O
to	O
women	O
with	O
normal	O
glucose	O
tolerance	O
.	O

[	O
15	O
]	O
Nimitphong	O
et	O
al	O
.	O

The	O
observed	O
transcriptional	O
postnatal	O
regulations	O
were	O
delayed	O
long	O
-	O
term	O
effects	O
of	O
the	O
prenatal	O
nutritional	O
supply	O
.	O

Such	O
overviews	O
are	O
,	O
however	O
,	O
rarely	O
included	O
in	O
the	O
relevant	O
literature	O
associated	O
with	O
extended	O
lifetime	O
studies	O
.	O

Discussion	O
Iron	O
deficiency	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
maternal	O
death	O
,	O
preterm	O
delivery	O
,	O
impaired	O
foetal	O
growth	O
and	O
development	O
,	O
low	O
birth	O
weight	O
,	O
increased	O
neonatal	O
mortality	O
and	O
impaired	O
infant	O
development	O
[	O
17	O
].	O

For	O
example	O
,	O
epigenetic	O
changes	O
have	O
the	O
potential	O
to	O
provide	O
(	O
1	O
)	O
more	O
sensitive	O
/	O
earlier	O
end	O
points	O
of	O
toxicity	O
within	O
existing	O
regulatory	O
test	O
guidelines	O
(	O
TGs	O
),	O
(	O
2	O
)	O
novel	O
markers	O
of	O
exposure	O
/	O
predictors	O
of	O
future	O
toxicity	O
for	O
the	O
development	O
of	O
in	O
vitro	O
chemical	O
screening	O
assays	O
and	O
(	O
3	O
)	O
novel	O
end	O
points	O
of	O
toxicities	O
for	O
which	O
we	O
are	O
currently	O
rarely	O
able	O
to	O
conduct	O
definitive	O
regulatory	O
testing	O
due	O
to	O
animal	O
welfare	O
,	O
cost	O
and	O
time	O
considerations	O
(	O
such	O
as	O
non	O
-	O
genotoxic	O
carcinogens	O
,	O
multigenerational	O
toxicity	O
and	O
chronic	O
low	O
-	O
dose	O
exposures	O
that	O
impact	O
health	O
in	O
later	O
life	O
).	O

Currently	O
,	O
maternal	O
undernutrition	O
is	O
a	O
problem	O
not	O
exclusive	O
of	O
developing	O
countries	O
.	O

Fasting	O
and	O
post	O
-	O
prandial	O
glucose	O
testing	O
is	O
necessary	O
for	O
monitoring	O
and	O
guidance	O
of	O
therapy	O
.	O

It	O
was	O
concluded	O
that	O
although	B
autism	O
is	O
unlikely	O
to	O
be	O
caused	O
by	O
a	O
single	O
obstetric	O
factor	O
,	O
there	O
was	O
an	O
increased	O
prevalence	O
of	O
obstetric	O
complications	O
among	O
autism	O
cases	O
that	O
is	O
most	O
likely	O
due	O
to	O
underlying	O
genetic	O
factors	O
and	O
an	O
interaction	O
of	O
these	O
factors	O
with	O
the	O
environment	O
[	O
8	O
].	O

1	O
.	O

Study	O
setting	O
We	O
will	O
conduct	O
the	O
Shonjibon	O
trial	O
in	O
five	O
districts	O
in	O
Dhaka	O
Division	O
,	O
Bangladesh	O
.	O

Initiating	O
IFA	O
supplements	O
in	O
the	O
first	O
four	O
months	O
of	O
pregnancy	O
,	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
neonatal	O
mortality	O
by	O
35	O
%	O
[	O
11	O
].	O

Fatty	O
acid	O
metabolism	O
,	O
Biosynthesis	O
of	O
steroids	O
,	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodies	O
,	O
FA	O
elongation	O
in	O
mitochondria	O
,	O
Bile	O
acid	O
synthesis	O
)	O
and	O
cell	O
cycle	O
regulation	O
(	O
e	O
.	O
g	O
.	O

No	O
studies	O
reported	O
adjusting	O
results	O
from	O
the	O
FFQ	O
for	O
energy	O
intake	O
,	O
a	O
recommendation	O
made	O
by	O
Freedman	O
et	O
al	O
.	O

Conversely	O
,	O
a	O
high	O
proportion	O
of	O
CpGs	O
in	O
the	O
relatively	O
unmethylated	O
classes	O
1	O
–	O
6	O
and	O
8	O
are	O
in	O
CGIs	O
(	O
Figure	O
2E	O
).	O

After	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
,	O
making	O
more	O
than	O
four	O
prenatal	O
consultations	O
remained	O
associated	O
with	O
the	O
use	O
of	O
multivitamin	O
supplements	O
.	O

Such	O
changes	O
may	O
still	O
prove	O
useful	O
for	O
regulatory	O
purposes	O
and	O
also	O
do	O
not	O
rule	O
out	O
the	O
possibility	O
of	O
later	O
onset	O
effects	O
.	O

Another	O
study	O
investigating	O
the	O
effect	O
of	O
a	O
paternal	O
folate	O
-	O
deficient	O
diet	O
in	O
mice	O
found	O
a	O
relationship	O
with	O
decreased	O
placental	O
weight	O
,	O
placental	O
folate	O
and	O
an	O
increased	O
expression	O
of	O
the	O
folate	O
transporter	O
folate	O
receptor	O
[	O
7	O
].	O

Additionally	O
,	O
a	O
number	O
of	O
nonrandomized	O
or	O
retrospective	O
studies	O
examining	O
the	O
treatment	O
of	O
GDM	O
with	O
glyburide	O
have	O
been	O
reported	O
(	O
Table	O
4	O
).	O

However	B
,	O
excluding	O
preeclampsia	O
cases	O
from	O
the	O
analysis	O
did	O
not	O
change	O
the	O
results	O
.	O

Analyses	O
were	O
performed	O
by	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
,	O
Mass	O
spectrometer	O
API	O
4000	O
)	O
by	O
the	O
clinical	O
chemistry	O
laboratory	O
in	O
Region	O
Skåne	O
,	O
Sweden	O
,	O
certified	O
by	O
the	O
Vitamin	O
D	O
External	O
Quality	O
Assessment	O
Scheme	O
[	O
15	O
].	O

Smoking	O
during	O
pregnancy	O
was	O
rare	O
at	O
4	O
.	O
8	O
%,	O
and	O
the	O
population	O
was	O
slightly	O
overweight	O
with	O
an	O
average	O
pre	O
-	O
pregnancy	O
BMI	O
of	O
25	O
.	O
6	O
.	O

Of	O
the	O
32	O
Navajo	O
men	O
who	O
developed	O
lung	O
cancer	O
,	O
72	O
%	O
had	O
worked	O
as	O
uranium	O
miners	O
,	O
compared	O
with	O
none	O
of	O
the	O
controls	O
.	O

In	O
order	O
to	O
minimize	O
the	O
estrous	O
cycle	O
-	O
related	O
variability	O
,	O
the	O
female	O
rats	O
were	O
closely	O
housed	O
in	O
adjacent	O
cages	O
and	O
randomly	O
distributed	O
among	O
the	O
different	O
experimental	O
groups	O
(	O
McClintock	O
,	O
1978	O
,	O
1984	O
).	O

The	O
level	O
of	O
25	O
-	O
hydroxy	O
Vitamin	O
D	O
(	O
25	O
-	O
OH	O
Vit	O
D	O
)	O
and	O
the	O
sources	O
of	O
Vitamin	O
D	O
intake	O
and	O
the	O
frequency	O
of	O
food	O
consumption	O
rich	O
in	O
Vitamin	O
D	O
were	O
investigated	O
.	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

Expression	O
of	O
psychotic	O
symptoms	O
in	O
populations	O
is	O
continuous	O
and	O
characterized	O
by	O
differing	O
levels	O
of	O
severity	O
and	O
persistence	O
[	O
7	O
].	O

Women	O
with	O
no	O
or	O
few	O
psychotic	O
-	O
like	O
symptoms	O
smoked	O
less	O
than	O
women	O
in	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
.	O

As	O
with	O
the	O
trials	O
in	O
the	O
older	O
children	O
,	O
giving	O
higher	O
doses	O
of	O
vitamin	O
D	O
,	O
25	O
,	O
34we	O
too	O
did	O
not	O
record	O
any	O
adverse	O
effects	O
associated	O
with	O
vitamin	O
D	O
supplementation	O
.	O

Even	B
though	B
our	O
results	O
highlight	O
the	O
importance	O
of	O
nutritional	O
knowledge	O
in	O
the	O
decision	O
to	O
use	O
iron	O
or	O
folic	O
acid	O
,	O
we	O
cannot	O
draw	O
conclusions	O
about	O
overall	O
compliance	O
with	O
supplement	O
regimes	O
,	O
because	O
we	O
did	O
not	O
record	O
the	O
dose	O
or	O
duration	O
of	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
use	O
.	O

The	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
is	O
then	O
metabolized	O
in	O
the	O
kidneys	O
to	O
its	O
biologically	O
more	O
active	O
form	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
].	O

Trial	O
outcomes	O
The	O
primary	O
trial	O
outcome	O
will	O
be	O
the	O
difference	O
in	O
the	O
neonatal	O
mortality	O
rate	O
between	O
the	O
intervention	O
and	O
control	O
areas	O
.	O

Thus	O
,	O
an	O
overview	O
of	O
non	O
-	O
neoplastic	O
,	O
pre	O
-	O
neoplastic	O
,	O
neoplastic	O
and	O
benign	O
pathologies	O
within	O
each	O
model	O
system	O
is	O
essential	O
for	O
the	O
accurate	O
interpretation	O
of	O
life	O
-	O
long	O
rodent	O
studies	O
.	O

In	O
tandem	O
with	O
living	O
on	O
a	O
farm	O
,	O
infants	O
have	O
unique	O
vulnerabilities	O
that	O
may	O
lead	O
to	O
higher	O
levels	O
of	O
exposures	O
in	O
the	O
same	O
environment	O
than	O
adults	O
[	O
9	O
].	O

Misclassification	O
of	O
fish	O
and	O
PUFA	O
or	O
vitamin	O
D	O
intake	O
due	O
to	O
measurement	O
error	O
associated	O
with	O
the	O
food	O
frequency	O
questionnaire	O
is	O
unavoidable	O
,	O
but	O
given	O
the	O
study	O
design	O
likely	O
non	O
-	O
differential	O
,	O
and	O
thus	O
attenuating	O
any	O
true	O
association	O
.	O

Although	B
,	O
the	O
point	O
estimates	O
indicated	O
a	O
marginal	O
increased	O
risk	O
for	O
developing	O
any	O
pregnancy	O
complication	O
with	O
severe	O
(<	O
25	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
those	O
who	O
had	O
levels	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
(	O
aRR	O
:	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
).	O

MTRL	O
has	O
been	O
funded	O
by	O
a	O
FPU	O
predoctoral	O
fellowship	O
of	O
the	O
Spanish	O
Ministerio	O
de	O
Educación	O
,	O
Cultura	O
y	O
Deporte	O
(	O
AP	O
-	O
2009	O
-	O
0225	O
);	O
JS	O
holds	O
a	O
“	O
Miguel	O
Servet	O
”	O
research	O
contract	O
from	O
the	O
National	O
System	O
of	O
Health	O
,	O
ISCIII	O
(	O
grant	O
number	O
CP12	O
/	O
03109	O
).	O

More	O
frequent	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
found	B
to	I
be	I
associated	O
with	O
a	O
higher	O
socio	O
-	O
economic	O
status	O
,	O
higher	O
level	O
of	O
education	O
and	O
use	O
of	O
prenatal	O
medical	O
services	O
in	O
studies	O
conducted	O
in	O
Finland	O
[	O
15	O
],	O
the	O
United	O
Kingdom	O
[	O
16	O
],	O
the	O
United	O
States	O
of	O
America	O
[	O
17	O
],	O
Denmark	O
[	O
18	O
]	O
and	O
Tanzania	O
[	O
19	O
].	O

This	O
review	O
,	O
therefore	O
,	O
examines	O
the	O
present	O
understanding	O
of	O
epigenetic	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
,	O
evaluates	O
the	O
current	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
and	O
highlights	O
the	O
research	O
considerations	O
and	O
implications	O
of	O
this	O
emerging	O
knowledge	O
for	O
public	O
health	O
and	O
regulatory	O
toxicology	O
.	O

Patients	O
whose	O
asthma	O
is	O
not	O
controlled	O
with	O
maximal	O
doses	O
of	O
bronchodilators	O
and	O
anti	O
-	O
inflammatory	O
agents	O
may	O
need	O
systemic	O
corticosteroids	O
.	O

Further	O
,	O
other	O
studies	O
using	O
animal	O
models	O
show	O
that	O
preclinical	O
findings	O
in	O
rodents	O
exposed	O
to	O
SSRIs	O
during	O
development	O
point	O
to	O
an	O
increase	O
in	O
depression	O
and	O
anxiety	O
,	O
exhibiting	O
alteration	O
in	O
social	O
behaviors	O
in	O
the	O
offspring	O
.	O

Finally	O
,	O
lambda	O
stat	O
was	O
used	O
to	O
compare	O
correlation	O
coefficients	O
of	O
variables	O
in	O
the	O
two	O
groups	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Finding	O
a	O
molecule	O
with	O
as	O
much	O
efficiency	O
as	O
the	O
β3	O
agonist	O
in	O
rodents	O
,	O
would	O
be	O
of	O
considerable	O
therapeutic	O
relevance	O
for	O
the	O
treatment	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

For	O
our	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
we	O
included	O
all	O
children	O
randomly	O
assigned	O
to	O
our	O
study	O
groups	O
.	O

There	O
are	O
no	O
representative	O
country	O
data	O
available	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
Europe	O
.	O

Tissue	O
-	O
specific	O
FGF21	O
regulation	O
was	O
shown	O
to	O
occur	O
in	O
response	O
to	O
chronic	O
cold	O
exposure	O
in	O
mice	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

The	O
lowest	O
possible	O
effective	O
dose	O
(	O
alternate	O
-	O
day	O
dose	O
or	O
single	O
daily	O
dose	O
)	O
should	O
be	O
used	O
.	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

of	O
commonly	O
regulated	O
probe	O
-	O
sets	O
of	O
LP	O
and	O
AP	O
offspring	O
(	O
intersection	O
)	O
94	O
dpc	O
12	O
,	O
6507	O
,	O
9371	O
,	O
001	O
(	O
541	O
up	O
,	O
460	O
down	O
)	O
1	O
dpn	O
12	O
,	O
0059	O
,	O
0991	O
(	O
0	O
up	O
,	O
1	O
down	O
)	O
28	O
dpn	O
12	O
,	O
3078	O
,	O
250483	O
(	O
214	O
up	O
,	O
269	O
down	O
)	O
188	O
dpn	O
11	O
,	O
7848	O
,	O
9432	O
,	O
084	O
(	O
952	O
up	O
,	O
1	O
,	O
132	O
down	O
)	O
developmental	O
period	O
1	O
13	O
,	O
35710	O
,	O
2938	O
,	O
166	O
(	O
3	O
,	O
731	O
up	O
,	O
4	O
,	O
435	O
down	O
)	O
1	O
,	O
042	O
(	O
384	O
up	O
,	O
658	O
down	O
)	O
1	O
,	O
034	O
(	O
503	O
up	O
,	O
531	O
down	O
)	O
6	O
,	O
090	O
(	O
2	O
,	O
844	O
up	O
,	O
3	O
,	O
246	O
down	O
)	O
developmental	O
period	O
2	O
13	O
,	O
35910	O
,	O
3178	O
,	O
329	O
(	O
4	O
,	O
118	O
up	O
,	O
4	O
,	O
211	O
down	O
)	O
881	O
(	O
423	O
up	O
,	O
458	O
down	O
)	O
991	O
(	O
448	O
up	O
,	O
543	O
down	O
)	O
6	O
,	O
457	O
(	O
3	O
,	O
247	O
up	O
,	O
3	O
,	O
210	O
down	O
)	O
developmental	O
period	O
3	O
12	O
,	O
6378	O
,	O
8926	O
,	O
612	O
(	O
2	O
,	O
810	O
up	O
,	O
3	O
,	O
803	O
down	O
)	O
1	O
,	O
959	O
(	O
834	O
up	O
,	O
1	O
,	O
125	O
down	O
)	O
1	O
,	O
549	O
(	O
697	O
up	O
,	O
852	O
down	O
)	O
3	O
,	O
104	O
(	O
1	O
,	O
279	O
up	O
,	O
1	O
,	O
825	O
down	O
)	O
Developmental	O
period	O
1	O
indicates	O
the	O
comparisons	O
between	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
;	O
Developmental	O
period	O
2	O
indicates	O
the	O
comparisons	O
between	O
stages	O
1	O
dpc	O
and	O
28	O
dpn	O
;	O
Developmental	O
period	O
3	O
indicates	O
the	O
comparisons	O
between	O
stages	O
28	O
dpc	O
and	O
188	O
dpn	O
;	O
'	O
Up	O
'	O
indicates	O
higher	O
expression	O
values	O
of	O
later	O
stages	O
,	O
'	O
down	O
'	O
indicates	O
lower	O
expression	O
values	O
at	O
later	O
stages	O
.	O

If	O
an	O
association	O
exists	O
the	O
effect	O
probably	O
represents	O
the	O
interplay	O
between	O
various	O
environmental	O
,	O
genetic	O
,	O
lifestyle	O
,	O
and	O
socioeconomic	O
factors	O
,	O
operating	O
on	O
mother	O
and	O
child	O
within	O
a	O
precise	O
window	O
of	O
vulnerability	O
.	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

Dietary	O
information	O
was	O
consistent	O
with	O
current	O
Australian	O
standards	O
[	O
25	O
],	O
while	O
physical	O
activity	O
advice	O
focussed	O
on	O
the	O
benefits	O
of	O
exercise	O
in	O
pregnancy	O
[	O
26	O
].	O

Based	O
on	O
our	O
interpretation	O
of	O
the	O
data	O
and	O
of	O
the	O
earlier	O
literature	O
,	O
these	O
3	O
factors	O
were	O
labeled	O
as	O
the	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
patterns	O
.	O

The	O
day	O
of	O
birth	O
was	O
defined	O
as	O
postnatal	O
day	O
0	O
(	O
PND	O
0	O
).	O

All	O
the	O
different	O
cell	O
types	O
that	O
comprise	O
the	O
new	O
individual	O
develop	O
from	O
this	O
zygote	O
and	O
so	O
contain	O
the	O
same	O
unique	O
genome	O
.	O

Red	O
and	O
processed	O
meat	O
intake	O
is	O
considered	O
less	O
healthful	O
,	O
and	O
consumption	O
below	O
the	O
median	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
asthma	O
,	O
wheeze	O
,	O
eczema	O
,	O
hay	O
fever	O
and	O
atopy	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAsthma	O
n	O
=	O
7677	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
14	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
41	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
23	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
56	O
)	O
1	O
.	O
37	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
81	O
)	O
1	O
.	O
07	O
(	O
1	O
.	O
00	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
04	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
18	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
29	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Wheeze	O
n	O
=	O
7762	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
21	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
52	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
54	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
85	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
25	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
42	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
08	O
Eczema	O
n	O
=	O
7748	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
19	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
44	O
)	O
1	O
.	O
13	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
70	O
–	O
1	O
.	O
17	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
33	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
17	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
41	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
33	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
74	O
–	O
1	O
.	O
26	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
05	O
)	O
0	O
.	O
70	O
Hay	O
fever	O
n	O
=	O
7728	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
07	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
88	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
13	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
03	O
(	O
0	O
.	O
79	O
–	O
1	O
.	O
33	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
21	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
10	O
Atopy	O
n	O
=	O
6117	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
21	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
34	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
06	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
98	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
20	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
20	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
49	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
09	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
006	O
#:	O
controlling	O
for	O
energy	O
intake	O
;¶:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

Transfer	O
Mechanisms	O
of	O
Allergy	O
(	O
Immunopathogenesis	O
of	O
Atopy	O
)	O
The	O
allergic	O
status	O
of	O
the	O
mother	O
can	O
potentially	O
affect	O
the	O
immune	O
response	O
of	O
the	O
offspring	O
through	O
numerous	O
factors	O
that	O
are	O
transferable	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
.	O

Nulliparous	O
women	O
carrying	O
a	O
singleton	O
pregnancy	O
were	O
recruited	O
between	O
November	O
2004	O
and	O
September	O
2008	O
in	O
Adelaide	O
(	O
Australia	O
)	O
and	O
Auckland	O
(	O
New	O
Zealand	O
).	O

Infant	O
allergy	O
assessment	O
A	O
medical	O
doctor	O
assesses	O
the	O
allergy	O
phenotype	O
and	O
sensitisation	O
of	O
infants	O
with	O
the	O
Childhood	O
Allergy	O
and	O
Immunology	O
Research	O
(	O
CAIR	O
)	O
questionnaire	O
and	O
skin	O
prick	O
tests	O
at	O
phases	O
7	O
and	O
8	O
postnatally	O
.	O

Any	O
agent	O
that	O
can	O
cause	O
anaphylaxis	O
in	O
the	O
nonpregnant	O
state	O
could	O
also	O
cause	O
anaphylaxis	O
in	O
the	O
susceptible	O
or	O
sensitized	O
pregnant	O
patient	O
.	O

It	O
is	O
the	O
largest	O
prospective	O
cohort	O
study	O
to	O
assess	O
vitamin	O
D	O
status	O
within	O
the	O
international	O
SCOPE	O
cohort	O
,	O
comparing	O
and	O
combining	O
two	O
distinct	O
populations	O
of	O
pregnant	O
women	O
living	O
at	O
similar	O
latitude	O
and	O
provides	O
a	O
greater	O
understanding	O
of	O
vitamin	O
D	O
deficiency	O
and	O
the	O
risk	O
of	O
adverse	O
pregnancy	O
outcomes	O
.	O

Data	O
analysis	O
Overall	O
,	O
data	O
processing	O
and	O
statistical	O
analysis	O
are	O
performed	O
using	O
the	O
SAS	O
statistical	O
package	O
(	O
SAS	O
,	O
Cary	O
,	O
NC	O
,	O
USA	O
).	O

The	O
ethnic	O
homogeneity	O
of	O
our	O
study	O
population	O
reduces	O
the	O
risk	O
of	O
confounding	O
by	O
unmeasured	O
factors	O
,	O
both	O
genetic	O
and	O
environmental	O
.	O

Women	O
with	O
a	O
higher	O
level	O
of	O
nutritional	O
knowledge	O
used	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
more	O
frequently	O
(	O
Table	O
2	O
).	O

In	O
particular	O
,	O
the	O
degradation	O
of	O
essential	O
,	O
branch	O
-	O
chained	O
amino	O
acids	O
like	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
was	O
found	B
to	I
be	I
regulated	O
,	O
which	O
may	O
illustrate	O
the	O
LP	O
offspring	O
'	O
s	O
efforts	O
to	O
mimic	O
prenatal	O
experiences	O
in	O
terms	O
of	O
dietary	O
supply	O
during	O
postnatal	O
development	O
in	O
the	O
face	O
of	O
richer	O
conditions	O
.	O

A	O
study	O
of	O
Angus	O
-	O
crossbred	O
steers	O
showed	O
that	O
animals	O
not	O
supplemented	O
with	O
vitamin	O
A	O
had	O
higher	O
MS	O
and	O
QG	O
compared	O
to	O
vitamin	O
A	O
-	O
supplemented	O
animals	O
[	O
132	O
].	O

In	O
addition	O
to	O
the	O
uncertainty	O
concerning	O
the	O
optimal	O
vitamin	O
D	O
intakes	O
preventing	O
vitamin	O
D	O
deficiency	O
,	O
there	O
exists	O
also	O
a	O
lack	O
of	O
recommendations	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

This	O
committee	O
will	O
assist	O
in	O
translating	O
the	O
Shonjibon	O
study	O
findings	O
into	O
policy	O
.	O

UCP1	O
is	O
expressed	O
in	O
classical	O
brown	O
adipocytes	O
,	O
as	O
well	O
as	O
in	O
“	O
beige	O
cells	O
”	O
in	O
white	O
adipose	O
tissue	O
(	O
WAT	O
).	O

They	O
have	O
all	O
demonstrated	O
that	O
the	O
rapid	O
acting	O
analogues	O
are	O
as	O
effective	O
as	O
regular	O
insulin	O
in	O
the	O
treatment	O
of	O
GDM	O
,	O
with	O
comparable	O
,	O
if	O
not	O
favorable	O
,	O
outcomes	O
(	O
Table	O
3	O
).	O

However	O
,	O
the	O
potential	O
side	O
effects	O
of	O
any	O
drug	O
must	O
be	O
balanced	O
against	O
the	O
risks	O
of	O
the	O
mother	O
or	O
the	O
infant	O
having	O
inadequately	O
treated	O
disease	O
.	O

or	O
more	O
.	O

The	O
drop	O
-	O
outs	O
had	O
a	O
slightly	O
higher	O
BMI	O
,	O
lower	O
education	O
and	O
were	O
more	O
often	O
smokers	O
and	O
born	O
outside	O
of	O
the	O
Nordic	O
countries	O
.	O

Indeed	O
,	O
murine	O
spermatozoal	O
miRNAs	O
and	O
/	O
or	O
esiRNAs	O
have	O
been	O
shown	O
to	O
function	O
in	O
fertilization	O
and	O
early	O
embryo	O
development	O
(	O
Liu	O
et	O
al	O
.	O
2012	O
,	O
2016	O
;	O
Yuan	O
et	O
al	O
.	O
2016	O
),	O
and	O
to	O
influence	O
phenotypic	O
outcomes	O
in	O
subsequent	O
progeny	O
(	O
Rassoulzadegan	O
et	O
al	O
.	O
2006	O
;	O
Wagner	O
et	O
al	O
.	O
2008	O
;	O
Grandjean	O
et	O
al	O
.	O
2009	O
).	O

Considering	O
type	O
of	O
pet	O
,	O
the	O
relationship	O
for	O
no	O
pet	O
compared	O
to	O
1	O
or	O
>	O
1	O
dog	O
(	O
37	O
.	O
7	O
,	O
46	O
.	O
1	O
,	O
49	O
.	O
9	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
001	O
)	O
was	O
similar	O
to	O
that	O
for	O
no	O
pet	O
versus	O
1	O
or	O
>	O
1	O
cat	O
(	O
37	O
.	O
7	O
,	O
43	O
.	O
0	O
,	O
46	O
.	O
5	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
065	O
).	O

Some	O
of	O
the	O
respondents	O
(	O
25	O
.	O
6	O
%)	O
were	O
recommended	O
an	O
ANC	O
site	O
.	O

Indeed	O
,	O
the	O
higher	O
leptin	O
levels	O
in	O
plasma	O
without	O
reduction	O
in	O
food	O
intake	O
suggest	O
leptin	O
resistance	O
and	O
,	O
therefore	O
,	O
an	O
altered	O
leptin	O
signaling	O
(	O
Friedman	O
and	O
Halaas	O
,	O
1998	O
).	O

The	O
threshold	O
of	O
≥	O
10	O
was	O
used	O
based	O
on	O
the	O
EPDS	O
[	O
62	O
].	O

Since	O
iron	O
tablets	O
induce	O
a	O
high	O
concentration	O
of	O
free	O
radicals	O
in	O
the	O
intestinal	O
milieu	O
,	O
which	O
may	O
damage	O
the	O
intestinal	O
epithelium	O
,	O
the	O
minimal	O
essential	O
iron	O
dose	O
is	O
to	O
be	O
recommended	O
[	O
59	O
].	O

Maternal	O
blood	O
samples	O
were	O
obtained	O
at	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
(	O
at	O
baseline	O
)	O
and	O
once	O
more	O
,	O
at	O
childbirth	O
(	O
during	O
first	O
24	O
h	O
after	O
birth	O
in	O
postpartum	O
ward	O
).	O

Briefly	O
,	O
data	O
are	O
collected	O
early	O
pregnancy	O
,	O
mid	O
-	O
pregnancy	O
,	O
late	O
pregnancy	O
and	O
at	O
birth	O
.	O

We	O
will	O
check	O
the	O
model	O
assumptions	O
and	O
make	O
appropriate	O
adjustments	O
to	O
the	O
analysis	O
where	O
necessary	O
.	O

RESULTS	O
Food	O
Intake	O
,	O
Weight	O
Gain	O
and	O
Glucose	O
Response	O
There	O
was	O
no	O
difference	O
in	O
body	O
weight	O
at	O
birth	O
and	O
weaning	O
between	O
the	O
offspring	O
born	O
to	O
dams	O
on	O
the	O
HV	O
diet	O
compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
a	O
RV	O
diet	O
.	O

The	O
outcome	O
in	O
each	O
model	O
was	O
the	O
infant	O
gut	O
microbiome	O
cluster	O
membership	O
;	O
cluster	O
1	O
was	O
used	O
as	O
the	O
reference	O
in	O
all	O
models	O
.	O

These	O
studies	O
are	O
highly	O
therapeutically	O
relevant	O
,	O
as	O
BAT	O
activation	O
in	O
overweight	O
or	O
obese	O
subjects	O
will	O
activate	O
thermogenesis	O
and	O
dissipate	O
heat	O
,	O
while	O
at	O
the	O
same	O
time	O
improving	O
glucose	O
metabolism	O
and	O
insulin	O
resistance	O
.	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
measured	O
by	O
ELISA	O
and	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

Vitamin	O
D	O
therapy	O
may	O
be	O
of	O
benefit	O
in	O
wheezing	O
children	O
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

Statistical	O
methods	O
.	O

Neonatal	O
and	O
gestational	O
data	O
were	O
obtained	O
from	O
antenatal	O
and	O
obstetrics	O
medical	O
records	O
.	O

Most	O
pregnant	O
mothers	O
tolerated	O
the	O
2000	O
IU	O
well	O
without	O
any	O
adverse	O
effects	O
and	O
just	O
a	O
few	O
of	O
them	O
temporarily	O
complained	O
about	O
nausea	O
.	O

Recently	O
,	O
investigators	O
reported	O
that	O
mild	O
sleep	O
restriction	O
induces	O
marked	O
reduction	O
in	O
basal	O
glucagon	O
concentrations	O
[	O
19	O
].	O

In	O
particular	O
,	O
the	O
cellular	O
energy	O
sensor	O
AMPK	O
is	O
essential	O
for	O
a	O
proper	O
mitochondrial	O
activity	O
and	O
metabolic	O
health	O
citeTowler2007	O
.	O

However	O
,	O
it	O
is	O
unclear	O
at	O
this	O
time	O
whether	O
or	O
not	O
supplementation	O
of	O
vitamins	O
such	O
as	O
folate	O
can	O
reduce	O
congenital	O
anomalies	O
in	O
men	O
with	O
an	O
otherwise	O
well	O
-	O
balanced	O
diet	O
.	O

In	O
this	O
study	O
only	O
183	O
autistic	O
children	O
were	O
considered	O
and	O
medical	O
conditions	O
of	O
the	O
mother	O
based	O
on	O
a	O
maternal	O
self	O
-	O
report	O
[	O
18	O
].	O

the	O
same	O
epigenetic	O
change	O
(	O
s	O
)	O
reported	O
in	O
multiple	O
independent	O
studies	O
or	O
multiple	O
epigenetic	O
changes	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
,	O
therefore	O
,	O
are	O
included	O
in	O
Supplementary	O
Table	O
3	O
.	O

Results	O
:	O
The	O
infants	O
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

We	O
analysed	O
the	O
repeat	O
episodes	O
accounting	O
for	O
clustering	O
within	O
individuals	O
.	O

In	O
mothers	O
,	O
sensitisation	O
to	O
a	O
house	O
dust	O
mite	O
mixture	O
including	O
Dermatophagoides	O
farinae	O
,	O
as	O
well	O
as	O
German	O
cockroach	O
,	O
mould	O
mixture	O
,	O
cat	O
and	O
dog	O
dander	O
,	O
maize	O
pollen	O
,	O
Bermuda	O
grass	O
and	O
Quercus	O
robur	O
(	O
English	O
oak	O
),	O
Eucalyptus	O
,	O
Cypressus	O
arizonica	O
(	O
Arizona	O
cypress	O
),	O
Platanus	O
hybrida	O
(	O
London	O
plane	O
)	O
and	O
Acacia	O
trees	O
are	O
measured	O
.	O

Prokaryote	O
genomes	O
contain	O
only	O
10	O
%	O
ncDNA	O
,	O
more	O
complex	O
fungi	O
and	O
animals	O
>	O
50	O
%,	O
rising	O
to	O
>	O
98	O
%	O
in	O
complex	O
mammals	O
(	O
including	O
mice	O
and	O
humans	O
)	O
(	O
Carey2011	O
).	O

The	O
associations	O
were	O
J	O
-	O
shaped	O
with	O
the	O
strongest	O
reduced	O
risk	O
for	O
an	O
intermediate	O
intake	O
of	O
fish	O
or	O
PUFA	O
.	O

Mothers	O
are	O
asked	O
how	O
soon	O
after	O
birth	O
the	O
infant	O
was	O
breastfed	O
,	O
if	O
the	O
infant	O
is	O
currently	O
being	O
breastfed	O
and	O
if	O
not	O
,	O
the	O
duration	O
of	O
breastfeeding	O
.	O

Epigenetics	O
and	O
the	O
mammalian	O
life	O
cycle	O
.	O

The	O
median	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
was	O
21	O
.	O
2	O
ng	O
/	O
mL	O
.	O

Our	O
present	O
pilot	O
study	O
has	O
several	O
important	O
strengths	O
.	O

However	O
,	O
inconsistencies	O
between	O
studies	O
reflect	O
uncertainty	O
about	O
the	O
true	O
effect	O
of	O
vitamin	O
D	O
deficiency	O
on	O
pregnancy	O
outcome	O
[	O
5	O
,	O
6	O
].	O

These	O
offspring	O
also	O
had	O
higher	O
rates	O
of	O
physiological	O
changes	O
,	O
including	O
atypical	O
sperm	O
formation	O
.	O
38And	O
a	O
mouse	O
study	O
produced	O
evidence	O
that	O
uranium	O
in	O
drinking	O
water	O
caused	O
estrogenic	O
activity	O
even	B
at	O
levels	O
below	O
the	O
EPA	O
safe	O
drinking	O
water	O
level	O
of	O
30	O
µg	O
/	O
L	O
.	O
39	O
To	O
look	O
more	O
closely	O
at	O
the	O
effects	O
of	O
uranium	O
exposure	O
on	O
human	O
reproduction	O
and	O
development	O
,	O
Lewis	O
has	O
recently	O
begun	O
recruiting	O
up	O
to	O
1	O
,	O
500	O
pregnant	O
women	O
to	O
participate	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
.	O
40Besides	O
tracking	O
birth	O
outcomes	O
and	O
infant	O
development	O
,	O
pharmacologist	O
Laurie	O
Hudson	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
is	O
looking	O
at	O
molecular	O
changes	O
that	O
may	O
be	O
induced	O
by	O
exposure	O
to	O
uranium	O
waste	O
.	O

Alcohol	O
dehydrogenase	O
1	O
(	O
ADH	O
)	O
is	O
the	O
primary	O
enzyme	O
that	O
oxidizes	O
retinol	O
to	O
retinaldehyde	O
[	O
138	O
],	O
and	O
retinaldehyde	O
inhibits	O
adipocyte	O
differentiation	O
[	O
139	O
].	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

A	O
recent	O
study	O
illustrates	O
that	O
the	O
neuropathology	O
of	O
some	O
individuals	O
who	O
are	O
diagnosed	O
as	O
having	O
ASD	O
may	O
actually	O
also	O
have	O
focal	O
cortical	O
dysplasias	O
,	O
which	O
could	O
explain	O
the	O
high	O
incidence	O
of	O
sensory	O
irregularities	O
and	O
seizures	O
in	O
ASD	O
diagnosed	O
patients	O
[	O
59	O
].	O

RPMM	O
classes	O
were	O
labeled	O
using	O
a	O
series	O
of	O
numbers	O
,	O
ranging	O
from	O
1	O
to	O
16	O
(	O
with	O
class	O
1	O
having	O
the	O
lowest	O
methylation	O
level	O
and	O
class	O
16	O
having	O
the	O
highest	O
methylation	O
level	O
).	O

We	O
will	O
also	O
exclude	O
three	O
Upazilas	O
from	O
Gazipur	O
because	O
of	O
the	O
high	O
number	O
of	O
garment	O
industries	O
,	O
which	O
would	O
have	O
high	O
numbers	O
of	O
working	O
women	O
and	O
would	O
be	O
difficult	O
to	O
follow	O
-	O
up	O
and	O
eight	O
Upazilas	O
from	O
Mymensingh	O
because	O
of	O
the	O
high	O
prevalence	O
of	O
malaria	O
and	O
kalazar	O
.	O

This	O
multiplex	O
immune	O
-	O
assay	O
also	O
includes	O
the	O
acute	O
phase	O
proteins	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
and	O
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
),	O
as	O
well	O
as	O
the	O
malaria	O
marker	O
HRP2	O
and	O
thyroglobulin	O
,	O
which	O
is	O
a	O
marker	O
of	O
iodine	O
status	O
.	O

In	O
the	O
absence	O
of	O
survey	O
data	O
from	O
other	O
European	O
countries	O
,	O
we	O
suspect	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
Belgium	O
likely	O
reflects	O
the	O
situation	O
in	O
other	O
Western	O
European	O
countries	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Thus	O
,	O
spermatozoal	O
chromatin	O
may	O
also	O
transmit	O
unique	O
epigenetic	O
information	O
that	O
helps	O
to	O
activate	O
and	O
regulate	O
early	O
embryo	O
development	O
and	O
contribute	O
to	O
epigenetic	O
inheritance	O
across	O
multiple	O
generations	O
.	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

The	O
disorder	O
is	O
debilitating	O
for	O
the	O
patient	O
and	O
immensely	O
challenging	O
for	O
his	O
/	O
her	O
family	O
.	O

Primary	O
outcomes	O
were	O
uptake	O
of	O
the	O
new	O
dietetic	O
schedule	O
(	O
process	O
)	O
and	O
requirement	O
for	O
pharmacotherapy	O
(	O
clinical	O
).	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

Multivitamins	O
were	O
used	O
by	O
68	O
%	O
of	O
the	O
women	O
in	O
our	O
study	O
,	O
comparable	O
with	O
the	O
60	O
%	O
reported	O
by	O
the	O
IOMC	O
study	O
[	O
14	O
].	O

Only	O
the	O
HFol	O
pup	O
diet	O
lowered	O
SeroR2A	O
expression	O
compared	O
to	O
the	O
HV	O
offspring	O
weaned	O
to	O
a	O
RV	O
pup	O
diet	O
(	O
P	O
=	O
0	O
.	O
008	O
)	O
(	O
Figure	O
5b	O
).	O

2	O
.	O
2	O
.	O

Fish	O
consumption	O
is	O
generally	O
recommended	O
as	O
healthful	O
due	O
to	O
its	O
DHA	O
and	O
EPA	O
content	O
despite	B
the	O
exposure	O
to	O
heavy	O
metals	O
and	O
other	O
contaminants	O
that	O
may	O
be	O
detrimental	O
to	O
health	O
[	O
12	O
].	O

The	O
consumptions	O
of	O
pills	O
were	O
assessed	O
in	O
later	O
prenatal	O
care	O
visits	O
and	O
over	O
the	O
phone	O
.	O

This	O
DSMB	O
is	O
responsible	O
for	O
assessing	O
the	O
interim	O
data	O
,	O
data	O
quality	O
,	O
data	O
completeness	O
,	O
adequacy	O
of	O
compliance	O
with	O
goals	O
for	O
recruitment	O
and	O
retention	O
,	O
and	O
factors	O
that	O
might	O
affect	O
the	O
study	O
outcome	O
or	O
compromise	O
the	O
confidentiality	O
of	O
the	O
trial	O
data	O
.	O

The	O
median	O
age	O
at	O
diagnosis	O
is	O
low	O
,	O
below	O
40	O
years	O
in	O
most	O
populations	O
.	O

Pyrosequencing	O
of	O
these	O
repeat	O
elements	O
was	O
successful	O
in	O
380	O
samples	O
;	O
we	O
noted	O
no	O
significant	O
differences	O
in	O
the	O
demographics	O
or	O
clinical	O
characteristics	O
of	O
these	O
samples	O
compared	O
with	O
the	O
larger	O
population	O
.	O

This	O
may	O
have	O
arisen	O
as	O
a	O
consequence	O
of	O
the	O
IOMC	O
study	O
only	O
examining	O
folic	O
acid	O
use	O
during	O
the	O
last	O
trimester	O
of	O
pregnancy	O
[	O
14	O
].	O

Therefore	O
,	O
cell	O
division	O
is	O
synchronous	O
with	O
cell	O
growth	O
[	O
19	O
,	O
20	O
].	O

Intravenous	O
aminophylline	O
is	O
not	O
generally	O
recommended	O
in	O
the	O
emergency	O
management	O
of	O
acute	O
asthma	O
(	O
because	O
of	O
its	O
potentially	O
harmful	O
effects	O
)	O
but	O
may	O
be	O
used	O
in	O
pregnant	O
patients	O
hospitalized	O
for	O
acute	O
asthma	O
(	O
theophylline	O
levels	O
should	O
be	O
monitored	O
).	O

Oral	O
antihistamines	O
should	O
be	O
avoided	O
during	O
the	O
first	O
trimester	O
,	O
unless	O
definitely	O
clinically	O
indicated	O
,	O
and	O
then	O
should	O
be	O
used	O
at	O
the	O
lowest	O
effective	O
dose	O
,	O
starting	O
with	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
.	O

The	O
repeated	O
measures	O
analysis	O
showed	O
that	O
the	O
control	O
group	O
had	O
gone	O
through	O
significant	O
changes	O
with	O
regards	O
to	O
depression	O
scores	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Fig	O
.	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

However	O
,	O
a	O
weak	O
association	O
does	O
not	O
necessarily	O
imply	O
the	O
absence	O
of	O
causality	O
,	O
nor	O
is	O
a	O
strong	O
association	O
necessary	O
or	O
sufficient	O
for	O
causality	O
[	O
213	O
,	O
214	O
].	O

In	O
previous	O
work	O
and	O
a	O
scoping	O
study	O
,	O
we	O
found	O
that	O
most	O
of	O
the	O
research	O
carried	O
out	O
in	O
relation	O
to	O
impaired	O
spermatogenesis	O
had	O
investigated	O
time	O
trends	O
rather	O
than	O
association	O
with	O
specific	O
risk	O
factors	O
(	O
Martin	O
et	O
al	O
.	O

The	O
distribution	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
baseline	O
and	O
childbirth	O
was	O
not	O
normal	O
in	O
the	O
all	O
participants	O
.	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
similar	O
results	O
were	O
observed	O
.	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
upon	O
enrollment	O
,	O
and	O
depression	O
score	O
of	O
0	O
to	O
13	O
.	O

Significant	O
differences	O
were	O
noted	B
in	O
the	O
use	O
of	O
folic	O
acid	O
and	O
multivitamin	O
supplements	O
,	O
but	O
not	O
in	O
the	O
use	O
of	O
iron	O
supplements	O
,	O
depending	O
on	O
area	O
of	O
residence	O
(	O
rural	O
versus	O
urban	O
)	O
and	O
parity	O
.	O

Specifically	O
,	O
these	O
studies	O
provide	O
mechanistic	O
associations	O
between	O
bisphenol	O
A	O
(	O
BPA	O
),	O
formaldehyde	O
,	O
arsenic	O
,	O
nickel	O
,	O
or	O
cigarette	O
smoke	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
,	O
and	O
potential	O
mechanisms	O
of	O
epigenetic	O
toxicity	O
in	O
humans	O
.	O

In	O
contrast	O
,	O
“	O
brite	O
”	O
adipocytes	O
have	O
been	O
shown	O
to	O
originate	O
from	O
Myf	O
-	O
negative	O
(	O
Myf	O
5	O
−)	O
progenitor	O
cells	O
,	O
much	O
like	O
white	O
adipocytes	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
;	O
Long	O
et	O
al	O
.,	O
2014	O
).	O

1	O
.	O

Only	O
POU2F1	O
was	O
found	O
to	O
be	O
overrepresented	O
among	O
loci	O
associated	O
with	O
both	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
.	O

Although	B
not	O
significant	O
,	O
a	O
negative	O
trend	O
was	O
seen	O
between	O
the	O
number	O
of	O
infections	O
a	O
child	O
experienced	O
and	O
cathelicidin	O
concentration	O
.	O

The	O
use	O
of	O
self	O
-	O
reported	O
snoring	O
as	O
a	O
tool	O
to	O
detect	O
sleep	O
disordered	O
breathing	O
is	O
well	O
established	O
.	O

This	O
slurry	O
was	O
frequently	O
stored	O
in	O
large	O
,	O
unlined	O
ponds	O
,	O
says	O
Chris	O
Shuey	O
,	O
an	O
environmental	O
health	O
specialist	O
with	O
the	O
Southwest	O
Research	O
and	O
Information	O
Center	O
in	O
Albuquerque	O
,	O
who	O
has	O
spent	O
the	O
last	O
three	O
decades	O
working	O
with	O
Navajo	O
communities	O
affected	O
by	O
uranium	O
mining	O
and	O
milling	O
.	O

Similar	O
results	O
were	O
found	O
when	O
analysing	O
the	O
contributing	O
factors	O
for	O
the	O
use	O
of	O
multivitamins	O
:	O
more	O
than	O
12	O
years	O
of	O
schooling	O
(	O
aOR	O
,	O
3	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
4	O
-	O
7	O
.	O
9	O
)	O
and	O
appropriate	O
prenatal	O
care	O
(	O
aOR	O
,	O
9	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
4	O
.	O
5	O
-	O
19	O
.	O
5	O
).	O

Additional	O
studies	O
are	O
warranted	O
to	O
produce	O
beef	O
with	O
appropriate	O
levels	O
of	O
IMF	O
deposition	O
to	O
satisfy	O
beef	O
quality	O
and	O
taste	O
,	O
support	O
human	O
health	O
,	O
and	O
sustain	O
the	O
animal	O
industry	O
,	O
depending	O
on	O
the	O
situation	O
of	O
each	O
country	O
.	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

Therefore	O
,	O
understanding	O
the	O
differences	O
between	O
healthy	O
,	O
western	O
,	O
and	O
traditional	O
dietary	O
patterns	O
and	O
usual	O
Iranian	O
dietary	O
pattern	O
might	O
help	O
interpreting	O
the	O
importance	O
of	O
the	O
findings	O
we	O
reached	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
associations	O
of	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
with	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
versus	O
paternal	O
intake	O
after	O
pregnancyFree	O
sugar	O
intakep	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
n	O
=	O
3063	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
04	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
55	O
)	O
1	O
.	O
33	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
82	O
)	O
1	O
.	O
64	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
37	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
23	O
)	O
0	O
.	O
004	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
02	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
36	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
53	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
79	O
)	O
1	O
.	O
61	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
33	O
)	O
1	O
.	O
13	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
22	O
)	O
0	O
.	O
005	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
12	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
28	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
73	O
)	O
1	O
.	O
36	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
86	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
68	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
22	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
10	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
30	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
34	O
Atopic	O
asthma	O
n	O
=	O
2830	O
Maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
11	O
(	O
1	O
.	O
26	O
–	O
3	O
.	O
52	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
66	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
82	O
(	O
1	O
.	O
60	O
–	O
4	O
.	O
96	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
01	O
–	O
4	O
.	O
00	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
36	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
002	O
.	O
13	O
(	O
1	O
.	O
27	O
–	O
3	O
.	O
57	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
65	O
–	O
2	O
.	O
11	O
)	O
2	O
.	O
80	O
(	O
1	O
.	O
58	O
–	O
4	O
.	O
94	O
)	O
1	O
.	O
96	O
(	O
0	O
.	O
98	O
–	O
3	O
.	O
93	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
35	O
)	O
0	O
.	O
04	O
Paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
60	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
26	O
(	O
0	O
.	O
75	O
–	O
2	O
.	O
11	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
87	O
–	O
2	O
.	O
48	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
48	O
–	O
1	O
.	O
77	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
21	O
)	O
0	O
.	O
55	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
96	O
(	O
0	O
.	O
59	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
73	O
–	O
2	O
.	O
06	O
)	O
1	O
.	O
39	O
(	O
0	O
.	O
82	O
–	O
2	O
.	O
35	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
45	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
19	O
)	O
0	O
.	O
72	O
#:	O
controlling	O
only	O
for	O
previously	O
mentioned	O
potential	O
confounders	O
;¶:	O
mutually	O
adjusting	O
for	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
paternal	O
free	O
sugar	O
intake	O
after	O
pregnancy	O
,	O
in	O
addition	O
to	O
previously	O
mentioned	O
potential	O
confounders	O
When	O
we	O
analysed	O
the	O
association	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
the	O
number	O
of	O
positive	O
reactions	O
to	O
cat	O
,	O
grass	O
and	O
dust	O
mite	O
allergens	O
,	O
we	O
observed	O
a	O
stronger	O
association	O
for	O
children	O
with	O
two	O
or	O
more	O
positive	O
reactions	O
(	O
table	O
5	O
).	O

After	O
delivery	O
,	O
thyroxine	O
dose	O
can	O
be	O
gradually	O
reduced	O
to	O
pre	O
-	O
pregnancy	O
levels	O
,	O
while	O
TSH	O
levels	O
should	O
be	O
constantly	O
monitored1015	O
.	O

It	O
is	O
noteworthy	O
that	O
the	O
book	O
covers	O
several	O
aspects	O
of	O
food	O
policies	O
as	O
well	O
including	O
food	O
sustainability	O
,	O
food	O
labelling	O
,	O
food	O
industry	O
and	O
consumer	O
nutrition	O
.	O

2009	O
;	O
Lupski	O
2010	O
;	O
Weisenberger	O
et	O
al	O
.	O

For	O
instance	O
,	O
the	O
Mediterranean	O
diet	O
during	O
pregnancy	O
has	O
been	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
both	O
persistent	O
and	O
atopic	O
wheeze	O
and	O
atopy	O
in	O
children	O
at	O
6	O
.	O
5	O
years	O
old	O
[	O
1	O
,	O
2	O
].	O

Two	O
-	O
week	O
-	O
old	O
Korean	O
cattle	O
calves	O
were	O
fed	O
different	O
diets	O
,	O
i	O
.	O
e	O
.,	O
mother	O
’	O
s	O
milk	O
+	O
roughage	O
(	O
control	O
),	O
milk	O
replacement	O
+	O
concentrate	O
,	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
,	O
and	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
[	O
58	O
].	O

Portions	O
(	O
100	O
–	O
300	O
mg	O
)	O
of	O
liver	O
and	O
PAT	O
,	O
and	O
the	O
whole	O
hypothalamus	O
were	O
homogenized	O
in	O
ice	O
and	O
RNA	O
was	O
extracted	O
using	O
the	O
Trizol	O
®	O
method	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instruction	O
(	O
Gibco	O
BRL	O
).	O

Therefore	O
,	O
consumption	O
of	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
is	O
associated	O
with	O
higher	O
Vitamin	O
D2	O
detection	O
rate	O
among	O
pregnant	O
women	O
.	O

Having	O
done	O
so	O
,	O
however	O
,	O
some	O
of	O
our	O
participants	O
may	O
not	O
have	O
accurately	O
remembered	O
their	O
use	O
of	O
supplements	O
early	O
in	O
pregnancy	O
or	O
before	O
conception	O
.	O

Regarding	O
the	O
absence	O
of	O
hyperphagia	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
the	O
food	O
intake	O
has	O
been	O
associated	O
with	O
the	O
cannabinoid	O
activation	O
in	O
specific	O
hypothalamic	O
areas	O
(	O
Soria	O
-	O
Gomez	O
et	O
al	O
.,	O
2014	O
).	O

Maternal	O
short	O
stature	O
is	O
,	O
in	O
turn	O
,	O
a	O
risk	O
factor	O
for	O
birth	O
complications	O
[	O
24	O
]	O
–	O
illustrating	O
the	O
intergenerational	O
effect	O
of	O
poor	O
nutrition	O
.	O

Generally	O
,	O
the	O
relationship	O
between	O
visfatin	O
and	O
the	O
infants	O
’	O
s	O
growth	O
indicators	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Fetal	O
programming	O
of	O
nutritional	O
restriction	O
with	O
pasture	O
-	O
based	O
systems	O
retarded	O
offspring	O
growth	O
performance	O
(	O
body	O
weight	O
,	O
feed	O
intake	O
,	O
carcass	O
weight	O
)	O
and	O
production	O
parameters	O
including	O
muscle	O
weight	O
,	O
meat	O
yield	O
,	O
and	O
fat	O
and	O
bone	O
weight	O
at	O
any	O
given	O
age	O
.	O

Statistical	O
Analysis	O
Analysis	O
was	O
completed	O
using	O
the	O
cathelicidin	O
concentration	O
values	O
obtained	O
from	O
each	O
child	O
’	O
s	O
yearly	O
follow	O
-	O
up	O
visit	O
.	O

They	O
were	O
not	O
told	O
that	O
the	O
men	O
who	O
worked	O
in	O
the	O
mines	O
were	O
breathing	O
carcinogenic	O
radon	O
gas	O
and	O
showering	O
in	O
radioactive	O
water	O
,	O
nor	O
that	O
the	O
women	O
washing	O
their	O
husbands	O
’	O
work	O
clothes	O
could	O
spread	O
radionuclides	O
to	O
the	O
rest	O
of	O
the	O
family	O
’	O
s	O
laundry	O
.	O

Further	O
,	O
our	O
analysis	O
was	O
limited	O
to	O
prenatal	O
exposure	O
to	O
estrogenic	O
agents	O
.	O

GDM	O
cases	O
were	O
older	O
,	O
and	O
heavier	O
than	O
women	O
who	O
did	O
not	O
develop	O
the	O
disorder	O
.	O

Additionally	O
,	O
classes	O
7	O
,	O
11	O
,	O
and	O
12	O
were	O
marginally	O
positively	O
associated	O
with	O
AluYb8	O
methylation	O
levels	O
,	O
with	O
CpGs	O
exhibiting	O
low	O
to	O
intermediate	O
methylation	O
.	O

All	O
study	O
procedures	O
were	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
Swedish	O
Medical	O
Center	O
.	O

(	O
2014	O
)*	O
Di	O
-(	O
2	O
-	O
ethyl	O
-	O
hexyl	O
)-	O
phthalate	O
(	O
DEHP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
100	O
-	O
950	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1offspring	O
↓	O
serum	O
testosteroneDNA	O
methylationMartinez	O
-	O
Arguelles	O
et	O
al	O
.	O

Conversely	O
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

The	O
placenta	O
and	O
brain	O
,	O
in	O
particular	O
,	O
express	O
many	O
of	O
the	O
imprinted	O
genes	O
,	O
in	O
keeping	O
with	O
experimentally	O
identified	O
roles	O
for	O
imprinted	O
genes	O
in	O
prenatal	O
nutrient	O
acquisition	O
and	O
growth	O
regulation	O
,	O
neurodevelopment	O
,	O
and	O
postnatal	O
energy	O
homeostasis	O
and	O
behavior	O
.	O

Another	O
finding	O
of	O
this	O
study	O
was	O
that	O
vitamin	O
D3supplementation	O
was	O
effective	O
in	O
decreasing	O
depression	O
level	O
in	O
both	O
nulliparous	O
and	O
multiparous	O
subgroups	O
.	O

The	O
cohort	O
has	O
been	O
followed	O
since	O
birth	O
with	O
annual	O
questionnaires	O
and	O
,	O
since	O
age	O
7	O
years	O
,	O
with	O
objective	O
measures	O
in	O
annual	O
research	O
clinics	O
.	O

All	O
statistical	O
tests	O
were	O
two	O
-	O
sided	O
,	O
and	O
P	O
<	O
0	O
.	O
05	O
was	O
considered	O
as	O
statistically	O
significant	O
.	O

The	O
effect	O
of	O
maternal	O
diet	O
on	O
child	O
leukemia	O
risk	O
has	O
not	O
been	O
rigorously	O
studied	O
;	O
the	O
few	O
studies	O
that	O
have	O
been	O
done	O
have	O
focused	O
on	O
specific	O
dietary	O
factors	O
,	O
and	O
the	O
results	O
have	O
been	O
mixed	O
.	O

Our	O
findings	O
provide	O
further	O
support	O
for	O
the	O
hypothesis	O
that	O
an	O
aberration	O
in	O
lipid	O
metabolism	O
may	O
be	O
involved	O
in	O
the	O
biochemical	O
basis	O
for	O
psychiatric	O
disorders	O
[	O
13	O
].	O

The	O
inclusion	O
criteria	O
were	O
:	O
being	O
18	O
years	O
or	O
older	O
,	O
healthy	O
women	O
means	O
;	O
any	O
one	O
with	O
no	O
history	O
of	O
mental	O
illness	O
and	O
internal	O
diseases	O
such	O
as	O
hyper	O
/	O
hypothyroidism	O
,	O
parathyroid	O
,	O
renal	O
,	O
diabetes	O
and	O
heart	O
diseases	O
,	O
no	O
addiction	O
to	O
any	O
kind	O
of	O
narcotic	O
drugs	O
,	O
living	O
with	O
a	O
husband	O
,	O
a	O
singleton	O
live	O
fetus	O
,	O
without	O
any	O
pregnancy	O
complications	O
such	O
as	O
preeclampsia	O
,	O
gestational	O
diabetes	O
,	O
ruptured	O
membranes	O
and	O
suspicion	O
of	O
preterm	O
birth	O
,	O
no	O
previous	O
cesarean	O
sections	O
,	O
gestational	O
age	O
of	O
26	O
–	O
28	O
weeks	O
based	O
on	O
ultrasound	O
results	O
,	O
and	O
the	O
EPDS	O
baseline	O
scores	O
of	O
0	O
to	O
13	O
.	O

Of	O
this	O
source	O
population	O
,	O
96	O
000	O
women	O
were	O
randomly	O
selected	O
from	O
four	O
age	O
strata	O
(	O
30	O
-	O
34	O
,	O
35	O
-	O
39	O
,	O
40	O
-	O
44	O
and	O
45	O
-	O
49	O
years	O
)	O
and	O
were	O
invited	O
to	O
participate	O
in	O
the	O
Swedish	O
component	O
of	O
the	O
Scandinavian	O
Women	O
'	O
s	O
Lifestyle	O
and	O
Health	O
Cohort	O
[	O
19	O
,	O
20	O
].	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

We	O
used	O
qPCR	O
(	O
Kapa	O
Biosystems	O
)	O
to	O
quantify	O
the	O
amplicon	O
pool	O
,	O
and	O
one	O
Illumina	O
MiSeq	O
500	O
cycle	O
paired	O
-	O
end	O
run	O
to	O
sequence	O
each	O
pool	O
of	O
96	O
libraries	O
.	O

Compared	O
to	O
women	O
with	O
a	O
large	O
increase	O
in	O
25OHD	O
(≥	O
30	O
nmol	O
/	O
L	O
),	O
women	O
with	O
a	O
decrease	O
in	O
25OHD	O
had	O
significantly	O
higher	O
OR	O
of	O
having	O
a	O
child	O
born	O
SGA	O
(	O
OR	O
=	O
3	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
002	O
),	O
with	O
LBW	O
(	O
OR	O
=	O
4	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
014	O
)	O
as	O
well	O
as	O
a	O
trend	O
toward	O
higher	O
odds	O
of	O
preterm	O
delivery	O
(	O
OR	O
=	O
2	O
.	O
9	O
,	O
p	O
=	O
0	O
.	O
061	O
).	O

Only	B
,	O
4	O
women	O
(	O
2	O
.	O
2	O
%)	O
were	O
sufficient	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
≥	O
30	O
ng	O
/	O
mL	O
).	O

Some	O
of	O
the	O
results	O
presented	O
above	O
suggest	O
restricted	O
nutrition	O
at	O
certain	O
stages	O
of	O
pregnancy	O
has	O
more	O
favourable	O
outcomes	O
.	O

There	O
was	O
no	O
significant	O
difference	O
of	O
using	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
in	O
relation	O
to	O
the	O
number	O
of	O
prenatal	O
visits	O
,	O
for	O
women	O
with	O
higher	O
education	O
level	O
(	O
Table	O
3	O
).	O

Although	B
not	O
statistically	O
significant	O
,	O
a	O
slightly	O
negative	O
trend	O
of	O
increased	O
cathelicidin	O
correlated	O
with	O
a	O
decreased	O
frequency	O
of	O
diagnosed	O
infections	O
within	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
147	O
,	O
p	O
=	O
0	O
.	O
092	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Cathelicidin	O
Concentration	O
by	O
Age	O
.	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
14	O
.	O

Due	O
to	O
developmental	O
plasticity	O
,	O
environmental	O
factors	O
induce	O
altered	O
expression	O
of	O
the	O
genome	O
and	O
ultimately	O
modify	O
the	O
offspring	O
'	O
s	O
phenotype	O
[	O
7	O
].	O

[	O
12	O
]	O
conducted	O
the	O
largest	O
-	O
scale	O
examination	O
of	O
vitamin	O
D	O
status	O
in	O
Thai	O
population	O
and	O
reported	O
a	O
45	O
.	O
2	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
insufficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
30	O
ng	O
/	O
mL	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
a	O
5	O
.	O
7	O
%	O
prevalence	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
,	O
defined	O
as	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
).	O

The	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
,	O
Vitamin	O
D	O
supplement	O
intake	O
and	O
control	O
group	O
.	O

All	O
children	O
clinically	O
diagnosed	O
with	O
pneumonia	O
were	O
offered	O
free	O
chest	O
radiographs	O
taken	O
by	O
radiographers	O
trained	O
by	O
a	O
WHO	O
trainer	O
.	O

The	O
present	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
with	O
the	O
ethics	O
code	O
93	O
–	O
7212	O
.	O

All	O
analyses	O
were	O
analogously	O
performed	O
in	O
the	O
Cesarean	O
section	O
group	O
to	O
assess	O
if	O
an	O
effect	O
of	O
maternal	O
diet	O
on	O
the	O
infant	O
gut	O
microbiome	O
exists	O
in	O
the	O
case	O
of	O
surgical	O
delivery	O
.	O

injection	O
of	O
1	O
.	O
25	O
mg	O
propionyl	O
-	O
promazine	O
(	O
0	O
.	O
2	O
ml	O
Combelen	O
,	O
Bayer	O
AG	O
,	O
Leverkusen	O
,	O
Germany	O
)	O
and	O
50	O
mg	O
ketamine	O
(	O
Ursotamin	O
,	O
Serumwerk	O
Bernburg	O
AG	O
,	O
Germany	O
).	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

No	O
effects	O
of	O
diet	O
and	O
sex	O
were	O
detected	O
,	O
but	O
interaction	O
between	O
time	O
and	O
diet	O
was	O
significant	O
[	O
F	O
(	O
22	O
,	O
145	O
)=	O
11	O
.	O
27	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

The	O
women	O
were	O
selected	O
according	O
to	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
stratified	O
sampling	O
design	O
as	O
recommended	O
for	O
studies	O
assessing	O
iodine	O
deficiency	O
[	O
31	O
].	O

2	O
).	O

Based	O
on	O
the	O
PAR	O
hypothesis	O
,	O
the	O
high	O
multivitamin	O
gestational	O
diet	O
would	O
lead	O
to	O
developmental	O
adaptation	O
in	O
the	O
offspring	O
consistent	O
with	O
a	O
high	O
vitamin	O
post	O
-	O
weaning	O
environment	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

Higher	O
IMF	O
deposition	O
with	O
higher	O
concentrate	O
feeding	O
may	O
occur	O
if	O
IMF	O
preferentially	O
uses	O
glucose	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
,	O
while	O
subcutaneous	O
fat	O
uses	O
acetate	O
,	O
as	O
described	O
by	O
Smith	O
and	O
Crouse	O
[	O
88	O
].	O

Foetal	O
crown	O
-	O
rump	O
length	O
is	O
used	O
to	O
determine	O
gestational	O
age	O
of	O
participants	O
in	O
their	O
first	O
trimester	O
[	O
55	O
].	O

